Roxana Mehran
#20,906
Most Influential Person Now
Iranian cardiologist
Roxana Mehran's AcademicInfluence.com Rankings
Roxana Mehranmedical Degrees
Medical
#195
World Rank
#291
Historical Rank
Cardiology
#22
World Rank
#22
Historical Rank
Roxana Mehranphilosophy Degrees
Philosophy
#2300
World Rank
#3960
Historical Rank
Logic
#752
World Rank
#1277
Historical Rank
Download Badge
Medical Philosophy
Roxana Mehran's Degrees
- Doctorate Medicine Tehran University of Medical Sciences
- PhD Cardiology Tehran University of Medical Sciences
Why Is Roxana Mehran Influential?
(Suggest an Edit or Addition)According to Wikipedia, Roxana Mehran is an Iranian-American cardiologist and Mount Sinai Endowed Professor of Medicine at the Icahn School of Medicine at Mount Sinai. She is known for her work in interventional cardiology.
Roxana Mehran's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions (2007) (5088)
- Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium (2011) (3111)
- From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. (2003) (2963)
- A prospective natural-history study of coronary atherosclerosis. (2011) (2643)
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. (2011) (2418)
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. (2011) (2262)
- A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. (2004) (2200)
- Bivalirudin during primary PCI in acute myocardial infarction. (2008) (1816)
- Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) (1784)
- Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) (1700)
- Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. (2007) (1694)
- Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease (2017) (1358)
- 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2016) (1234)
- From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. (2003) (1200)
- Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) (1192)
- Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI. (2016) (1176)
- Bivalirudin for patients with acute coronary syndromes. (2006) (1122)
- Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium† (2010) (975)
- 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infa (2016) (866)
- Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. (2007) (849)
- Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease. (2016) (847)
- Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. (2011) (842)
- Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease. (2016) (769)
- Contrast-induced nephropathy: definition, epidemiology, and patients at risk. (2006) (751)
- Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. (2005) (741)
- Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study (2013) (734)
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. (2011) (720)
- Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation (2019) (698)
- 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention (2013) (682)
- In-stent restenosis in the drug-eluting stent era. (2010) (668)
- Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). (2012) (642)
- A risk score to predict bleeding in patients with acute coronary syndromes. (2010) (640)
- Safety and Efficacy of Drug-Eluting and Bare Metal Stents: Comprehensive Meta-Analysis of Randomized Trials and Observational Studies (2009) (582)
- 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). (2015) (560)
- Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. (2005) (558)
- Ticagrelor with or without Aspirin in High-Risk Patients after PCI. (2019) (539)
- Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study (2013) (532)
- Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. (2005) (514)
- Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. (2004) (477)
- Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial (2011) (458)
- Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. (2009) (455)
- Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. (2005) (440)
- Exome-wide association study of plasma lipids in >300,000 individuals (2017) (428)
- Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI). (2013) (422)
- Impact of Renal Insufficiency in Patients Undergoing Primary Angioplasty for Acute Myocardial Infarction (2003) (417)
- Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. (2002) (416)
- Percutaneous Recanalization of Chronically Occluded Coronary Arteries: A Consensus Document Part II (2005) (411)
- Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. (2007) (410)
- Comparison of Propensity Score Methods and Covariate Adjustment: Evaluation in 4 Cardiovascular Studies. (2016) (410)
- Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial (2009) (408)
- Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS. (2016) (406)
- Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial. (2012) (402)
- Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes. (1996) (400)
- Complete Revascularization with Multivessel PCI for Myocardial Infarction. (2019) (399)
- 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2016) (396)
- Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease. (2019) (393)
- Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial (2007) (392)
- Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) (388)
- Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (2011) (356)
- Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study. (2015) (349)
- Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions: A Consensus Document From the Mitral Valve Academic Research Consortium. (2015) (345)
- Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement. (2017) (345)
- Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial. (2009) (344)
- Distal Microcirculatory Protection During Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction: A Randomized Controlled Trial (2005) (341)
- Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting (2017) (338)
- 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2021) (336)
- Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019 (2020) (335)
- Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRI (2014) (323)
- Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. (2005) (322)
- Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention. (2015) (315)
- Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score. (2012) (313)
- Intracoronary β-Radiation Therapy Inhibits Recurrence of In-Stent Restenosis (2000) (310)
- Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials. (2015) (306)
- Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial. (2007) (304)
- Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention. (2019) (302)
- Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention (2019) (293)
- Intravascular ultrasound predictors of angiographic restenosis in lesions treated with Palmaz-Schatz stents. (1998) (289)
- Long-term outcome of percutaneous coronary intervention for chronic total occlusions. (2011) (286)
- 2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. (2017) (286)
- 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. (2018) (285)
- Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents: The Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents (ADAPT-DES) Study (2014) (284)
- Contribution of Stent Underexpansion to Recurrence After Sirolimus-Eluting Stent Implantation for In-Stent Restenosis (2004) (282)
- Contrast-induced nephropathy and long-term adverse events: cause and effect? (2009) (281)
- Prosthetic Heart Valve Thrombosis. (2016) (278)
- Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials. (2011) (278)
- An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. (2020) (278)
- 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary (2021) (275)
- A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement. (2019) (272)
- Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial. (2005) (268)
- Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document (2018) (268)
- Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial. (2007) (267)
- Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk (2019) (266)
- Pre-eclampsia and future cardiovascular risk among women: a review. (2014) (266)
- International Expert Consensus on Switching Platelet P2Y12 Receptor–Inhibiting Therapies (2017) (264)
- Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach. (2007) (260)
- Characterization of Myocardial Injury in Patients With COVID-19 (2020) (260)
- Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. (2011) (260)
- Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies. (2010) (257)
- Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention. (2011) (254)
- Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial. (2011) (254)
- Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. (2004) (254)
- 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials (2018) (248)
- Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale. (2004) (246)
- Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). (2015) (243)
- Intravascular Ultrasound Assessment of Ulcerated Ruptured Plaques: A Comparison of Culprit and Nonculprit Lesions of Patients With Acute Coronary Syndromes and Lesions in Patients Without Acute Coronary Syndromes (2003) (242)
- Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. (1999) (240)
- Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis. (2000) (239)
- Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. (2021) (236)
- 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). (2015) (235)
- Acute renal failure requiring dialysis after percutaneous coronary interventions (2001) (235)
- Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. (2001) (233)
- Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association. (2005) (232)
- Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document (2018) (228)
- Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents: The ADAPT-DES Study (2013) (224)
- A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial. (2014) (221)
- The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030 (2021) (218)
- Differential Impact on Survival of Electrocardiographic Q-Wave Versus Enzymatic Myocardial Infarction After Percutaneous Intervention: A Device-Specific Analysis of 7147 Patients (2001) (211)
- Bifurcation coronary lesions treated with the "crush" technique: an intravascular ultrasound analysis. (2005) (211)
- Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy. (2014) (209)
- Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial. (2012) (207)
- Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy). (2013) (199)
- Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. (2004) (198)
- Early Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Drug-Eluting and Bare Metal Stents: The Acute Catheterization and Urgent Intervention Triage Strategy Trial (2009) (197)
- Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction. (2005) (197)
- One-year follow-up after intravascular ultrasound assessment of moderate left main coronary artery disease in patients with ambiguous angiograms. (1999) (195)
- Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. (2009) (193)
- Frequency and Predictors of Stent Thrombosis After Percutaneous Coronary Intervention in Acute Myocardial Infarction (2011) (190)
- Gender Differences in Outcomes After Primary Angioplasty Versus Primary Stenting With and Without Abciximab for Acute Myocardial Infarction: Results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial (2005) (190)
- Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. (2004) (189)
- Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research. (2021) (189)
- Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction. (2004) (187)
- Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. (2005) (186)
- Intravascular Ultrasound Findings of Early Stent Thrombosis After Primary Percutaneous Intervention in Acute Myocardial Infarction: A Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Substudy (2011) (185)
- Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. (2002) (182)
- Intravascular Ultrasound Classification of Plaque Distribution in Left Main Coronary Artery Bifurcations: Where Is the Plaque Really Located? (2010) (180)
- Echocardiography-guided interventions. (2009) (179)
- Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. (2009) (176)
- Differential Impact on Survival of Electrocardiographic Q-Wave Versus Enzymatic Myocardial Infarction After Percutaneous Intervention (2001) (175)
- Strut Coverage and Late Malapposition With Paclitaxel-Eluting Stents Compared With Bare Metal Stents in Acute Myocardial Infarction: Optical Coherence Tomography Substudy of the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial (2011) (175)
- Incidence, Mechanisms, Predictors, and Clinical Impact of Acute and Late Stent Malapposition After Primary Intervention in Patients With Acute Myocardial Infarction: An Intravascular Ultrasound Substudy of the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HOR (2010) (167)
- The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale. (2008) (166)
- Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials. (2008) (166)
- Postprocedural hypotension after carotid artery stent placement: predictors and short- and long-term clinical outcomes. (2000) (163)
- 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents. (2009) (162)
- An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI). (2015) (162)
- Benefits and Risks of Abciximab Use in Primary Angioplasty for Acute Myocardial Infarction: The Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial (2003) (161)
- Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials. (2019) (161)
- Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. (2009) (159)
- Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial). (2007) (159)
- Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events. (2013) (158)
- Contrast-Associated Acute Kidney Injury. (2019) (157)
- Treatment of in-stent restenosis with excimer laser coronary angioplasty versus rotational atherectomy: comparative mechanisms and results. (2000) (157)
- Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention (2018) (156)
- Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis. (2009) (155)
- Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk. (2020) (154)
- In-stent restenosis: the Washington Hospital Center experience. (1998) (153)
- Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction--the smoker's paradox revisited. (2005) (153)
- Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome. (2010) (150)
- 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: Executive Summary (2012) (149)
- SYNTAX Score Reproducibility and Variability Between Interventional Cardiologists, Core Laboratory Technicians, and Quantitative Coronary Measurements (2011) (148)
- Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial. (2006) (148)
- Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement. (2019) (146)
- Stable coronary artery disease: revascularisation and invasive strategies (2015) (146)
- Sex-Based Differences in Outcomes With Transcatheter Aortic Valve Therapy: TVT Registry From 2011 to 2014. (2016) (143)
- Impact of coronary culprit lesion calcium in patients undergoing paclitaxel-eluting stent implantation (a TAXUS-IV sub study). (2005) (143)
- Predictors of infarct size after primary coronary angioplasty in acute myocardial infarction from pooled analysis from four contemporary trials. (2007) (143)
- Expert consensus statement on the use of fractional flow reserve, intravascular ultrasound, and optical coherence tomography (2014) (142)
- Stent thrombosis: a clinical perspective. (2014) (142)
- Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease. (2005) (142)
- Prognosis of Patients With Non–ST-Segment–Elevation Myocardial Infarction and Nonobstructive Coronary Artery Disease: Propensity-Matched Analysis From the Acute Catheterization and Urgent Intervention Triage Strategy Trial (2014) (140)
- Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. (2012) (139)
- Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure (2002) (138)
- Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation. (1998) (138)
- Short- and long-term results after multivessel stenting in diabetic patients. (2004) (137)
- Impact of the Presence and Extent of Incomplete Angiographic Revascularization After Percutaneous Coronary Intervention in Acute Coronary Syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) Trial (2012) (137)
- Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. (2011) (137)
- Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myocardial infarction: analysis from the CADILLAC trial. (2006) (136)
- Outcome in Elderly Patients Undergoing Primary Coronary Intervention for Acute Myocardial Infarction: Results From the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial (2004) (135)
- Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials (2013) (134)
- Intracoronary beta-radiation therapy inhibits recurrence of in-stent restenosis. (2000) (134)
- Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer. (2016) (132)
- Choice of arterial access site and outcomes in patients with acute coronary syndromes managed with an early invasive strategy: the ACUITY trial. (2009) (131)
- Vasa vasorum imaging: A new window to the clinical detection of vulnerable atherosclerotic plaques (2005) (131)
- Prognostic Modeling of Individual Patient Risk and Mortality Impact of Ischemic and Hemorrhagic Complications: Assessment From the Acute Catheterization and Urgent Intervention Triage Strategy Trial (2010) (131)
- Percutaneous recanalization of chronically occluded coronary arteries: Procedural techniques, devices, and results (2005) (129)
- Impact of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention on Short- and Long-Term Outcomes: Pooled Analysis From the HORIZONS-AMI and ACUITY Trials (2015) (128)
- Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association (2020) (128)
- Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction. (2005) (127)
- Quantitative angiographic methods for appropriate end-point analysis, edge-effect evaluation, and prediction of recurrent restenosis after coronary brachytherapy with gamma irradiation. (2002) (126)
- Nonuniform Strut Distribution Correlates With More Neointimal Hyperplasia After Sirolimus-Eluting Stent Implantation (2004) (126)
- Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. (2011) (124)
- A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study. (2008) (123)
- Meta-analysis on the impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcome. (2015) (122)
- 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee. (2020) (120)
- Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents. (2017) (119)
- The truth and consequences of the COURAGE trial. (2007) (119)
- Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial). (2007) (119)
- A volumetric intravascular ultrasound comparison of early drug-eluting stent thrombosis versus restenosis. (2009) (119)
- Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials. (2008) (115)
- Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis. (2009) (113)
- Treatment of coronary artery perforations complicating percutaneous coronary intervention with a polytetrafluoroethylene-covered stent graft. (2006) (113)
- Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 Trial. (2015) (112)
- Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: An expert consensus document from the society for cardiovascular angiography and interventions (SCAI) (2014) (112)
- Impact of Femoral Vascular Closure Devices and Antithrombotic Therapy on Access Site Bleeding in Acute Coronary Syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) Trial (2010) (111)
- Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review. (2019) (111)
- Gender-specific outcomes after sirolimus-eluting stent implantation. (2007) (111)
- Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarction. (2006) (110)
- Randomized trial of Rotational Atherectomy Versus Balloon Angioplasty for Diffuse In-stent Restenosis (ROSTER). (2004) (110)
- Sex‐based differences in bleeding and long term adverse events after percutaneous coronary intervention for acute myocardial infarction: Three year results from the HORIZONS‐AMI trial (2015) (109)
- A Simple Disease-Guided Approach to Personalize ACC/AHA-Recommended Statin Allocation in Elderly People: The BioImage Study. (2016) (109)
- 9-month clinical, angiographic, and intravascular ultrasound results of a prospective evaluation of the Axxess self-expanding biolimus A9-eluting stent in coronary bifurcation lesions: the DIVERGE (Drug-Eluting Stent Intervention for Treating Side Branches Effectively) study. (2009) (109)
- Intravascular ultrasound assessment of lesions with target vessel failure after sirolimus-eluting stent implantation. (2005) (107)
- When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trials. (2010) (107)
- Randomized Comparison of GR-II Stent and Palmaz-Schatz Stent for Elective Treatment of Coronary Stenoses (2000) (107)
- The urgent need for integrated science to fight COVID-19 pandemic and beyond (2020) (106)
- Correlation of angiographic morphology and clinical presentation in unstable angina. (1997) (106)
- Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents. (2011) (105)
- Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease. (2014) (105)
- Stent-Related Adverse Events >1 Year After Percutaneous Coronary Intervention. (2020) (105)
- Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: A consensus document from the Mitral Valve Academic Research Consortium. (2015) (104)
- Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients. (2020) (104)
- The REMEDEE trial: a randomized comparison of a combination sirolimus-eluting endothelial progenitor cell capture stent with a paclitaxel-eluting stent. (2013) (103)
- Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study. (2016) (103)
- The relationship between attenuated plaque identified by intravascular ultrasound and no-reflow after stenting in acute myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. (2011) (103)
- Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes. (2012) (103)
- Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial. (2011) (102)
- Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD Trial). (2007) (102)
- The contribution of "mechanical" problems to in-stent restenosis: An intravascular ultrasonographic analysis of 1090 consecutive in-stent restenosis lesions. (2001) (101)
- Carotid plaque thickness and carotid plaque burden predict future cardiovascular events in asymptomatic adult Americans (2018) (101)
- Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction. (2014) (100)
- Incidence and angiographic characteristics of patients With apical ballooning syndrome (takotsubo/stress cardiomyopathy) in the HORIZONS‐AMI trial (2014) (100)
- Duration of Dual Antiplatelet Therapy After Coronary Stenting: A Review of the Evidence. (2015) (99)
- Selection criteria for drug-eluting versus bare-metal stents and the impact of routine angiographic follow-up: 2-year insights from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. (2010) (98)
- Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy (2017) (98)
- Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes. (2012) (97)
- Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study (2017) (96)
- P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials (2021) (96)
- Classification and potential mechanisms of intravascular ultrasound patterns of stent fracture. (2009) (96)
- Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials. (2019) (94)
- Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial). (2005) (94)
- A risk score for prediction of contrast induced nephropathy after percutaneous coronary intervention (2003) (93)
- Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV Trial. (2005) (93)
- Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction. (2004) (93)
- First human experience with the 17-beta-estradiol-eluting stent: the Estrogen And Stents To Eliminate Restenosis (EASTER) trial. (2004) (93)
- 2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Solution S (2020) (90)
- Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transfemoral transcatheter aortic valve implantation: from the CENTER-collaboration (2019) (90)
- Importance of mitral regurgitation inpatients undergoing percutaneous coronary intervention for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. (2004) (89)
- Risk scores in acute coronary syndrome and percutaneous coronary intervention: a review. (2013) (89)
- Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials. (2006) (89)
- ST-segment elevation myocardial infarction (2019) (88)
- New approaches to preventing restenosis (2003) (87)
- Edge stenosis and geographical miss following intracoronary gamma radiation therapy for in-stent restenosis. (2001) (87)
- 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials (2015) (87)
- Cerebral Embolic Protection During TAVR: A Clinical Event Meta-Analysis. (2017) (87)
- Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial (2016) (86)
- Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial). (2009) (85)
- Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes. (2008) (85)
- Nonrandomized comparison of coronary stenting under intravascular ultrasound guidance of direct stenting without predilation versus conventional predilation with a semi-compliant balloon versus predilation with a new scoring balloon. (2007) (85)
- Impact of delay to angioplasty in patients with acute coronary syndromes undergoing invasive management: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. (2010) (85)
- Early lumen loss after treatment of in-stent restenosis: an intravascular ultrasound study. (1998) (85)
- Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results. (2001) (83)
- A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique". (2006) (83)
- Six-month clinical and angiographic results of a dedicated drug-eluting stent for the treatment of coronary bifurcation narrowings. (2007) (83)
- Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial. (2004) (83)
- Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. (2008) (83)
- Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasound. (2006) (83)
- Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. (2008) (83)
- Mortality, Length of Stay, and Cost Implications of Procedural Bleeding After Percutaneous Interventions Using Large-Bore Catheters (2017) (82)
- Assessing intermediate left main coronary lesions using intravascular ultrasound. (2007) (82)
- Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction (2016) (82)
- Impact and determinants of left ventricular function in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction. (2005) (82)
- The prognostic importance of left ventricular function in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial (2014) (81)
- Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. (2009) (81)
- Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial. (2009) (80)
- Procedural results and late clinical outcomes following multivessel coronary stenting. (1998) (80)
- Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial). (2014) (80)
- Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial). (2010) (79)
- Impact of coronary lesion complexity on drug-eluting stent outcomes in patients with and without diabetes mellitus: analysis from 18 pooled randomized trials. (2014) (79)
- Surgical versus percutaneous revascularization for multivessel disease in patients with acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. (2010) (79)
- Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR. (2021) (79)
- Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials). (2006) (78)
- Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial). (2006) (78)
- Impact of major bleeding and blood transfusions after cardiac surgery: analysis from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial. (2012) (78)
- Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry. (2016) (78)
- Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous (2013) (78)
- Update on In-stent Restenosis. (2001) (77)
- Intravascular ultrasound assessment of the incidence and predictors of edge dissections after drug-eluting stent implantation. (2009) (77)
- Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI trial. (2011) (77)
- A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial. (2013) (76)
- Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study. (2009) (75)
- Comparison of angiographic and intravascular ultrasonic detection of myocardial bridging of the left anterior descending coronary artery. (2008) (74)
- Estrogen‐eluting, phosphorylcholine‐coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model (2002) (74)
- Intravascular ultrasound study of patterns of calcium in ruptured coronary plaques. (2005) (74)
- Clinical and Angiographic Predictors of Short- and Long-Term Ischemic Events in Acute Coronary Syndromes: Results From the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) Trial (2010) (74)
- Prevalence and prediction of previously unrecognized peripheral arterial disease in patients with coronary artery disease: The peripheral arterial disease in Interventional Patients Study (2009) (74)
- Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions (2018) (74)
- Contrast‐induced nephropathy (2008) (73)
- Impact of hyperglycemia in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: the HORIZONS-AMI trial. (2013) (73)
- Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: a patient-level propensity-matched analysis (2019) (73)
- ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for Multimodality Imaging in Valvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society (2017) (72)
- Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) substudy. (2009) (71)
- Procedural results and late clinical outcomes after placement of three or more stents in single coronary lesions. (1998) (71)
- Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study. (2002) (71)
- Radiocontrast nephropathy: identifying the high-risk patient and the implications of exacerbating renal function. (2003) (70)
- Long-term prognosis of patients presenting with ST-segment elevation myocardial infarction with no significant coronary artery disease (from the HORIZONS-AMI trial). (2013) (70)
- Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: analysis from the TAXUS-IV trial. (2005) (70)
- Incidence, Predictors, and Implications of Reinfarction After Primary Percutaneous Coronary Intervention in ST-Segment–Elevation Myocardial Infarction: The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial (2014) (69)
- Safety and efficacy of bivalirudin monotherapy in patients with diabetes mellitus and acute coronary syndromes: a report from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. (2008) (69)
- Stroke After Transcatheter Aortic Valve Replacement: Incidence, Risk Factors, Prognosis, and Preventive Strategies (2014) (69)
- Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for acute myocardial infarction. (2006) (69)
- Magnitude and impact of treatment delays on weeknights and weekends in patients undergoing primary angioplasty for acute myocardial infarction (the cadillac trial). (2004) (68)
- Reduction in cardiac mortality with bivalirudin in patients with and without major bleeding: The HORIZONS-AMI trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction). (2014) (68)
- Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary percutaneous coronary intervention: pooled patient-level analysis from the HORIZONS-AMI and EUROMAX trials. (2015) (68)
- Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention (2020) (68)
- Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. (2008) (68)
- Two-year outcomes after percutaneous coronary intervention of calcified lesions with drug-eluting stents. (2017) (67)
- Impact of Leukocyte Count on Mortality and Bleeding in Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary Interventions: Analysis From the Harmonizing Outcome With Revascularization and Stent in Acute Myocardial Infarction Trial (2011) (67)
- Embedding a randomized clinical trial into an ongoing registry infrastructure: unique opportunities for efficiency in design of the Study of Access site For Enhancement of Percutaneous Coronary Intervention for Women (SAFE-PCI for Women). (2013) (67)
- 1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry. (2018) (66)
- Ticagrelor With or Without Aspirin After Complex PCI (2020) (66)
- Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions. (2004) (66)
- ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for Multimodality Imaging in Valvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society (2018) (66)
- Procedural Strategies to Reduce the Incidence of Contrast-Induced Acute Kidney Injury During Percutaneous Coronary Intervention. (2019) (66)
- A Critical Appraisal of Aspirin in Secondary Prevention: Is Less More? (2016) (65)
- Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction. (2005) (65)
- Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary PCI: An updated meta-analysis of 10,350 patients from five randomized clinical trials (2016) (65)
- Stent Thrombosis in Patients with Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial. (2019) (65)
- Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis. (2008) (65)
- Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS. (2020) (65)
- Prognostic significance of postprocedural sustained ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention (from the HORIZONS-AMI Trial). (2012) (64)
- Meta-analysis of trials on mortality after percutaneous coronary intervention compared with medical therapy in patients with stable coronary heart disease and objective evidence of myocardial ischemia. (2015) (64)
- ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for Thor (2012) (64)
- Prevalence and Impact of High Platelet Reactivity in Chronic Kidney Disease: Results From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Registry (2015) (64)
- Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial. (2019) (64)
- Prevalence, correlates, and impact of coronary calcification on adverse events following PCI with newer‐generation DES: Findings from a large multiethnic registry (2018) (63)
- 5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trial. (2011) (63)
- Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial. (2011) (62)
- Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update. (2021) (61)
- A novel technique for ultra‐low contrast administration during angiography or intervention (2010) (61)
- Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention. (2008) (61)
- Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations. (2021) (61)
- Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I) how this access benefits you. Your story matters (2016) (61)
- Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysis. (2020) (61)
- Neurological Outcomes With Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. (2016) (60)
- Female gender and mortality after percutaneous coronary intervention: Results from a large registry (2012) (60)
- Polymer-Free Biolimus A9-Coated Stents in the Treatment of De Novo Coronary Lesions: 4- and 12-Month Angiographic Follow-Up and Final 5-Year Clinical Outcomes of the Prospective, Multicenter BioFreedom FIM Clinical Trial. (2016) (60)
- Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis model. (2002) (60)
- Sex‐related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS study (2017) (60)
- Utility of peak creatine kinase-MB measurements in predicting myocardial infarct size, left ventricular dysfunction, and outcome after first anterior wall acute myocardial infarction (from the INFUSE-AMI trial). (2015) (59)
- Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial). (2005) (59)
- Thrombo-embolic prevention after transcatheter aortic valve implantation (2017) (58)
- Negative Risk Markers for Cardiovascular Events in the Elderly. (2019) (58)
- Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease (2020) (58)
- Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Procedures: Evidence From a Hierarchical Bayesian Network Meta-Analysis of 124 Trials and 28 240 Patients (2017) (58)
- Intralesional Abciximab and Thrombus Aspiration in Patients With Large Anterior Myocardial Infarction: One-Year Results From the INFUSE-AMI Trial (2013) (58)
- Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction. (2021) (57)
- ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization (2012) (57)
- Necrotic core and its ratio to dense calcium are predictors of high-risk non-ST-elevation acute coronary syndrome. (2008) (57)
- Impact of delay to reperfusion on reperfusion success, infarct size, and clinical outcomes in patients with ST-segment elevation myocardial infarction: the INFUSE-AMI Trial (INFUSE-Anterior Myocardial Infarction). (2014) (56)
- Comparative efficacy of coronary artery bypass surgery vs. percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease with or without chronic kidney disease. (2016) (56)
- Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary angioplasty in acute myocardial infarction (the CADILLAC trial). (2005) (56)
- ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic (2019) (56)
- Coronary Pressure–Derived Fractional Flow Reserve Measurements: Recommendations for Standardization, Recording, and Reporting as a Core Laboratory Technique. Proposals for Integration in Clinical Trials (2012) (56)
- Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical Trials: A Systematic Review. (2020) (56)
- Complete vs Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-analysis. (2020) (55)
- Relationship between infarct artery location, epicardial flow, and myocardial perfusion after primary percutaneous revascularization in acute myocardial infarction. (2006) (55)
- Two-year follow-up after beta and gamma intracoronary radiation therapy for patients with diffuse in-stent restenosis. (2001) (55)
- Radiocontrast-Induced Acute Renal Failure—Impact beyond the Acute Phase Contrast-Induced Nephropathy after Percutaneous Coronary Interventions in Relation to Chronic Kidney Disease and Hemodynamic Variables. Am J Cardiol 95: 13–19, 2005 (2006) (54)
- Complete Revascularization During Primary Percutaneous Coronary Intervention Reduces Death and Myocardial Infarction in Patients With Multivessel Disease: Meta-Analysis and Meta-Regression of Randomized Trials. (2018) (54)
- Effect of Ischemia Duration and Door-to-Balloon Time on Myocardial Perfusion in ST-Segment Elevation Myocardial Infarction: An Analysis From HORIZONS-AMI Trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction). (2015) (54)
- Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials. (2020) (54)
- Dynamic nature of nonculprit coronary artery lesion morphology in STEMI: a serial IVUS analysis from the HORIZONS-AMI trial. (2013) (54)
- Diabetes mellitus, myocardial reperfusion, and outcome in patients with acute ST-elevation myocardial infarction treated with primary angioplasty (from HORIZONS AMI). (2012) (54)
- Adverse event rates following primary PCI for STEMI at US and non-US hospitals: three-year analysis from the HORIZONS-AMI trial. (2013) (54)
- Antithrombotic Therapy After Transcatheter Aortic Valve Replacement (2019) (53)
- Volumetric Intravascular Ultrasound Analysis of Paclitaxel-Eluting and Bare Metal Stents in Acute Myocardial Infarction: The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Intravascular Ultrasound Substudy (2009) (53)
- Ticagrelor With or Without Aspirin After PCI: The TWILIGHT Platelet Substudy. (2020) (53)
- Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Artery Revascularization: From the WIN-DES Collaborative Patient-Level Pooled Analysis. (2016) (53)
- Outcomes of patients treated with triple antithrombotic therapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial). (2012) (53)
- Comparison of Three-year outcomes after primary percutaneous coronary intervention in patients with left ventricular ejection fraction <40% versus ≥ 40% (from the HORIZONS-AMI trial). (2013) (53)
- Intravascular ultrasonic assessment of stent diameters derived from manufacturer's compliance charts. (2005) (53)
- Risk factors for the development of slow flow during rotational coronary atherectomy. (1997) (52)
- The occupational effects of interventional cardiology: results from the WIN for Safety survey. (2012) (52)
- Angioplasty of complex lesions in ischemic rest angina: results of the Thrombolysis and Angioplasty in Unstable Angina (TAUSA) trial. (1995) (52)
- Intra-procedural stent thrombosis: a new risk factor for adverse outcomes in patients undergoing percutaneous coronary intervention for acute coronary syndromes. (2013) (52)
- Safety of an Aspirin-Alone Regimen After Intracoronary Stenting With a Heparin-Coated Stent: Final Results of the HOPE (HEPACOAT and an Antithrombotic Regimen of Aspirin Alone) Study (2003) (51)
- Inverse relationship between body mass index and coronary artery calcification in patients with clinically significant coronary lesions. (2012) (51)
- Serial Intravascular Ultrasound Assessment of the Efficacy of Intracoronary &ggr;-Radiation Therapy for Preventing Recurrence in Very Long, Diffuse, In-Stent Restenosis Lesions (2001) (51)
- Relation between angiographic lesion severity, vulnerable plaque morphology and future adverse cardiac events (from the Providing Regional Observations to Study Predictors of Events in the Coronary Tree study). (2012) (51)
- Clinical outcomes following stent thrombosis occurring in-hospital versus out-of-hospital: results from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trial. (2012) (51)
- Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation—Rationale and design of the ENVISAGE‐TAVI AF trial (2018) (51)
- Effect of switching antithrombin agents for primary angioplasty in acute myocardial infarction: the HORIZONS-SWITCH analysis. (2011) (51)
- Intracoronary Imaging, Cholesterol Efflux, and Transcriptomes After Intensive Statin Treatment: The YELLOW II Study. (2017) (50)
- Predictors, Incidence, and Outcomes of Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation Complicated by Stroke: From the CENTER-Collaboration (2019) (50)
- Non-fibroatheroma lesion phenotype and long-term clinical outcomes: a substudy analysis from the PROSPECT study. (2013) (50)
- Sharing Data from Cardiovascular Clinical Trials--A Proposal. (2016) (50)
- Trial characteristics associated with under‐enrolment of females in randomized controlled trials of heart failure with reduced ejection fraction: a systematic review (2020) (50)
- High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound study. (2012) (50)
- Cerebral Embolism During Transcatheter Aortic Valve Replacement: The BRAVO-3 MRI Study. (2016) (49)
- Predictors and implications of coronary infarct artery patency at initial angiography in patients with acute myocardial infarction (from the CADILLAC and HORIZONS-AMI Trials). (2011) (49)
- Treatment of focal in-stent restenosis with balloon angioplasty alone versus stenting: Short- and long-term results. (2001) (49)
- Effect of anemia on frequency of short- and long-term clinical events in acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial). (2014) (49)
- Impact of cigarette smoking on extent of coronary artery disease and prognosis of patients with non-ST-segment elevation acute coronary syndromes: an analysis from the ACUITY Trial (Acute Catheterization and Urgent Intervention Triage Strategy). (2014) (49)
- Body mass index and acute and long-term outcomes after acute myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial). (2014) (48)
- Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC). (2018) (48)
- Fibrous Cap Thickness by Optical Coherence Tomography In Vivo. (2017) (48)
- Impact of myocardial bridge on clinical outcome after coronary stent placement. (2009) (48)
- Effect of Baseline Thrombocytopenia on Ischemic Outcomes in Patients With Acute Coronary Syndromes Who Undergo Percutaneous Coronary Intervention. (2016) (48)
- Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial. (2019) (48)
- Predictors of reperfusion delay in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention from the HORIZONS-AMI trial. (2010) (48)
- Impact of target vessel on long‐term survival after percutaneous coronary intervention for chronic total occlusions (2013) (48)
- Coronary Calcification and Long-Term Outcomes According to Drug-Eluting Stent Generation. (2020) (47)
- Reperfusion strategies in acute myocardial infarction and multivessel disease (2017) (47)
- Long-Term Outcomes in Women and Men Following Percutaneous Coronary Intervention. (2020) (47)
- Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention: Results From the PARIS Registry. (2016) (47)
- Clinical and angiographic outcome in the laser angioplasty for restenotic stents (LARS) multicenter registry (2001) (47)
- Prospective validation of the Bleeding Academic Research Consortium classification in the all-comer PRODIGY trial. (2014) (47)
- Carotid artery stenting in patients with high-risk anatomy for carotid endarterectomy. (2001) (47)
- Ticagrelor with or without Aspirin in High-Risk Patients with Diabetes Mellitus undergoing Percutaneous Coronary Intervention. (2020) (47)
- Evidence‐based management of patients undergoing PCI: Contrast‐induced acute kidney injury (2010) (47)
- Influence of patient age on acute and late clinical outcomes following Palmaz-Schatz coronary stent implantation. (2000) (47)
- Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial. (2013) (47)
- Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients With Diabetes. (2019) (46)
- SCAI consensus document on occupational radiation exposure to the pregnant cardiologist and technical personnel. (2011) (46)
- Sex-Based Differences in Acute Coronary Syndromes: Insights From Invasive and Noninvasive Coronary Technologies. (2016) (46)
- Nonculprit Lesion Plaque Morphology in Patients With ST-Segment–Elevation Myocardial Infarction (2020) (45)
- Dual antiplatelet therapy duration and clinical outcomes following treatment with zotarolimus-eluting stents. (2011) (45)
- Ending Gender Inequality in Cardiovascular Clinical Trial Leadership: JACC Review Topic of the Week. (2021) (45)
- The XIENCE nano™ everolimus eluting coronary stent system for the treatment of small coronary arteries: The SPIRIT small vessel trial (2012) (45)
- Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery. (2005) (45)
- Choice of Estimated Glomerular Filtration Rate Equation Impacts Drug-Dosing Recommendations and Risk Stratification in Patients With Chronic Kidney Disease Undergoing Percutaneous Coronary Interventions. (2015) (44)
- D-dimer levels predict ischemic and hemorrhagic outcomes after acute myocardial infarction: a HORIZONS-AMI biomarker substudy (2013) (44)
- Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI. (2017) (44)
- Outcomes of patients with coronary artery perforation complicating percutaneous coronary intervention and correlations with the type of adjunctive antithrombotic therapy: pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials. (2009) (44)
- Intraprocedural thrombotic events during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes are associated with adverse outcomes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. (2012) (44)
- Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCI. (2016) (44)
- Women in interventional cardiology: Update in percutaneous coronary intervention practice patterns and outcomes of female operators from the National Cardiovascular Data Registry® (2016) (44)
- Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention. (2019) (44)
- Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era. (2008) (43)
- Gender differences in long-term clinical outcomes after percutaneous coronary intervention of chronic total occlusions. (2012) (43)
- Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial. (2018) (43)
- Acute myocardial infarction in young women: current perspectives (2018) (43)
- Prognostic utility of left ventricular end-diastolic pressure in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. (2011) (42)
- Pegnivacogin results in near complete FIX inhibition in acute coronary syndrome patients: RADAR pharmacokinetic and pharmacodynamic substudy. (2011) (42)
- Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the academic bleeding consensus (ABC) multidisciplinary working group. (2009) (42)
- Relation between leucocyte count, myonecrosis, myocardial perfusion, and outcomes following primary angioplasty. (2007) (42)
- Residual plaque burden in patients with acute coronary syndromes after successful percutaneous coronary intervention. (2012) (42)
- Standardized Definitions for Cardiovascular and Stroke Endpoint Events in Clinical Trials (2014) (42)
- First Report of the Resolute Onyx 2.0-mm Zotarolimus-Eluting Stent for the Treatment of Coronary Lesions With Very Small Reference Vessel Diameter. (2017) (42)
- Radiation‐associated lens changes in the cardiac catheterization laboratory: Results from the IC‐CATARACT (CATaracts Attributed to RAdiation in the CaTh lab) study (2018) (42)
- Prognostic utility of the SYNTAX score in patients with single versus multivessel disease undergoing percutaneous coronary intervention (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] trial). (2014) (42)
- Association of APOC3 Loss-of-Function Mutations With Plasma Lipids and Subclinical Atherosclerosis: The Multi-Ethnic BioImage Study. (2015) (42)
- Comparison of in-hospital and one-year outcomes after multiple coronary arterial stenting in patients > or =80 years old versus those <80 years old. (2003) (42)
- Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study (2015) (41)
- SCAI consensus document on occupational radiation exposure to the pregnant cardiologist and technical personnel. (2011) (41)
- Postmarket evaluation of breakthrough technologies. (2008) (41)
- Effect of plaque debulking and stenting on short- and long-term outcomes after revascularization of chronic total occlusions. (2000) (41)
- Autopsy validation study of the academic research consortium stent thrombosis definition. (2011) (41)
- Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials (2021) (41)
- Predictors and Implications of Stent Thrombosis in Non–ST-Segment Elevation Acute Coronary Syndromes: The ACUITY Trial (2011) (41)
- Comparison of clinical and angiographic prognostic risk scores in patients with acute coronary syndromes: Analysis from the Acute Catheterization and Urgent Intervention Triage StrategY (ACUITY) trial. (2012) (41)
- Comparison of direct stenting with conventional stent implantation in acute myocardial infarction. (2011) (41)
- First-in-man 1-year clinical outcomes of the Catania Coronary Stent System with Nanothin Polyzene-F in de novo native coronary artery lesions: the ATLANTA (Assessment of The LAtest Non-Thrombogenic Angioplasty stent) trial. (2009) (40)
- Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial. (2011) (40)
- Safety and Performance of Targeted Renal Therapy: The Be-RITe! Registry (2009) (40)
- Impact of Symptomatic Peripheral Arterial Disease on 1-Year Mortality in Patients Undergoing Percutaneous Coronary Interventions (2004) (40)
- Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study. (2017) (39)
- One-Year Clinical Outcome After Minimally Invasive Direct Coronary Artery Bypass (2000) (39)
- Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial). (2004) (39)
- Gender Differences in Transfemoral Transcatheter Aortic Valve Replacement. (2019) (39)
- Impact of the severity of coronary artery calcification on clinical events in patients undergoing coronary artery bypass grafting (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial). (2013) (39)
- B-type Natriuretic Peptide and Risk of Contrast-Induced Acute Kidney Injury in Acute ST-Segment–Elevation Myocardial Infarction: A Substudy from the HORIZONS-AMI Trial (2012) (39)
- A new score for risk stratification of patients with acute coronary syndromes undergoing percutaneous coronary intervention: the ACUITY-PCI (Acute Catheterization and Urgent Intervention Triage Strategy-Percutaneous Coronary Intervention) risk score. (2012) (39)
- Multiethnic Exome-Wide Association Study of Subclinical Atherosclerosis (2016) (39)
- Ticagrelor With Aspirin or Alone After Complex PCI: The TWILIGHT-COMPLEX Analysis. (2020) (39)
- Outcomes in Women and Minorities Compared With White Men 1 Year After Everolimus-Eluting Stent Implantation: Insights and Results From the PLATINUM Diversity and PROMUS Element Plus Post-Approval Study Pooled Analysis (2017) (39)
- Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI) (2021) (39)
- Sex Differences in the Pursuit of Interventional Cardiology as a Subspecialty Among Cardiovascular Fellows-in-Training. (2019) (38)
- Reasonable incomplete revascularisation after percutaneous coronary intervention: the SYNTAX Revascularisation Index. (2015) (38)
- Long-term clinical outcomes of percutaneous coronary intervention for chronic total occlusions in patients with versus without diabetes mellitus. (2011) (38)
- Outcomes of Saphenous Vein Graft Intervention With and Without Embolic Protection Device: A Comprehensive Review and Meta-Analysis (2017) (38)
- Prognostic value of access site and nonaccess site bleeding after percutaneous coronary intervention: a cohort study in ST-segment elevation myocardial infarction and comprehensive meta-analysis. (2014) (38)
- Safety and Efficacy of Double Antithrombotic Therapy With Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta‐Analysis (2020) (38)
- Impact of infarct-related artery patency before primary PCI on outcome in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial. (2013) (38)
- Impact of Clinical Presentation (Stable Angina Pectoris vs Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction vs ST-Elevation Myocardial Infarction) on Long-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents. (2015) (38)
- Gender differences in outcomes in patients with acute coronary syndrome in the current era: A review (2016) (37)
- Transient contrast encephalopathy after carotid artery stenting. (2001) (37)
- Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass (2014) (37)
- SCAI consensus document on occupational radiation exposure to the pregnant cardiologist and technical personnel (2011) (37)
- Prognostic Impact of Race in Patients Undergoing PCI: Analysis From 10 Randomized Coronary Stent Trials. (2020) (37)
- Effects of sex and gender on adaptation to space: cardiovascular alterations. (2014) (37)
- Comparison of quality-of-life measures after radial versus femoral artery access for cardiac catheterization in women: Results of the Study of Access Site for Enhancement of Percutaneous Coronary Intervention for Women quality-of-life substudy. (2015) (37)
- Impact of collateral flow on myocardial reperfusion and infarct size in patients undergoing primary angioplasty for acute myocardial infarction. (2007) (37)
- Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey. (2020) (37)
- Usefulness of minimum stent cross sectional area as a predictor of angiographic restenosis after primary percutaneous coronary intervention in acute myocardial infarction (from the HORIZONS-AMI Trial IVUS substudy). (2012) (36)
- Outcomes in patients with ST-segment elevation acute myocardial infarction treated with clopidogrel versus prasugrel (from the INFUSE-AMI trial). (2014) (36)
- The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery Disease. (2017) (36)
- Six-month outcomes after percutaneous intervention for lesions in aortocoronary saphenous vein grafts using distal protection devices: results from the FIRE trial. (2006) (36)
- Combined and independent impact of diabetes mellitus and chronic kidney disease on residual platelet reactivity (2013) (36)
- Bleeding avoidance strategies in percutaneous coronary intervention (2021) (36)
- Association of Sex With Outcomes in Patients Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the GLOBAL LEADERS Randomized Clinical Trial. (2019) (36)
- Impact of percutaneous coronary intervention extent, complexity and platelet reactivity on outcomes after drug-eluting stent implantation. (2018) (36)
- Relationship Between ST-Segment Recovery and Clinical Outcomes After Primary Percutaneous Coronary Intervention: The HORIZONS-AMI ECG Substudy Report (2013) (36)
- Association between intraprocedural thrombotic events and adverse outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (a Harmonizing Outcomes With RevasculariZatiON and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Substudy). (2014) (35)
- Contrast-induced acute kidney injury (2020) (35)
- Post–Market Approval Surveillance: A Call for a More Integrated and Comprehensive Approach (2004) (35)
- Trials of implantable monitoring devices in heart failure: which design is optimal? (2014) (35)
- Bivalirudin Versus Heparin Plus a Glycoprotein IIb/IIIa Inhibitor in Patients With Non–ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention After Clopidogrel Pretreatment: Pooled Analysis from the ACUITY and ISAR-REACT 4 Trials (2012) (35)
- Outcomes of patients with prior coronary artery bypass grafting and acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. (2012) (35)
- SYNTAX score and the risk of stent thrombosis after percutaneous coronary intervention in patients with non‐ST‐segment elevation acute coronary syndromes: An ACUITY trial substudy (2015) (34)
- Prognostic significance of coronary thrombus in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a subanalysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. (2011) (34)
- Predictors of suboptimal TIMI flow after primary angioplasty for acute myocardial infarction: results from the HORIZONS-AMI trial. (2013) (34)
- The academic research consortium governance charter. (2011) (34)
- Contemporary overview and clinical perspectives of chronic total occlusions (2014) (34)
- Randomized comparison between 3-month Cre8 DES vs. 1-month Vision/Multilink8 BMS neointimal coverage assessed by OCT evaluation: the DEMONSTRATE study. (2014) (34)
- Advanced c‐myc antisense (AVI‐4126)‐eluting phosphorylcholine‐coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis model (2004) (34)
- Three-year clinical results of the Axxess Biolimus A9 eluting bifurcation stent system: the DIVERGE study. (2013) (34)
- Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trial (2011) (34)
- Non-atherosclerotic causes of acute coronary syndromes (2019) (34)
- One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patients (2020) (34)
- Patients with 3-vessel coronary artery disease and impaired ventricular function undergoing PCI with Impella 2.5 hemodynamic support have improved 90-day outcomes compared to intra-aortic balloon pump: a sub-study of the PROTECT II trial. (2015) (33)
- Percutaneous Recanalization of Chronically Occluded Coronary Arteries A New Drugs and Technologies (2005) (33)
- Intravascular ultrasound comparison of left main coronary artery disease between white and Asian patients. (2013) (33)
- Quantitative angiographic analysis of stent restenosis in the Scripps Coronary Radiation to Inhibit Intimal Proliferation Post Stenting (SCRIPPS) Trial. (1999) (33)
- Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent Implantation: The ARC-High Bleeding Risk Trade-off Model. (2021) (33)
- Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With Stents. (2016) (33)
- Complementary prognostic utility of myocardial blush grade and ST-segment resolution after primary percutaneous coronary intervention: analysis from the HORIZONS-AMI trial. (2013) (33)
- The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After Percutaneous Coronary Intervention: The ADAPT-DES Study. (2016) (33)
- Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. (2016) (33)
- Successful use of the frontrunner catheter in the treatment of in‐stent coronary chronic total occlusions (2004) (33)
- A Survey of Interventional Cardiologists’ Attitudes and Beliefs About Public Reporting of Percutaneous Coronary Intervention (2018) (32)
- Short Duration of DAPT Versus De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes. (2022) (32)
- Clinical outcomes of compromised side branch (stent jail) after coronary stenting with the NIR stent (2001) (32)
- Safety and efficacy of high- versus low-dose aspirin after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. (2012) (32)
- An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. (2020) (32)
- Percutaneous Coronary Intervention of Saphenous Vein Graft (2017) (32)
- Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents). (2015) (32)
- Impact of Clinical Presentation on Bleeding Risk after Percutaneous Coronary Intervention and Implications for the ARC-HBR Definition. (2021) (32)
- A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes: design and rationale of the RADAR Phase IIb trial. (2011) (32)
- Relation of Baseline Hemoglobin Levels and Adverse Events in Patients With Acute Coronary Syndromes (from the Acute Catheterization and Urgent Intervention Triage strategY and Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction Trials). (2017) (32)
- Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry). (2015) (32)
- Outcome of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention during on- versus off-hours (a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial substudy). (2013) (32)
- Impact of smoking on outcomes of patients with ST-segment elevation myocardial infarction (from the HORIZONS-AMI Trial). (2011) (31)
- Intravascular ultrasound assessment of cobalt chromium versus stainless steel drug-eluting stent expansion. (2010) (31)
- Postprocedure creatine kinase-MB elevation and baseline left ventricular dysfunction predict one-year mortality after percutaneous coronary intervention. (2002) (31)
- Debris Heterogeneity Across Different Valve Types Captured by a Cerebral Protection System During Transcatheter Aortic Valve Replacement. (2018) (31)
- Long-term outcomes of percutaneous coronary interventions or coronary artery bypass grafting for left main coronary artery disease in octogenarians (from a Drug-Eluting stent for LefT main Artery registry substudy). (2014) (31)
- An evaluation of fluoroscopy time and correlation with outcomes after percutaneous coronary intervention. (2007) (31)
- Optimal P2Y12 Inhibitor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Network Meta-Analysis. (2016) (31)
- Radial versus femoral access for coronary interventions: An updated systematic review and meta‐analysis of randomized trials (2021) (31)
- Is accurate intravascular ultrasound evaluation of the left circumflex ostium from a left anterior descending to left main pullback possible? (2010) (31)
- Intravascular ultrasound-guided renal artery stenting. (2001) (31)
- Minimally invasive coronary artery bypass grafting versus stenting for patients with proximal left anterior descending coronary artery disease. (2004) (31)
- The relationship among extent of lipid-rich plaque, lesion characteristics, and plaque progression/regression in patients with coronary artery disease: a serial near-infrared spectroscopy and intravascular ultrasound study. (2015) (31)
- Percutaneous recanalization of chronic total occlusions: wherein lies the body of proof? (2013) (31)
- Impact of diabetes mellitus on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty: analysis from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trial. (2011) (31)
- Increasing Participation of Women in Cardiovascular Trials: JACC Council Perspectives. (2021) (30)
- ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease (2019) (30)
- Patterns of Caregiving Among Patients Hospitalized With Cardiovascular Disease (2011) (30)
- Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO‐3 randomized trial (2019) (30)
- Rationale and design of the Onyx ONE global randomized trial: A randomized controlled trial of high-bleeding risk patients after stent placement with 1 month of dual antiplatelet therapy. (2019) (30)
- Meta-analysis of randomized trials comparing the effectiveness of different strategies for the treatment of drug-eluting stent restenosis. (2014) (30)
- Impact of Diabetes Mellitus on the Pharmacodynamic Effects of Ticagrelor Versus Clopidogrel in Troponin‐Negative Acute Coronary Syndrome Patients Undergoing Ad Hoc Percutaneous Coronary Intervention (2017) (30)
- Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowings. (2011) (30)
- Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study. (2017) (29)
- Surgical Versus Percutaneous Coronary Revascularization for Multivessel Disease in Diabetic Patients With Non–ST-Segment–Elevation Acute Coronary Syndrome: Analysis From the Acute Catheterization and Early Intervention Triage Strategy Trial (2015) (29)
- Gender-based issues in interventional cardiology: a consensus statement from the Women in Innovations (WIN) initiative. (2010) (29)
- Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial. (2006) (29)
- Infarct size and mortality in patients with proximal versus mid left anterior descending artery occlusion: the Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction (INFUSE-AMI) trial. (2013) (29)
- CORONARY ARTERY DISEASE Original Studies Expert Consensus Statement on the Use of Fractional Flow Reserve, Intravascular Ultrasound, and Optical Coherence Tomography: A Consensus Statement of the Society of Cardiovascular Angiography and Interventions (2014) (29)
- Gender differences in clinical outcome after coronary artery stenting with use of glycoprotein IIb/IIIa inhibitors. (2002) (29)
- Impact of bivalirudin therapy in high-risk patients with acute myocardial infarction: 1-year results from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trial. (2010) (29)
- Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From a Patient-Level Pooled Analysis of Randomized Controlled Trials. (2018) (29)
- Overcoming Lack of Diversity in Cardiovascular Clinical Trials: A New Challenge and Strategies for Success. (2019) (29)
- 829-5 Primary angioplasty in acute myocardial infarction with distal protection of the microcirculation: Principal results from the prospective, randomized EMERALD trial (2004) (28)
- Correlation between index electrocardiographic patterns and pre‐intervention angiographic findings: Insights from the HORIZONS‐AMI trial (2012) (28)
- Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR. (2021) (28)
- Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry. (2016) (28)
- The role of mucomyst administration prior to percutaneous interventions on renal function in patients with chronic renal failure (2002) (28)
- Contrast-induced nephropathy remains a serious complication of PCI. (2007) (28)
- Optimal final lumen area and predictors of target lesion revascularization after stent implantation in small coronary arteries. (2003) (28)
- DAPT duration after DES: what is the "mandatory" duration? (2015) (28)
- 3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation. (2021) (28)
- Continuous subcutaneous angiopeptin treatment significantly reduces neointimal hyperplasia in a porcine coronary in-stent restenosis model. (1997) (27)
- Comparison of differences in outcome after percutaneous coronary intervention in men versus women <40 years of age. (2004) (27)
- Mortality After Repeat Revascularization Following PCI or Coronary Artery Bypass Grafting for Left Main Disease: The EXCEL Trial. (2020) (27)
- Understanding the consequences of contrast-induced nephropathy. (2003) (27)
- Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents) (2017) (27)
- Evaluation of the Pooled Cohort Equations for Prediction of Cardiovascular Risk in a Contemporary Prospective Cohort. (2017) (27)
- Statin use prior to angiography for the prevention of contrast-induced acute kidney injury: a meta-analysis of 19 randomised trials. (2016) (27)
- Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: A Patient-Level Pooled Analysis of Randomized Controlled Trials. (2016) (27)
- Incidence and impact of acute kidney injury in patients with acute coronary syndromes treated with coronary artery bypass grafting: Insights from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) and Acute Catheterization and Urgent Intervention (2016) (27)
- Relationship between angiographic dynamic and densitometric assessment of myocardial reperfusion and survival in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: the harmonizing outcomes with revascularization and stents in AMI (HORIZONS-AMI) trial. (2011) (27)
- Evidence based management of patients undergoing PCI. Conclusion. (2010) (27)
- Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography. (2018) (27)
- Procedural and one-year outcomes of patients treated with orbital and rotational atherectomy with mechanistic insights from optical coherence tomography. (2019) (26)
- Indirect Comparison of the Efficacy and Safety of Alirocumab and Evolocumab: A Systematic Review and Network Meta-Analysis. (2020) (26)
- Impact of calcification on percutaneous coronary intervention: MACE‐Trial 1‐year results (2019) (26)
- The impact of the coronary collateral circulation on outcomes in patients with acute coronary syndromes: results from the ACUITY trial (2013) (26)
- Procedural variation in the performance of primary percutaneous coronary intervention for ST‐elevation myocardial infarction: A SCAI‐based survey study of US interventional cardiologists (2014) (26)
- Impact of Bleeding and Bivalirudin Therapy on Mortality Risk in Women Undergoing Percutaneous Coronary Intervention (from the REPLACE-2, ACUITY, and HORIZONS-AMI Trials). (2016) (26)
- Rationale and design of Apo-I Event Reduction in Ischemic Syndromes I (AEGIS-I): A phase 2b, randomized, placebo-controlled, dose-ranging trial to investigate the safety and tolerability of CSL112, a reconstituted, infusible, human apoA-I, after acute myocardial infarction. (2016) (26)
- Female-specific survival advantage from transcatheter aortic valve implantation over surgical aortic valve replacement: Meta-analysis of the gender subgroups of randomised controlled trials including 3758 patients. (2018) (26)
- Current periprocedural anticoagulation in transcatheter aortic valve replacement: could bivalirudin be an option? Rationale and design of the BRAVO 2/3 studies (2013) (26)
- Preventing Contrast-induced Renal Failure: A Guide. (2016) (26)
- Evaluation of Early Healing Profile and Neointimal Transformation Over 24 Months Using Longitudinal Sequential Optical Coherence Tomography Assessments and 3-Year Clinical Results of the New Dual-Therapy Endothelial Progenitor Cell Capturing Sirolimus-Eluting Combo Stent: The EGO-Combo Study (2016) (26)
- Relation of final lumen dimensions in saphenous vein grafts after stent implantation to outcome. (2004) (25)
- Long‐term clinical outcomes after percutaneous coronary intervention for chronic total occlusions in elderly patients (≥75 Years) (2013) (25)
- Effect of percutaneous coronary interventions for in-stent restenosis in degenerated saphenous vein grafts without distal embolic protection. (2003) (25)
- ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 appropriate use criteria for multimodality imaging in the assessment of cardiac structure and function in nonvalvular heart disease: A report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic (2019) (25)
- Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert Panel. (2020) (25)
- Sleep Duration and Cardiovascular Health in a Representative Community Population (from NHANES, 2005 to 2016). (2020) (25)
- Rationale and design of ApoA-I event reducing in ischemic syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction. (2020) (25)
- Prognostic significance of cerebrovascular and peripheral arterial disease in patients having percutaneous coronary interventions. (2004) (25)
- Transient Contrast Encephalopathy after Carotid Artery Stenting (2001) (25)
- Left Ventricular Thrombus Following Acute Myocardial Infarction: JACC State-of-the-Art Review. (2022) (25)
- Relationship between ST-segment resolution and anterior infarct size after primary percutaneous coronary intervention: analysis from the INFUSE-AMI trial (2014) (25)
- Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study. (2016) (25)
- Safety and efficacy of the next generation Resolute Onyx zotarolimus‐eluting stent: Primary outcome of the RESOLUTE ONYX core trial (2018) (25)
- Comparison of the angiographic outcomes after beta versus gamma vascular brachytherapy for treatment of in-stent restenosis. (2003) (24)
- Resistant in‐stent restenosis in the drug eluting stent era (2016) (24)
- Use of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI study. (2014) (24)
- Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research Consortium (2020) (24)
- Creatine kinase-MB enzyme elevation and long-term clinical events after successful coronary stenting in lesions with ruptured plaque. (2005) (24)
- Bleeding events are associated with an increase in markers of inflammation in acute coronary syndromes: an ACUITY trial substudy (2011) (24)
- Comparison of Outcomes and Prognosis of Patients With Versus Without Newly Diagnosed Diabetes Mellitus After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (the HORIZONS-AMI Study). (2017) (24)
- ACS and STEMI treatment: gender-related issues. (2012) (24)
- Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study (2017) (24)
- Clinical and angiographic evaluation of the resolute zotarolimus-eluting coronary stent in Japanese patients – long-term outcome in the RESOLUTE Japan and RESOLUTE Japan small vessel study. (2014) (24)
- Effect of bivalirudin on aortic valve intervention outcomes study: a two-centre registry study comparing bivalirudin and unfractionated heparin in balloon aortic valvuloplasty. (2014) (24)
- Relation between coronary calcium and major bleeding after percutaneous coronary intervention in acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage Strategy and Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trials). (2014) (24)
- Analysis of biomarkers for risk of acute kidney injury after primary angioplasty for acute ST‐segment elevation myocardial infarction: Results of the HORIZONS‐AMI trial (2015) (23)
- Transfemoral TAVR in Nonagenarians: From the CENTER Collaboration. (2019) (23)
- White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry) (2017) (23)
- Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study. (2017) (23)
- Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial. (2018) (23)
- Real world safety and efficacy of the Janus tacrolimus‐eluting stent: Long‐term clinical outcome and angiographic findings from the tacrolimus‐eluting stent (TEST) registry (2009) (23)
- Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents: Two-Year Follow-Up of the ADAPT-DES Study (2018) (23)
- Prognostic Significance of Elevated Baseline Troponin in Patients With Acute Coronary Syndromes and Chronic Kidney Disease Treated With Different Antithrombotic Regimens: A Substudy From the ACUITY Trial (2012) (23)
- Effect of bivalirudin compared with unfractionated heparin plus abciximab on infarct size and myocardial recovery after primary percutaneous coronary intervention: The horizons‐AMI CMRI substudy (2012) (23)
- A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry (2021) (23)
- Safety of Intracoronary γ-Radiation on Uninjured Reference Segments During the First 6 Months After Treatment of In-Stent Restenosis A Serial Intravascular Ultrasound Study (2000) (23)
- Stent thrombosis after primary angioplasty for STEMI in relation to non-adherence to dual antiplatelet therapy over time: results of the HORIZONS-AMI trial. (2013) (23)
- Current challenges for clinical trials of cardiovascular medical devices. (2014) (22)
- Global Prevalence and Impact of Hostility, Discrimination, and Harassment in the Cardiology Workplace. (2021) (22)
- Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration (2017) (22)
- Postmarket surveillance for drug-eluting coronary stents: a comprehensive approach. (2006) (22)
- ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for Multimodality Imaging in Valvular Heart Disease (2017) (22)
- New-Device Angioplasty in Women: Clinical Outcome and Predictors in a 7,372-Patient Registry (2002) (22)
- Outcomes of optimal or "stent-like"balloon angioplasty in acutemyocardial infarction: the CADILLAC trial. (2003) (22)
- Serial intravascular ultrasound analysis of edge recurrence after intracoronary gamma radiation treatment of native artery in-stent restenosis lesions. (2001) (22)
- Balancing ischaemia and bleeding risks with novel oral anticoagulants (2014) (22)
- Implications of ventricular arrhythmia “bursts” with normal epicardial flow, myocardial blush, and ST-segment recovery in anterior ST-elevation myocardial infarction reperfusion: A biosignature of direct myocellular injury “downstream of downstream” (2015) (22)
- Antithrombotic Treatment after Transcatheter Heart Valves Implant (2018) (22)
- Predictors of Outcomes in Medically Treated Patients With Acute Coronary Syndromes After Angiographic Triage: An Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) Substudy (2010) (22)
- Incidence, Predictors, and Outcomes of High-Grade Atrioventricular Block in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (from the HORIZONS-AMI Trial). (2017) (22)
- Minimally invasive direct coronary artery bypass (MIDCAB) versus coronary artery stenting for elective revascularization of the left anterior descending artery. (2002) (22)
- Sex Disparities in Cardiovascular Device Evaluations: Strategies for Recruitment and Retention of Female Patients in Clinical Device Trials. (2019) (22)
- Comparison of clinical outcomes using stents versus no stents after percutaneous coronary intervention for proximal left anterior descending versus proximal right and left circumflex coronary arteries. (2002) (22)
- Non-cardiac surgery in patients with coronary artery disease: risk evaluation and periprocedural management (2020) (21)
- Short‐versus long‐term Dual Antiplatelet therapy after drug‐eluting stent implantation in women versus men: A sex‐specific patient‐level pooled‐analysis of six randomized trials (2017) (21)
- Platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment during saphenous vein graft stenting: differential effects after randomization to occlusion or filter-based embolic protection (2006) (21)
- One-year clinical outcome after minimally invasive direct coronary artery bypass. (2000) (21)
- Computed tomography predictors of mortality, stroke and conduction disturbances in women undergoing TAVR: A sub-analysis of the WIN-TAVI registry. (2018) (21)
- Aortic Valve Stenosis Treatment Disparities in the Underserved: JACC Council Perspectives. (2019) (21)
- Drug-eluting stents in the real world: how intravascular ultrasound can improve clinical outcome. (2008) (21)
- Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting. (2018) (21)
- Gender-based issues in interventional cardiology: a consensus statement from the Women in Innovations (WIN) initiative. (2010) (21)
- Contrast-induced acute kidney injury. Underappreciated or a new marker of cardiovascular mortality? (2010) (21)
- Gastrointestinal bleeding in percutaneous coronary intervention and acute coronary syndromes. (2009) (21)
- ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic (2019) (21)
- Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients) (2018) (21)
- Outcomes in diabetic patients undergoing primary percutaneous coronary intervention for acute anterior myocardial infarction: Results from the INFUSE‐AMI study (2014) (20)
- Use of a pneumatic compression system (FemoStop) as a treatment option for femoral artery pseudoaneurysms after percutaneous cardiac procedures. (1996) (20)
- Long-term follow-up of patients after gamma intracoronary brachytherapy failure (from GAMMA-I, GAMMA-II, and SCRIPPS-III). (2003) (20)
- The CSL112–2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A‐I [human]), an intravenous formulation of plasma‐derived apolipoprotein A‐I, among subjects with moderate renal impairment after acute myocardial infarction (2019) (20)
- Influence of stent length to lesion length ratio on angiographic and clinical outcomes after implantation of bare metal and drug-eluting stents (the TAXUS-IV Study). (2005) (20)
- Comparison of Bivalirudin versus Bivalirudin plus glycoprotein IIb/IIIa inhibitor versus heparin plus glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes having percutaneous intervention for narrowed saphenous vein aorto-coronary grafts (the ACUITY trial investigators). (2010) (20)
- Comparison of Prasugrel and Bivalirudin vs Clopidogrel and Heparin in Patients With ST‐Segment Elevation Myocardial Infarction: Design and Rationale of the Bavarian Reperfusion Alternatives Evaluation (BRAVE) 4 Trial (2014) (20)
- Effect of Increasing Stent Length on 3-Year Clinical Outcomes in Women Undergoing Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents: Patient-Level Pooled Analysis of Randomized Trials From the WIN-DES Initiative. (2018) (19)
- Comparison of outcomes of patients with ST-segment elevation myocardial infarction with versus without previous coronary artery bypass grafting (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial). (2013) (19)
- Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. (2016) (19)
- Effect of Smoking on Infarct Size and Major Adverse Cardiac Events in Patients With Large Anterior ST-Elevation Myocardial Infarction (from the INFUSE-AMI Trial). (2016) (19)
- Prospective, multicenter study of thrombectomy in patients with acute myocardial infarction: the X-Tract AMI registry. (2007) (19)
- Intravascular ultrasonic differences between aorto-ostial and shaft narrowing in saphenous veins used as aortocoronary bypass grafts. (2006) (19)
- Leukocyte Count Is a Modulating Factor for the Mortality Benefit of Bivalirudin in ST-Segment–Elevation Acute Myocardial Infarction: The HORIZONS-AMI Trial (2013) (19)
- 1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration. (2018) (19)
- Relation Between Platelet Count and Platelet Reactivity to Thrombotic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study. (2016) (19)
- TCT-21 Use of IVUS Reduces Stent Thrombosis: Results from the Prospective, multicenter ADAPT-DES Study (2012) (19)
- Incidence and impact of totally occluded culprit coronary arteries in patients presenting with non-ST-segment elevation myocardial infarction. (2015) (19)
- SCAI expert consensus statement on out of hospital cardiac arrest (2020) (19)
- The use of vascular closure devices and impact on major bleeding and net adverse clinical events (NACEs) in balloon aortic valvuloplasty: A sub‐analysis of the BRAVO study (2014) (19)
- Impact of transfer for primary percutaneous coronary intervention on survival and clinical outcomes (from the HORIZONS-AMI Trial). (2010) (19)
- Angiographic predictors of 2‐year stent thrombosis in patients receiving drug‐eluting stents: Insights from the ADAPT‐DES study (2017) (19)
- Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis. (2021) (18)
- Valvular Heart Disease in Women, Differential Remodeling, and Response to New Therapies (2017) (18)
- Randomized, double‐blind, multicenter study of the polymer‐based 17‐β estradiol‐eluting stent for treatment of native coronary artery lesions: Six‐month results of the ETHOS I trial (2007) (18)
- Sex differences in the effect of diabetes mellitus on platelet reactivity and coronary thrombosis: From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study. (2017) (18)
- Usefulness of the SYNTAX score to predict acute kidney injury after percutaneous coronary intervention (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial). (2014) (18)
- CSL112, a reconstituted, infusible, plasma-derived apolipoprotein A-I: safety and tolerability profiles and implications for management in patients with myocardial infarction (2018) (18)
- Early Ventricular Tachycardia or Fibrillation in Patients With ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention and Impact on Mortality and Stent Thrombosis (from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial). (2017) (18)
- IMPACT OF FINAL MINIMAL STENT AREA BY IVUS ON 3-YEAR OUTCOME AFTER PCI OF LEFT MAIN CORONARY ARTERY DISEASE: THE EXCEL TRIAL (2017) (18)
- Usefulness of atrial fibrillation as a marker of outcome after percutaneous coronary intervention. (2003) (18)
- Serial volumetric intravascular ultrasound analysis of the efficacy of beta irradiation in preventing recurrent in-stent restenosis. (2000) (18)
- How Serious a Problem is Bleeding in Patients with Acute Coronary Syndromes? (2011) (18)
- Correlation of coronary arterial remodeling determined by intravascular ultrasound with angiographic diameter reduction of 20% to 60%. (2003) (18)
- Types of myocardial injury and mid-term outcomes in patients with COVID-19. (2021) (18)
- Plaque morphology predictors of side branch occlusion after provisional stenting in coronary bifurcation lesion: Results of optical coherence tomography bifurcation study (ORBID) (2017) (18)
- Usefulness of beta radiation for de novo and in-stent restenotic lesions in saphenous vein grafts. (2003) (17)
- Comparison of outcomes in men versus women having percutaneous coronary interventions in small coronary arteries. (2003) (17)
- Platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment during saphenous vein graft stenting: differential effects after randomization to occlusion or filter-based embolic protection. (2004) (17)
- Long-Term Follow-Up of Attenuated Plaques in Patients With Acute Myocardial Infarction: An Intravascular Ultrasound Substudy of the HORIZONS-AMI Trial (2012) (17)
- Contemporary outcomes of rescue percutaneous coronary intervention for acute myocardial infarction: comparison with primary angioplasty and the role of distal protection devices (EMERALD trial). (2008) (17)
- Dominant contribution of negative remodeling to development of significant coronary bifurcation narrowing. (2003) (17)
- Coronary artery stenting (2002) (17)
- Impact of Hemoglobin A1c Levels on Residual Platelet Reactivity and Outcomes After Insertion of Coronary Drug-Eluting Stents (from the ADAPT-DES Study). (2016) (17)
- Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry. (2017) (17)
- Clustering of Acute and Subacute Stent Thrombosis Related to the Introduction of Generic Clopidogrel (2014) (17)
- Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-Year final clinical outcomes from the MASCOT post-marketing registry. (2019) (17)
- Quantifying Ischemic Risk After Percutaneous Coronary Intervention Attributable to High Platelet Reactivity on Clopidogrel (From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents Study). (2017) (17)
- Prevention and treatment of contrast-associated nephropathy in interventional cardiology (2009) (17)
- Incidence, predictors, and outcomes of DAPT disruption due to non-compliance vs. bleeding after PCI: insights from the PARIS Registry (2019) (17)
- Benefits of optimising coronary flow before stenting in primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from INFUSE-AMI. (2014) (17)
- Usefulness of Clopidogrel Loading in Patients Who Underwent Transcatheter Aortic Valve Implantation (from the BRAVO-3 Randomized Trial). (2019) (17)
- Acute and long-term results of treatment of diffuse in-stent restenosis in aortocoronary saphenous vein grafts. (2000) (16)
- Gender differences on benefits and risks associated with oral antithrombotic medications for coronary artery disease (2018) (16)
- Risk of contrast‐induced acute kidney injury in ST‐elevation myocardial infarction patients undergoing multi‐vessel intervention‐meta‐analysis of randomized trials and risk prediction modeling study using observational data (2017) (16)
- Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI. (2021) (16)
- Sex Difference in Chest Pain After Implantation of Newer Generation Coronary Drug-Eluting Stents: A Patient-Level Pooled Analysis From the TWENTE and DUTCH PEERS Trials. (2016) (16)
- Design and rationale of the COMPLETE trial: A randomized, comparative effectiveness study of complete versus culprit-only percutaneous coronary intervention to treat multivessel coronary artery disease in patients presenting with ST-segment elevation myocardial infarction. (2019) (16)
- Impact of bifurcation target lesion on angiographic, electrocardiographic, and clinical outcomes of patients undergoing primary percutaneous coronary intervention (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial). (2013) (16)
- Determinants of Significant Out-Of-Hospital Bleeding in Patients Undergoing Percutaneous Coronary Intervention (2018) (16)
- Mortality After Repeat Revascularization Following PCI or CABG for Left Main Disease (2020) (16)
- Creatine kinase-MB fraction elevation after percutaneous coronary intervention in patients with chronic renal failure. (2001) (16)
- Safety and Efficacy of New-Generation Drug-Eluting Stents in Women at High Risk for Atherothrombosis: From the Women in Innovation and Drug-Eluting Stents Collaborative Patient-Level Pooled Analysis (2016) (16)
- Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial. (2021) (16)
- Gender and Disparity in First Authorship in Cardiology Randomized Clinical Trials (2021) (16)
- Usefulness of the Left Anterior Descending Artery Wrapping Around the Left Ventricular Apex to Predict Adverse Clinical Outcomes in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction (an INFUSE-AMI Substudy). (2015) (16)
- Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry). (2018) (16)
- Restenosis after coronary angioplasty. (1997) (16)
- Comparison of percutaneous coronary intervention (with drug-eluting stents) versus coronary artery bypass grafting in women with severe narrowing of the left main coronary artery (from the Women-Drug-Eluting stent for LefT main coronary Artery disease Registry). (2014) (16)
- Which Intraprocedural Thrombotic Events Impact Clinical Outcomes After Percutaneous Coronary Intervention in Acute Coronary Syndromes?: A Pooled Analysis of the HORIZONS-AMI and ACUITY Trials. (2016) (16)
- Utility of post-procedural anticoagulation after primary PCI for STEMI: insights from a pooled analysis of the HORIZONS-AMI and EUROMAX trials (2017) (15)
- Impact of Baseline Atrial Fibrillation on Outcomes Among Women Who Underwent Contemporary Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry). (2018) (15)
- Radiocontrast-induced acute renal failure: allocations and outcomes. (2001) (15)
- Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk (2020) (15)
- Antithrombotic potency of ticagrelor versus clopidogrel in type-2 diabetic patients with cardiovascular disease (2017) (15)
- Abstract 13371: Frequency and Clinical Impact of Nuisance Bleeding Among Patients Receiving Aspirin and Clopidogrel: Insights from the Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial (2011) (15)
- Impact of Contrast Dose Reduction on Incidence of Acute Kidney Injury (AKI) Among Patients Undergoing PCI: A Modeling Study. (2016) (15)
- Volumetric intravascular ultrasound assessment of neointimal hyperplasia and nonuniform stent strut distribution in sirolimus-eluting stent restenosis. (2006) (15)
- Lipid Management in Patients Presenting With Acute Coronary Syndromes: A Review (2020) (15)
- Relation between the degree of procedural anticoagulation and complications after coronary stent implantation. (2003) (15)
- An intravascular ultrasound appraisal of atherosclerotic plaque distribution in diseased coronary arteries. (2012) (15)
- The use of the AVERT system to limit contrast volume administration during peripheral angiography and intervention (2015) (15)
- Association among leukocyte count, mortality, and bleeding in patients with non-ST-segment elevation acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] trial). (2013) (15)
- Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN‐TAVI registry (2018) (15)
- Comparison of outcomes in patients with ST-segment elevation myocardial infarction discharged on versus not on statin therapy (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial). (2014) (15)
- Outcomes of patients calling emergency medical services for suspected acute cardiovascular disease. (2015) (15)
- Predictors and impact of target vessel revascularization after stent implantation for acute ST-segment elevation myocardial infarction: lessons from HORIZONS-AMI. (2015) (15)
- Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD. (2021) (15)
- Anemia and Acute Coronary Syndrome: Time for Intervention Studies (2016) (15)
- Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization And Urgent Intervention Triage Strategy (ACUITY) substudy. (2010) (15)
- Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart Disease (2021) (15)
- Deferoxamine enhances neovascularization and recovery of ischemic skeletal muscle in an experimental sheep model. (2003) (15)
- Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population: Analysis From the ADAPT-DES Registry (2018) (15)
- Sex-Based Outcomes in Patients With a High Bleeding Risk After Percutaneous Coronary Intervention and 1-Month Dual Antiplatelet Therapy: A Secondary Analysis of the LEADERS FREE Randomized Clinical Trial. (2020) (15)
- Coronary In-Stent Restenosis: JACC State-of-the-Art Review. (2022) (15)
- Correlates and prognostic impact of new-onset heart failure after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: insights from the INFUSE-AMI trial (2018) (15)
- Relation between late patency of the infarct-related artery, left ventricular function, and clinical outcomes after primary percutaneous intervention for acute myocardial infarction (CADILLAC trial). (2004) (14)
- Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention (2020) (14)
- Intracoronary radiation for patients with refractory in-stent restenosis: an analysis from the WRIST-Crossover Trial. Washington Radiation for In-stent Restenosis Trial. (1999) (14)
- The Lancet Commission on women and cardiovascular disease: time for a shift in women's health (2019) (14)
- Compensatory enlargement of the left main coronary artery: insights from the PROSPECT study (2014) (14)
- Percutaneous transcatheter management of giant coronary aneurysms. (1999) (14)
- Relationship between the intensity of heparin anticoagulation and clinical outcomes in patients receiving glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction (2013) (14)
- Outcomes After Successful Percutaneous Coronary Intervention of Calcified Lesions Using Rotational Atherectomy, Cutting-Balloon Angioplasty, or Balloon-Only Angioplasty Before Drug-Eluting Stent Implantation. (2017) (14)
- Femoral vascular closure device use, bivalirudin anticoagulation, and bleeding after primary angioplasty for STEMI: Results from the HORIZONS‐AMI trial (2015) (14)
- Coronary stent implantation in patients committed to long-term oral anticoagulation therapy: successfully navigating the treatment options. (2011) (14)
- Feasibility and implications of an early discharge strategy after percutaneous intervention with abciximab in acute myocardial infarction (the CADILLAC Trial) (2003) (14)
- Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis. (2022) (14)
- Early Stent Thrombosis and Mortality After Primary Percutaneous Coronary Intervention in ST-Segment–Elevation Myocardial Infarction: A Patient-Level Analysis of 2 Randomized Trials (2016) (14)
- Impact of multiple complex plaques on short- and long-term clinical outcomes in patients presenting with ST-segment elevation myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Trial). (2014) (14)
- Acute and long-term outcomes of cutting balloon angioplasty followed by gamma brachytherapy for in-stent restenosis. (2003) (14)
- In vivo intravascular ultrasonic assessment of anomalous right coronary artery arising from left coronary sinus. (2009) (14)
- Thrombosis after implantation of drug-eluting stents. (2006) (14)
- Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry (2016) (13)
- Relationship between biomarkers and subsequent clinical and angiographic restenosis after paclitaxel-eluting stents for treatment of STEMI: a HORIZONS-AMI substudy (2011) (13)
- Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation: From the ADAPT-DES Study. (2018) (13)
- Impact of bivalirudin and paclitaxel-eluting stents on outcomes in patients undergoing primary percutaneous coronary intervention of the left anterior descending artery. (2013) (13)
- Intravascular ultrasound findings of stent fractures in patients with Sirolimus- and Paclitaxel-eluting stents. (2010) (13)
- Effectiveness of the concomitant use of bivalirudin and drug-eluting stents (from the prospective, multicenter BivAlirudin and Drug-Eluting STents [ADEST] study). (2005) (13)
- Usefulness of routine unfractionated heparin infusion following primary percutaneous coronary intervention for acute myocardial infarction in patients not receiving glycoprotein IIb/IIIa inhibitors. (2007) (13)
- Contemporary coronary artery bypass graft surgery and subsequent percutaneous revascularization (2021) (13)
- Impact of advanced age on the safety and effectiveness of paclitaxel‐eluting stent implantation in patients with ST‐segment elevation myocardial infarction undergoing primary angioplasty (2013) (13)
- Efficacy and safety of routine thrombus aspiration in patients with ST‐segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: An updated systematic review and meta‐analysis of randomized controlled trials (2016) (13)
- Ischemic Outcomes after Coronary Intervention of Calcified Vessels in Acute Coronary Syndromes: Pooled analysis from the HORIZONS-AMI and ACUITY trials (2014) (13)
- Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part€2: Endpoint Definitions (2017) (13)
- Prasugrel monotherapy after PCI with the SYNERGY stent in patients with chronic stable angina or stabilized acute coronary syndromes: rationale and design of the ASET pilot study. (2019) (13)
- Impact of Pre-Diabetes on Coronary Plaque Composition and Clinical Outcome in Patients With Acute Coronary Syndromes: An Analysis From the PROSPECT Study. (2017) (13)
- Age-related effects of smoking on coronary artery disease assessed by gray scale and virtual histology intravascular ultrasound. (2015) (13)
- Pharmacodynamic Effects of Vorapaxar in Prior Myocardial Infarction Patients Treated With Potent Oral P2Y12 Receptor Inhibitors With and Without Aspirin: Results of the VORA‐PRATIC Study (2020) (13)
- Risk stratification of patients undergoing medical therapy after coronary angiography. (2016) (13)
- Nonculprit Lesion Severity and Outcome of Revascularization in Patients With STEMI and Multivessel Coronary Disease. (2020) (13)
- Clinical features and prognosis of patients with spontaneous coronary artery dissection. (2020) (13)
- Accuracy of bleeding scores for patients presenting with myocardial infarction: a meta-analysis of 9 studies and 13 759 patients (2015) (13)
- Neurocognition and Cerebral Lesion Burden in High-Risk Patients Before Undergoing Transcatheter Aortic Valve Replacement: Insights From the SENTINEL Trial. (2018) (13)
- Paclitaxel-Eluting Stents Compared With Bare Metal Stents in Diabetic Patients With Acute Myocardial Infarction: The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial (2011) (13)
- Comparison of one-year outcomes after percutaneous coronary intervention among current smokers, ex-smokers, and nonsmokers. (2002) (13)
- Usefulness of the Left Anterior Descending Coronary Artery Wrapping Around the Left Ventricular Apex to Predict Adverse Clinical Outcomes in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Inf (2015) (12)
- Comparison of time course of target lesion revascularization following successful saphenous vein graft angioplasty versus successful native coronary angioplasty. (2000) (12)
- Bleeding Severity After Percutaneous Coronary Intervention (2018) (12)
- Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention: Insights From the PARIS Registry (2019) (12)
- Correlation of Admission Heart Rate With Angiographic and Clinical Outcomes in Patients With Right Coronary Artery ST‐Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: HORIZONS‐AMI (The Harmonizing Outcomes With Revascularization and Stents in Acute Myoca (2017) (12)
- N-acetylcysteine in preventing contrast-induced nephropathy. To give, or not to give: that is the question. (2010) (12)
- Predictors of Left Ventricular Ejection Fraction Improvement After Primary Stenting in ST-Segment Elevation Myocardial Infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial). (2017) (12)
- Comparison of safety and efficacy between first and second generation of angio-seal closure devices in interventional patients. (2004) (12)
- Individualizing treatment choices using quantitative methods. (2014) (12)
- Correlations between epicardial flow, microvascular reperfusion, infarct size and clinical outcomes in patients with anterior versus non-anterior myocardial infarction treated with primary or rescue angioplasty: analysis from the EMERALD trial. (2009) (12)
- Coronary reperfusion and clinical outcomes after thrombus aspiration during primary percutaneous coronary intervention: Findings from the HORIZONS‐AMI trial (2013) (12)
- Outcomes in elderly and young patients with ST‐segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with bivalirudin versus heparin: Pooled analysis from the EUROMAX and HORIZONS‐AMI trials (2017) (12)
- Antithrombotic Therapy after Percutaneous Coronary Intervention of Bifurcation Lesions. (2020) (12)
- Quantitative angiographic characterisation of coronary artery disease in patients with human immunodeficiency virus (HIV) infection undergoing percutaneous coronary intervention. (2017) (12)
- Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin versus Heparin in Acute Myocardial Infarction: Rationale and Methodology (2019) (12)
- The prevalence, predictors and outcomes of guideline‐directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry (2018) (12)
- Sex‐Based Differences in Bleeding Risk After Percutaneous Coronary Intervention and Implications for the Academic Research Consortium High Bleeding Risk Criteria (2021) (12)
- Photoplethysmography using a smartphone application for assessment of ulnar artery patency: a randomized clinical trial (2018) (12)
- The Obesity Paradox Revisited: Body Mass Index and Long-Term Outcomes After PCI From a Large Pooled Patient-Level Database. (2020) (12)
- Sex, adverse cardiac events, and infarct size in anterior myocardial infarction: an analysis of intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction (INFUSE-AMI). (2015) (12)
- SCAI multi‐society position statement on occupational health hazards of the catheterization laboratory: Shifting the paradigm for Healthcare Workers' Protection (2020) (12)
- Evidence base for the management of women with non-ST elevation acute coronary syndrome (2022) (11)
- Rationale and Design of the Small Annuli Randomized to EvolutTM or SAPIENTM Trial (SMART Trial). (2021) (11)
- Outcomes of patients consented but not randomized in a trial of primary percutaneous coronary intervention in acute myocardial infarction (the CADILLAC registry). (2005) (11)
- Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry. (2019) (11)
- P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention (2022) (11)
- Comparison of Radial Access, Guided Femoral Access, and Non-Guided Femoral Access Among Women Undergoing Percutaneous Coronary Intervention. (2018) (11)
- Non-vitamin K Antagonist Oral Anticoagulant After Acute Coronary Syndrome: Is There a Role? (2018) (11)
- Non-traditional risk factors and the risk of myocardial infarction in the young in the US population-based cohort (2020) (11)
- Impact of insulin treated and non‐insulin‐treated diabetes compared to patients without diabetes on 1‐year outcomes following contemporary PCI (2020) (11)
- Long-Term Clinical Impact of Contrast-Associated Acute Kidney Injury Following PCI: An ADAPT-DES Substudy. (2022) (11)
- Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable angina pectoris or provocable myocardial ischemia (a TAXUS IV substudy). (2005) (11)
- An Internet-based registry examining the efficacy of heparin coating in patients undergoing coronary stent implantation. (2005) (11)
- Vascular remodeling and plaque composition between focal and diffuse coronary lesions assessed by intravascular ultrasound. (2004) (11)
- Comparison of six risk scores in patients with triple vessel coronary artery disease undergoing PCI: Competing factors influence mortality, myocardial infarction, and target lesion revascularization (2013) (11)
- Intravascular brachytherapy for native coronary ostial in-stent restenotic lesions. (2003) (11)
- Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I) (2016) (11)
- Percutaneous Coronary Intervention and Adjunctive Pharmacotherapy in Women (2005) (11)
- Design and Rationale of the XIENCE Short DAPT Clinical Program: an Assessment of the Safety of 3-month or 1-month DAPT in Patients at High Bleeding Risk Undergoing PCI with an Everolimus-Eluting Stent. (2020) (11)
- Assessing and minimizing the risk of percutaneous coronary intervention in patients with chronic kidney disease (2018) (11)
- Gender‐based issues in interventional cardiology: A consensus statement from the Women in Innovations (WIN) Initiative (2010) (11)
- Sex‐Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient‐Level Pooled Analysis From 4 Postapproval Studies (2020) (11)
- Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents) (2017) (11)
- Operator Versus Core Laboratory Assessment of Angiographic Reperfusion Markers in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Myocardial Infarction (2012) (11)
- Guidelines for Patient-Reported Outcomes in Clinical Trial Protocols. (2018) (11)
- Impact of major bleeding on long-term mortality in anemic versus nonanemic patients undergoing percutaneous coronary intervention using bivalirudin. (2014) (11)
- Association of bleeding, mortality and sex in acute coronary syndromes: the missing triangle (2015) (11)
- Impact of chronic antiplatelet therapy before hospitalization on ischemic and bleeding events in invasively managed patients with acute coronary syndromes: the ACUITY trial (2011) (11)
- Complete vascular healing and sustained suppression of neointimal thickening after local delivery of advanced c-myc antisense at six months follow-up in a rabbit balloon injury model. (2002) (11)
- Hydration protocols to reduce the incidence of contrast-induced nephropathy. (2008) (11)
- Clinical profile and impact of family history of premature coronary artery disease on clinical outcomes of patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: analysis from the HORIZONS-AMI Trial. (2014) (11)
- Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry. (2017) (10)
- Intracoronary radiation therapy for patients with in-stent restenosis. Interim report from a randomized clinical study (1998) (10)
- Fixed and Modifiable Correlates of Drug-Eluting Stent Thrombosis From a Large All-Comers Registry: Insights From ADAPT-DES (2015) (10)
- Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta‐analysis (2018) (10)
- Incidence, predictors, and economic impact of contrast induced nephropathy: results in 8,628 patients treated with percutaneous coronary interventions (2002) (10)
- Intra-arterial reteplase for the treatment of acute limb ischemia. (1999) (10)
- Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry). (2017) (10)
- Radial versus femoral artery access in patients undergoing PCI for left main coronary artery disease: analysis from the EXCEL trial. (2018) (10)
- Outcomes following bail-out abciximab administration during primary intervention in acute myocardial infarction (The CADILLAC Trial). (2003) (10)
- Pretreatment with aspirin in acute coronary syndromes: Lessons from the ACUITY and HORIZONS-AMI trials (2016) (10)
- Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure: JACC State-of-the-Art Review. (2021) (10)
- The Bleeding Risk Score as a Mortality Predictor in Patients with Acute Coronary Syndrome (2013) (10)
- Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus‐eluting stents (2008) (10)
- The relative effects of abciximab and tirofiban on platelet inhibition and C-reactive protein during coronary intervention. (2010) (10)
- Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with ACS: a meta-analysis. (2021) (10)
- Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial (2019) (10)
- Patients with COVID‐19 who experience a myocardial infarction have complex coronary morphology and high in‐hospital mortality: Primary results of a nationwide angiographic study (2021) (10)
- Impact of Diabetes Mellitus on Ischemic Events in Men and Women After Percutaneous Coronary Intervention. (2017) (10)
- Contemporary practice patterns related to the risk of acute kidney injury in the catheterization laboratory: Results from a survey of Society of Cardiovascular Angiography and Intervention (SCAI) cardiologists (2017) (10)
- The impact of chronic kidney disease in women undergoing transcatheter aortic valve replacement: Analysis from the Women's INternational Transcatheter Aortic Valve Implantation (WIN‐TAVI) registry (2020) (10)
- Excimer laser coronary atherectomy for uncrossable coronary lesions. A multicenter registry (2020) (10)
- Post procedural risk assessment in patients undergoing trans aortic valve implantation according to the age, creatinine, and ejection fraction‐7 score: Advantages of age, creatinine, and ejection fraction‐7 in stratification of post‐procedural outcome (2018) (10)
- Characteristics and outcomes of patients with ST-segment elevation myocardial infarction excluded from the harmonizing outcomes with revascularization and stents in acute myocardial infarction (HORIZONS-AMI) trial. (2013) (10)
- Impact of scheduled angiographic follow-up in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. (2013) (10)
- Direct infusion of fenoldopam into the renal arteries to protect against contrast‐induced nephropathy in patients at increased risk (2012) (10)
- Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy. (2013) (10)
- Use of prasugrel vs clopidogrel and outcomes in patients with and without diabetes mellitus presenting with acute coronary syndrome undergoing percutaneous coronary intervention. (2019) (10)
- Erratum: Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents. J Am Coll Cardiol Intv 2011;4:97481 (2011) (10)
- Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarction (2021) (9)
- Coronary artery revascularization in chronic kidney disease: time for a randomized trial. (2015) (9)
- A null mutation in ANGPTL8 does not associate with either plasma glucose or type 2 diabetes in humans (2016) (9)
- Gender-specific outcomes after balloon aortic valvuloplasty: Inhospital and long-term outcomes. (2015) (9)
- Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention (2018) (9)
- The Implications of Acute Clinical Care Responsibilities on the Contemporary Practice of Interventional Cardiology. (2019) (9)
- Clinical endpoint adjudication in a contemporary all-comers coronary stent investigation: methodology and external validation. (2013) (9)
- One‐year results of the ICON (ionic versus non‐ionic contrast to obviate worsening nephropathy after angioplasty in chronic renal failure patients) Study (2016) (9)
- Comparison of abciximab versus eptifibatide during percutaneous coronary intervention in ST-segment elevation myocardial infarction (from the HORIZONS-AMI trial). (2012) (9)
- Serial intravascular ultrasound analysis of the impact of myocardial bridge on neointimal proliferation after coronary stenting in patients with acute myocardial infarction. (2010) (9)
- TCT-446 Long-Term Clinical Outcomes after Percutaneous Coronary Intervention for Chronic Total Occlusions in Elderly Patients (≥75 years): Five-Year Outcomes from a 1,791 Patient Multi-National Registry (2012) (9)
- Coronary artery disease in the young in the US population-based cohort. (2020) (9)
- Impact of pre‐existing or new‐onset atrial fibrillation on 30‐day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial (2017) (9)
- Sex-Specific Considerations in the Presentation, Diagnosis, and Management of Ischemic Heart Disease: JACC Focus Seminar 2/7. (2022) (9)
- Intracoronary Imaging, Cholesterol Efflux, and Transcriptomics after Intensive Statin Treatment in Diabetes (2017) (9)
- Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention: JACC Review Topic of the Week. (2021) (9)
- Long-Term Outcomes After Revascularization for Stable Ischemic Heart Disease (2020) (9)
- Cuestiones relativas al sexo en cardiología intervencionista: declaración de consenso de la iniciativa Women in Innovations (WIN) (2010) (9)
- Role of PLA2 polymorphism on clinical events after percutaneous coronary intervention (2009) (9)
- Relation of C-reactive protein levels to instability of untreated vulnerable coronary plaques (from the PROSPECT Study). (2014) (9)
- Bleeding Events Before Coronary Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome. (2016) (9)
- New‐generation drug‐eluting stents reduce stent thrombosis and myocardial infarction: A propensity‐score‐adjusted analysis from the multicenter REAL registry (REgistro Regionale AngiopLastiche Dell'Emilia‐Romagna) (2015) (9)
- The association between the extent of coronary artery disease and major bleeding events after percutaneous coronary intervention: from the ACUITY trial. (2015) (9)
- N-acetilcisteína en la prevención de la nefropatía inducida por contraste. Administrar o no administrar: ésta es la cuestión (2010) (9)
- Comparisons of the uptake and in-hospital outcomes associated with second-generation drug-eluting stents between men and women: results from the CathPCI Registry (2016) (9)
- Intravascular Ultrasound—Guided Renal Artery Stenting (2001) (9)
- Gender differences in industry payments among cardiologists. (2019) (9)
- Evaluating the bite of the BARC. (2012) (9)
- Safety of intracoronary gamma-radiation on uninjured reference segments during the first 6 months after treatment of in-stent restenosis: a serial intravascular ultrasound study. (2000) (9)
- 1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents: Propensity Score-Matched Comparison of the COMBO and Ultrathin-Strut Orsiro Stents. (2020) (9)
- Calculated Serum Osmolality, Acute Kidney Injury, and Relationship to Mortality after Percutaneous Coronary Intervention (2019) (9)
- Prevalence, predictors, and outcomes of patient prosthesis mismatch in women undergoing TAVI for severe aortic stenosis: Insights from the WIN‐TAVI registry (2020) (9)
- Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials. (2022) (8)
- Comparative effectiveness of upstream glycoprotein IIb/IIIa inhibitors in patients with moderate- and high-risk acute coronary syndromes: an Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) substudy. (2014) (8)
- Excimer laser angioplasty in the treatment of instent restenosis: An intravascular ultrasound study (1996) (8)
- A sex paradox in clinical outcomes following complex percutaneous coronary intervention. (2020) (8)
- Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DES. (2021) (8)
- Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review (2022) (8)
- Sex‐based differences in outcomes with bivalirudin or unfractionated heparin for transcatheter aortic valve replacement: Results from the BRAVO‐3 randomized trial (2017) (8)
- Prediction of 1‐year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient‐level pooled analysis from three randomized trials (2016) (8)
- Sex-Related Outcomes of Medical, Percutaneous, and Surgical Interventions for Coronary Artery Disease: JACC Focus Seminar 3/7. (2022) (8)
- Optimally deployed stents in the treatment of restenotic versus de novo lesions. (2000) (8)
- Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI. (2021) (8)
- APPOSITION V: STENTYS coronary stent system clinical trial in subjects with ST-segment elevation myocardial infarction--rationale and design. (2014) (8)
- Women’s Voices in Cardiology: An Uncomfortable Silence (2018) (8)
- Effects of baseline and early acquired thrombocytopaenia on long-term mortality in patients undergoing percutaneous coronary intervention with bivalirudin. (2016) (8)
- Hemoglobin A1c and Cardiovascular Outcomes Following Percutaneous Coronary Intervention: Insights From a Large Single-Center Registry. (2021) (8)
- Bleeding After Aortic Valve Replacement Matters: Important Mortality Risk. (2017) (8)
- Prognostic value of recurrent episodes of creatine kinase‐MB elevation following repeated catheter‐based coronary interventions (2000) (8)
- Net clinical benefit of patent foramen ovale closure in patients with cryptogenic stroke: Meta-analysis and meta-regression of randomized trials. (2018) (8)
- First clinical experience with 17- estradiol-eluting biodivYsio matrix LO stent to prevent restenosis in de-novo native coronary arteries: Six-month clinical outcomes and angiographic follow-up from the EASTER trial (2003) (8)
- Changes in reference vessel diameter in ST-segment elevation myocardial infarction after primary percutaneous coronary intervention: implications for appropriate stent sizing. (2011) (8)
- Prognostic Relation Between Severity of Diabetes Mellitus (On or Off Insulin) ± Chronic Kidney Disease with Cardiovascular Risk After Percutaneous Coronary Intervention. (2018) (8)
- The link between anemia and adverse outcomes in patients with acute coronary syndrome (2019) (8)
- Temporal trends, determinants, and impact of high‐intensity statin prescriptions after percutaneous coronary intervention: Results from a large single‐center prospective registry (2019) (8)
- Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench-to-bedside. (2022) (8)
- Contrast-Associated Acute Kidney Injury. Reply. (2019) (8)
- Impact of diabetes mellitus on short term vascular complications after TAVR: Results from the BRAVO-3 randomized trial. (2019) (8)
- Ticagrelor reduces thrombus formation more than clopidogrel, even when co-administered with bivalirudin (2014) (8)
- Defining Device Success for Percutaneous Coronary Intervention Trials: A Position Statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology. (2019) (8)
- Prognostic value of angiographic lesion complexity in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the acute catheterization and urgent intervention triage strategy trial). (2014) (8)
- SCAI Multi-Society Position Statement on Occupational Health Hazards of the Catheterization Laboratory: Shifting the Paradigm for Healthcare Workers' Protection. (2020) (8)
- A prospective, randomized trial of bivaliruclin in acute coronary syndromes: One year results from the ACUITY Trial (2007) (8)
- Impact of in-hospital major bleeding on outcomes in acute coronary syndromes (2012) (8)
- Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium (2022) (8)
- Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation (2022) (8)
- Is routine post-procedural anticoagulation warranted after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction? Insights from the HORIZONS-AMI trial (2017) (7)
- Classification for Assessing the Quality of Diagnostic Coronary Angiography. (2017) (7)
- Neuroprotection reduces the risk of peri-procedural major strokes and death in octogenarians (2002) (7)
- Implications of pre-procedural TIMI flow in patients with non ST-segment elevation acute coronary syndromes undergoing percutaneous coronary revascularization: insights from the ACUITY trial. (2013) (7)
- Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN‐TAVI registry (2020) (7)
- Safety and efficacy of non–vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: A bivariate analysis of the PIONEER AF‐PCI and RE‐DUAL PCI trial (2018) (7)
- Worsening atrioventricular conduction after hospital discharge in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the HORIZONS-AMI trial (2017) (7)
- Patient-centered contrast thresholds to reduce acute kidney injury in high-risk patients undergoing percutaneous coronary intervention. (2020) (7)
- Polymer-free Drug-Coated Coronary Stents. (2016) (7)
- Influence of Final Kissing Balloon Inflation on Long-term Outcomes After PCI of Distal Left Main Bifurcation Lesions: Analysis From the EXCEL Trial. (2019) (7)
- Does clinical presentation affect outcome among patients with acute coronary syndromes undergoing percutaneous coronary intervention? Insights from the Providing Regional Observations to Study Predictors of Events in the Coronary Tree study. (2012) (7)
- Feasibility and implications of an early discharge strategy after percutaneous intervention with abciximab in acute myocardial infarction (the CADILLAC Trial). (2003) (7)
- Comparison of the effects of pretreatment with tirofiban, clopidogrel or both on the inhibition of platelet aggregation and activation in patients with acute coronary syndromes (2007) (7)
- Incidence, predictors, and impact of neurological events in non-ST-segment elevation acute coronary syndromes: the ACUITY trial. (2015) (7)
- Clinical outcomes following "rescue" administration of abciximab in patients undergoing percutaneous coronary angioplasty. (2000) (7)
- The Contemporary Pulse of Bioresorbable-Scaffold Thrombosis Among Expert Operators. (2016) (7)
- Hospitalization among Patients with Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated with Apixaban or Aspirin: Insights from the AUGUSTUS Trial. (2019) (7)
- DETECTION AND IMPACT OF SUBCLINICAL CORONARY AND CAROTID ATHEROSCLEROSIS ON CARDIOVASCULAR RISK PREDICTION AND RECLASSIFICATION IN ASYMPTOMATIC US ADULTS: INSIGHTS FROM THE HIGH RISK PLAQUE BIOIMAGE STUDY (2014) (7)
- ascular Complications Associated With rteriotomy Closure Devices in Patients ndergoing Percutaneous Coronary Procedures (2016) (7)
- Coronary Artery Bypass Surgery Compared With Percutaneous Coronary Intervention for Proximal Left Anterior Descending Artery Treatment in Patients With Acute Coronary Syndrome: Analysis From the ACUITY Trial. (2015) (7)
- Women and Cardiology: The Value of Diversity. (2020) (7)
- Evaluation and Treatment of Patients With Lower Extremity Peripheral Artery Disease: (2015) (7)
- Temporal Trends in the Proportion of Women Physician Speakers at Major Cardiovascular Conferences. (2021) (7)
- Are drug-eluting stents safe in the long term? (2009) (7)
- Frequency, mechanisms, and implications of late peri-stent contrast staining: analysis (from the HORIZONS-AMI Trial). (2013) (7)
- Balancing ischaemia and bleeding risks with novel oral anticoagulants (2014) (7)
- The Ideal Anticoagulation Strategy in ST-Elevation Myocardial Infarction. (2015) (7)
- Safety and Efficacy of Bivalirudin in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: From the REPLACE-2, ACUITY and HORIZONS-AMI Trials. (2016) (7)
- How important is time to treatment with primary percutaneous coronary intervention for acute myocardial infarction? Results from the CADILLAC trial (2003) (7)
- Impact of Discharge Location After Transcatheter Aortic Valve Replacement on 1-Year Outcomes in Women: Results From the WIN-TAVI Registry. (2019) (7)
- Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention. (2022) (7)
- PCI and CABG surgery in 2014: CABG surgery versus PCI in CAD—surgery strikes again! (2015) (7)
- Impact of stent diameter on outcomes following percutaneous coronary intervention with second‐generation drug‐eluting stents: Results from a large single‐center registry (2019) (7)
- Patterns and Impact of Dual Antiplatelet Cessation on Cardiovascular Risk After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes. (2019) (7)
- Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review. (2022) (7)
- Relationship between insulin resistance, coronary plaque, and clinical outcomes in patients with acute coronary syndromes: an analysis from the PROSPECT study (2021) (7)
- Temporal Trends in Statin Prescriptions and Residual Cholesterol Risk in Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention. (2019) (7)
- Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk. (2021) (7)
- Prognostic utility of myocardial blush grade after PCI in patients with NSTE‐ACS: Analysis from the ACUITY trial (2016) (6)
- The impact of switching P2Y12 receptor inhibitor therapy during index hospitalization: a systematic review (2015) (6)
- A provisional strategy for treating true bifurcation lesions employing a scoring balloon for the side branch (2013) (6)
- Design and rationale of a randomized trial of COBRA PzF stenting to REDUCE duration of triple therapy (COBRA-REDUCE). (2021) (6)
- Prognostic implications of Q waves at presentation in patients with ST‐segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: An analysis of the HORIZONS‐AMI study (2017) (6)
- Usefulness of the angiographic pattern of in-stent restenosis in predicting the success of gamma vascular brachytherapy. (2003) (6)
- Incidence, determinants and clinical impact of definite stent thrombosis on mortality in women: From the WIN-DES collaborative patient-level pooled analysis. (2018) (6)
- Abstract 4949: Bleeding and Ischemic Complications in Patients With Acute Coronary Syndromes and Chronic Kidney Disease in Relation to Different Glycoprotein IIb/IIIa Inhibitors: Analysis From the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) Trial (2009) (6)
- Impact of Smoking on Platelet Reactivity and Clinical Outcomes After Percutaneous Coronary Intervention: Findings From the ADAPT-DES Study. (2019) (6)
- Impact of high on‐aspirin platelet reactivity on outcomes following successful percutaneous coronary intervention with drug‐eluting stents (2018) (6)
- Gender Differences in Associations Between Intraprocedural Thrombotic Events During Percutaneous Coronary Intervention and Adverse Outcomes. (2016) (6)
- Improving the Design of Future PCI Trials for Stable Coronary Artery Disease: JACC State-of-the-Art Review. (2020) (6)
- Efficacy and safety of bivalirudin in coronary artery disease patients with mild to moderate chronic kidney disease: Meta-analysis. (2018) (6)
- Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk: A Cost Consequence Simulation From PARIS (2019) (6)
- Small‐vessel PCI outcomes in men, women, and minorities following platinum chromium everolimus‐eluting stents: Insights from the pooled PLATINUM Diversity and PROMUS Element Plus Post‐Approval studies (2019) (6)
- Impact of Point-of-Care Platelet Function Testing Among Patients With and Without Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents (from the ADAPT-DES Study). (2019) (6)
- IMPACT OF POINT–OF–CARE PLATELET FUNCTION TESTING AMONG PATIENTS WITH AND WITHOUT ACUTE CORONARY SYNDROMES UNDERGOING PCI WITH DRUG–ELUTING STENTS: AN ADAPT–DES SUBSTUDY (2012) (6)
- Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations. (2022) (6)
- Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents. (2019) (6)
- Safety issues related to treating bifurcation lesions. (2010) (6)
- Procedural and 1‐year clinical outcomes of orbital atherectomy for treatment of coronary in‐stent restenosis: A single‐center, retrospective study (2020) (6)
- Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction: Results from the CADILLAC trial (2008) (6)
- Impact of high on‐treatment platelet reactivity on outcomes following PCI in patients on hemodialysis: An ADAPT‐DES substudy (2019) (6)
- Patterns of in-stent restenosis Classification and impact on subsequent target lesion revascularization (1998) (6)
- Relationship between biomarkers and subsequent bleeding risk in ST-segment elevation myocardial infarction patients treated with paclitaxel-eluting stents: a HORIZONS-AMI substudy (2013) (6)
- P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions. (2023) (6)
- Cost Implications of Anticoagulation Strategies After Percutaneous Coronary Intervention Among Patients With Atrial Fibrillation (A PIONEER-AF PCI Analysis). (2019) (6)
- Percutaneous coronary intervention of lesions with in‐stent restenosis: A report from the ADAPT‐DES study (2017) (6)
- Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study). (2019) (6)
- Paravalvular Leak: An Interesting Interplay of Acquired vWF-Disease and Late Bleeding After TAVR. (2018) (6)
- Effect of stent diameter in women undergoing percutaneous coronary intervention with early- and new-generation drug-eluting stents: From the WIN-DES collaboration. (2019) (6)
- DOES PLATELET FUNCTION TESTING ADD SIGNIFICANT INCREMENTAL RISK STRATIFICATION TO UNSELECTED PATIENTS UNDERGOING DES IMPLANTATION? THE ADAPT-DES STUDY (2012) (6)
- Treatment of restenotic drug-eluting stents: an intravascular ultrasound analysis. (2007) (5)
- Optimal catchment area and primary PCI centre volume revisited: a single-centre experience in transition from high-volume centre to "mega centre" for patients with ST-segment elevation myocardial infarction. (2015) (5)
- Impact of Atrial Fibrillation on Acute Coronary Syndrome--Analysis of In-Hospital Outcomes and 30-Day Readmissions. (2020) (5)
- SCAI Expert Consensus Statement on Sex-Specific Considerations in Myocardial Revascularization (2022) (5)
- Non‐femoral TAVR: Time to stratify alternative vascular approaches (2018) (5)
- Follow the data: bivalirudin (and not heparin alone) during percutaneous coronary intervention provides the best clinical outcomes. (2015) (5)
- Atrial fibrillation, with ACS and PCI: walking a tightrope. (2019) (5)
- Antithrombotic strategy variability in ATrial fibrillation and obstructive coronary disease revascularized with PCI-rationale and study design of the prospective observational multicenter AVIATOR 2 registry. (2015) (5)
- Trends and Outcomes of Intravascular Imaging-guided Percutaneous Coronary Intervention in the United States (2019) (5)
- Influence of vessel diameter on the efficacy of distal protection devices during saphenous vein graft intervention. (2005) (5)
- TCT-244 Baseline Thrombocytopenia: A Strong Predictor Of One-Year Adverse Ischemic Events In Patients With ACS Undergoing PCI: A Pooled analysis From ACUITY And HORIZONS-AMI Trials (2013) (5)
- Complete Revascularization vs Culprit Lesion-Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical Trial. (2022) (5)
- Two-year safety and effectiveness of sirolimus-eluting stents (from a prospective registry). (2011) (5)
- Percutaneous coronary intervention of bifurcation lesions and platelet reactivity. (2018) (5)
- Mechanisms and Results of Additional Stent Implantation to Treat Focal In-stent Restenosis (1998) (5)
- 843-2 Everolimus-eluting stents for the prevention of restenosis: Results of the FUTURE II trial (2004) (5)
- Treating Inflammation Prior to Percutaneous Coronary Intervention: Does the Heart Care? (2020) (5)
- Morphological changes and clinical impact of unstable plaques within untreated segments of acute myocardial infarction patients during a 3-year follow-up: an analysis from the HORIZONS-AMI trial (2015) (5)
- Clinical event committees in coronary stent trials: insights and recommendations based on experience in an unselected study population. (2012) (5)
- Safety and efficacy of the bioabsorbable polymer everolimus‐eluting stent versus durable polymer drug‐eluting stents in high‐risk patients undergoing PCI: TWILIGHT‐SYNERGY (2020) (5)
- Sirolimus‐coated balloon versus everolimus‐eluting stent in de novo coronary artery disease: Rationale and design of the TRANSFORM II randomized clinical trial (2022) (5)
- Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research Consortium. (2020) (5)
- Late quantitative angiographic results after NIR stent use: results from the NIRVANA randomized trial end registries (1998) (5)
- Negative remodeling at the ostium of the left circumflex artery. (2001) (5)
- Abstract 5986: Drug-Eluting Stent versus Bare Metal Stent Use: Meta-Analysis of Randomized Trials and Observational Studies (2008) (5)
- DIABETES MELLITUS, MYOCARDIAL REPERFUSION AND OUTCOME IN PATIENTS WITH ACUTE ST-ELEVATION MYOCARDIAL INFARCTION TREATED WITH PRIMARY ANGIOPLASTY; INSIGHTS FROM HORIZONS AMI (2012) (5)
- Cerebrovascular Events After a Primary Percutaneous Coronary Intervention Strategy for Acute ST-Segment– Elevation Myocardial Infarction: Analysis From the HORIZONS-AMI Trial (2015) (5)
- Relationship between high shear stress and OCT-verified thin-cap fibroatheroma in patients with coronary artery disease (2020) (5)
- Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention—Results from the PROMETHEUS registry (2020) (5)
- Childbearing Among Women Cardiologists: The Interface of Experience, Impact, and the Law. (2022) (5)
- Safety and Efficacy of Ticagrelor Monotherapy According to Drug-Eluting Stent Type: The TWILIGHT-STENT Study. (2021) (5)
- Effect of Short Procedural Duration With Bivalirudin on Increased Risk of Acute Stent Thrombosis in Patients With STEMI: A Secondary Analysis of the HORIZONS-AMI Randomized Clinical Trial (2017) (5)
- Prevalence and Impact of High Bleeding Risk in Patients Undergoing Left Main Artery Disease PCI (2021) (5)
- FAME and coronary stent investigations: is there a kink in the wire? (2011) (5)
- IMPACT OF CORONARY CALCIFICATION ON ONE–YEAR OUTCOMES AFTER PCI IN STEMI AND NSTEMI: POOLED ANALYSIS FROM HORIZONS AND ACUITY TRIALS (2013) (5)
- Impact of gender on infarct size, ST-segment resolution, myocardial blush and clinical outcomes after primary stenting for acute myocardial infarction: Substudy from the EMERALD trial. (2016) (5)
- Predictors of mortality in patients with non‐anterior ST‐segment elevation myocardial infarction: Analysis from the HORIZONS‐AMI trial (2019) (5)
- Radial artery occlusion: Preventing Insult to Injury (2015) (5)
- Dual Antiplatelet Therapy Dilemmas: Duration and Choice of Antiplatelets in Acute Coronary Syndromes (2013) (5)
- Intracoronary brachytherapy not associated with changes in major side branches (2000) (5)
- Handbook of chronic total occlusions (2008) (5)
- DE NOVO CORONARY LESIONS TREATED WITH THE NOVEL POLYMER-FREE BIOLIMUS-A9 COATED STENTS: 12-MONTH ANGIOGRAPHIC RESULTS FROM THE PROSPECTIVE RANDOMIZED MULTICENTER BIOFREEDOM CLINICAL TRIAL (2011) (4)
- New-generation drug-eluting stents for left main coronary artery disease according to the EXCEL trial enrollment criteria: Insights from the all-comers, international, multicenter DELTA-2 registry. (2019) (4)
- Revascularization Strategies for Calcified Lesions in Patients Presenting With Acute Coronary Syndromes (From the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] Trial). (2016) (4)
- Device profile of the Resolute Onyx Zotarolimus eluting coronary stent system for the treatment of coronary artery disease: overview of its safety and efficacy (2020) (4)
- Percutaneous Coronary Intervention Outcomes in Very Elderly Patients From a Single Large-Volume Tertiary Care Center, Specifically Focusing on Nonagenarians. (2017) (4)
- TCT-313 Incidence and Predictors of Very Late Major Adverse Cardiac Events After Metallic Stents: A Patient-Level Pooled Analysis from Seventeen Randomized Trials. (2016) (4)
- Sacubitril/valsartan versus ramipril for patients with acute myocardial infarction: win‐ratio analysis of the PARADISE‐MI trial (2022) (4)
- Intervention for Treating Side Branches Effectively) Study Stent in Coronary Bifurcation Lesions: The DIVERGE (Drug-Eluting Stent Prospective Evaluation of the Axxess Self-Expanding Biolimus A9-Eluting 9-Month Clinical, Angiographic, and Intravascular Ultrasound Results of a (2009) (4)
- Current developments in dual antiplatelet therapy after stenting. (2014) (4)
- Impact of body mass index on outcomes in patients undergoing transfemoral transcatheter aortic valve implantation (2021) (4)
- Role of new sirolimus self-apposing stent in coronary interventions. (2015) (4)
- Have the outcomes of rescue angioplasty after failed thrombolytic therapy in acute myocardial infarction improved in the stent era (2002) (4)
- Report of the European Society of Cardiology Cardiovascular Round Table regulatory workshop update of the evaluation of new agents for the treatment of acute coronary syndrome: Executive summary (2019) (4)
- Antiplatelets and AntithrombinsTCT-152 Is There a Therapeutic Window For Platelet Responsiveness Among PCI Patients? Analysis from the ADAPT-DES Study (2013) (4)
- Residual angina in female patients after coronary revascularization. (2019) (4)
- Becoming a Parent During Cardiovascular Training. (2022) (4)
- TCT-68 Does IVUS Reduce Stent Thrombosis with DES? Two-year results from the prospective, multicenter ADAPT-DES study (2013) (4)
- Abstract 4505: Presentation To Non-PCI Center Is Major Modifiable Factor Associated With Delayed Door-to-balloon Time In HORIZONS-AMI (2008) (4)
- Assessment of Fibrous Cap Thickness by Optical Coherence Tomography In Vivo: Reproducibility and Standardization (2016) (4)
- Prognostic Impact of High-Sensitivity C-Reactive Protein in Patients Undergoing Percutaneous Coronary Intervention According to BMI. (2020) (4)
- Future stent drug delivery systems. (2008) (4)
- Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS study (2020) (4)
- Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI (2022) (4)
- Outcomes of bail-out stenting for suboptimal balloon angioplasty during primary intervention in acute myocardial infarction (The CADILLAC trial). (2003) (4)
- Advances in dual therapy stenting. (2016) (4)
- Acute Coronary Syndromes: Advances in Antithrombotics (2013) (4)
- Comparison of frequency of hemorrhagic stroke in patients <75 years versus > or =75 years of age among patients receiving glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions. (2004) (4)
- Cardiogenic Shock in Women. (2012) (4)
- Bleeding avoidance in transcatheter aortic valve replacement: a call to ACTion? (2014) (4)
- Gender outcomes in acute myocardial infarction: are women from Venus and men from Mars? (2011) (4)
- Comparison of effect of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions on risk of hemorrhagic stroke in patients >or=75 years of age versus those <75 years of age. (2003) (4)
- Incidence, predictors, and outcomes associated with acute kidney injury in patients undergoing transcatheter aortic valve replacement: from the BRAVO-3 randomized trial (2021) (4)
- One‐year outcomes of patients undergoing complex percutaneous coronary intervention with three contemporary drug‐eluting stents (2020) (4)
- Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations. (2022) (4)
- Drug-Eluting Stents in the Treatment of Intermediate Lesions (2006) (4)
- Does lesion length affect late outcome of patients with in-stent restenosis? Results of the multicenter laser angioplasty for stent restenosis (LARS) registry (1998) (4)
- Relationship Between Stent Diameter, Platelet Reactivity, and Thrombotic Events After Percutaneous Coronary Artery Revascularization. (2019) (4)
- IMPACT OF GENDER ON PATTERNS OF DUAL ANTIPLATELET THERAPY CESSATION AND NON-ADHERENCE: ONE-YEAR RESULTS FROM THE PATTERNS OF NON-ADHERENCE TO ANTI-PLATELET REGIMENS IN STENTED PATIENTS (PARIS), AN OBSERVATIONAL SINGLE-ARM STUDY (2013) (4)
- OUTCOMES OF PATIENTS WITH ACUTE CORONARY SYNDROMES AND PRIOR CORONARY ARTERY BYPASS GRAFTING: ANALYSIS FROM THE ACUITY TRIAL (2010) (4)
- Dual Antiplatelet Therapy Discontinuation, Platelet Reactivity, and Adverse Outcomes After Successful Percutaneous Coronary Intervention. (2022) (4)
- "Capturing" the Benefits of Dual-Therapy Stent Technology: Is This a Promise or Reality? (2016) (4)
- Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO‐3 randomized trial (2019) (4)
- Current evidence for the safety and efficacy of the bio-engineered dual therapy COMBO stent. (2018) (4)
- Cost implications of intraprocedural thrombotic events during PCI (2015) (4)
- Revascularization of a chronically occluded left anterior descending artery: is it worth all the effort? (2008) (4)
- State of the art contemporary treatment of patients with ST elevation myocardial infarction: pre‐ and in‐hospital organization, devices and drugs (2014) (4)
- TCT-44 Frequency and Impact of Acute Stent Deformation After PCI of Left Main Coronary Artery Disease: An EXCEL trial intravascular ultrasound substudy (2017) (4)
- Edwards SAPIEN Versus Medtronic Aortic Bioprosthesis in Women Undergoing Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry). (2019) (4)
- Impact of Race and Ethnicity on the Clinical and Angiographic Characteristics, Social Determinants of Health, and 1-Year Outcomes After Everolimus-Eluting Coronary Stent Procedures in Women: Insights From the Pooled PLATINUM Diversity and PROMUS ELEMENT PLUS Postapproval Studies (2019) (4)
- Cardiovascular outcomes after percutaneous coronary intervention on bifurcation lesions with moderate to severe coronary calcium: A single‐center registry study (2020) (4)
- Clinical and angiographic predictors of haemodynamically significant angiographic lesions: development and validation of a risk score to predict positive fractional flow reserve. (2017) (4)
- Impact of thienopyridine administration prior to primary stenting in acute myocardial infarction. (2009) (4)
- Diabetes mellitus and multivessel coronary artery disease: an ongoing battle for an ideal treatment strategy. (2017) (4)
- The REMEDEE trial: 5‐Year results on a novel combined sirolimus‐eluting and endothelial progenitor cells capturing stent (2020) (4)
- A multicenter, randomized, dose-finding study of gamma intracoronary radiation therapy to inhibit recurrent restenosis after stenting. (2006) (4)
- Dedicated two-stent technique in complex bifurcation percutaneous coronary intervention with use of everolimus-eluting stents: the EES-bifurcation study. (2014) (4)
- Outcomes by Gender and Ethnicity After Percutaneous Coronary Intervention. (2019) (3)
- Gender Issues in Italian Catheterization Laboratories: The Gender‐CATH Study (2021) (3)
- Coronary artery bypass graft versus percutaneous coronary intervention with drug-eluting stent implantation for diabetic patients with unprotected left main coronary artery disease: the D-DELTA registry. (2013) (3)
- P5367Indirect comparison of the safety and efficacy of alirocumab and evolocumab: from a comprehensive meta-analysis of 30 randomized controlled trials (2019) (3)
- Safety and efficacy of very low LDL-cholesterol intensive lowering: a meta-analysis and meta-regression of randomized trials. (2022) (3)
- Letter by Mehran et al regarding article, "Bleeding academic research consortium consensus report: the food and drug administration perspective". (2012) (3)
- BIVALIRUDIN VERSUS HEPARIN WITH OR WITHOUT GLYCOPROTEIN IIB/IIIA INHIBITORS IN STEMI PATIENTS UNDERGOING PRIMARY PCI: A POOLED ANALYSIS OF PATIENT-LEVEL DATA FROM THE HORIZONS-AMI AND EUROMAX TRIALS (2014) (3)
- Ticagrelor Monotherapy After Coronary Stenting: Is the GLASS Half Full or Half Empty? (2019) (3)
- Safety and efficacy of bivalirudin monotherapy in patients with non-ST-segment elevation acute coronary syndromes with positive biomarkers undergoing percutaneous coronary intervention: a report from the Acute Catheterization and Urgent Intervention Triage Strategy trial. (2020) (3)
- ASSOCIATION BETWEEN VULNERABLE PLAQUE AND SERUM LDL-CHOLESTEROL LEVEL AS ASSESSED WITH VIRTUAL HISTOLOGY INTRAVASCULAR ULTRASOUND: ANALYSIS FROM PROSPECT (2011) (3)
- Are adverse events following an invasive strategy in patients with non‐ST‐segment elevation acute coronary syndromes more frequent at US sites versus Non‐US sites? analysis from the ACUITY trial (2013) (3)
- Impact of pre-procedural cardiopulmonary instability in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial). (2014) (3)
- Small proximal vessels are not always small: an intravascular ultrasound study (2002) (3)
- Correlates and Impact of Coronary Artery Calci fi cations in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents (3)
- Outcomes in Valve-in-Valve Transcatheter Aortic Valve Implantation. (2022) (3)
- Medication Nonadherence: A Challenging Conundrum for Clinical Trials, Patients, and Clinicians. (2022) (3)
- Balloon-Expandable versus Self-Expandable Valves in Transcatheter Aortic Valve Implantation: Complications and Outcomes from a Large International Patient Cohort (2021) (3)
- Abstract 20882: Predictors of Suboptimal TIMI Flow after Primary Angioplasty for Acute Myocardial Infarction: Results from the HORIZONS-AMI Trial (2010) (3)
- The clinical impact of sidebranch occlusion and sidebranch narrowing after elective coronary stent placement in STARS (1998) (3)
- Sex-Based Differences in Acute€Coronary€Syndromes (3)
- Postprocedural anticoagulation for specific therapeutic indications after revascularization for ST-segment elevation myocardial infarction (from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial). (2014) (3)
- Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry (2019) (3)
- Angiography and Interventions Association Task Force on Practice Guidelines and the Society for Cardiovascular Summary : A Report of the American College of Cardiology Foundation/American Heart 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive (2012) (3)
- Impact of bleeding assessment and adjudication methodology on event rates and clinical trial outcomes: insights from the HORIZONS-AMI trial. (2018) (3)
- Impact of antithrombotic treatment on short-term outcomes after percutaneous coronary intervention for left main disease: a pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials. (2014) (3)
- Impact of nonculprit vessel myocardial perfusion on outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes: analysis from the ACUITY trial (Acute Catheterization and Urgent Intervention Triage Strategy). (2014) (3)
- Revascularization Strategies for Patients With Femoropopliteal Peripheral Artery Disease. (2023) (3)
- Clinical Events Classification (CEC) in Clinical Trials: Report on the Current Landscape and Future Directions - Proceedings from the CEC Summit 2018. (2021) (3)
- Safety and Efficacy of Bivalirudin Monotherapy in Patients With Diabetes Mellitus and Acute Coronary Syndromes (2008) (3)
- TCT-593 Gender Difference in Chest Pain After Implantation of Newer Generation Coronary Drug-Eluting Stents: A Patient-Level Pooled Analysis From TWENTE and DUTCH PEERS (2015) (3)
- Post TAVI paravalvular regurgitation: Can we stop the leak? (2011) (3)
- Abluminus DES+ for the treatment of coronary artery disease in patients with diabetes mellitus. (2020) (3)
- IMPACT OF HYPERCHOLESTEROLEMIA ON ATHEROSCLEROTIC PLAQUE COMPOSITION: A VIRTUAL HISTOLOGY INTRAVASCULAR ULTRASOUND ANALYSIS FROM PROSPECT (2011) (3)
- Clinical Impact of Enhanced Inhibition of P2Y12-Mediated Platelet Aggregation in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention (2010) (3)
- The radiance P-32 RDX balloon in saphenous vein grafts: A comparison of De-Novo and In-Stent restenotic lesions in the SVG brite trial (2003) (3)
- Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients with Atrial Fibrillation After Acute Coronary Syndrome or PCI: Insights from The AUGUSTUS Trial. (2021) (3)
- Ticagrelor With or Without Aspirin in Chinese Patients Undergoing Percutaneous Coronary Intervention: A TWILIGHT China Substudy (2022) (3)
- Angiographic in-stent restenosis patten predicts outcome after gamma vascular brachytherapy (2003) (3)
- PROGNOSTIC IMPACT OF STAGED VERSUS "ONE-TIME" MULTIVESSEL PCI IN ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: LONG-TERM ANALYSIS FROM THE HORIZONS-AMI TRIAL (2011) (3)
- Cardiological Society of India practice guidelines for angiography in patients with renal dysfunction. (2012) (3)
- IMPACT OF EJECTION FRACTION ON MORTALITY IN PATIENTS UNDERGOING PCI: A PATIENT-LEVEL POOLED ANALYSIS FROM THE REPLACE-2, ACUITY AND HORIZONS-AMI TRIALS (2012) (3)
- O escore de risco de sangramento como preditor de mortalidade em pacientes com síndromes coronarianas agudas (2013) (3)
- Associations between use of prasugrel vs clopidogrel and outcomes by type of acute coronary syndrome: an analysis from the PROMETHEUS registry (2019) (3)
- COMPLETE VERSUS CULPRIT-LESION-ONLY REVASCULARIZATION FOR ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: A COLLABORATIVE META-ANALYSIS OF RANDOMIZED TRIALS (2020) (3)
- Insights into the mechanism of restenosis after PTCA and stenting. (1998) (3)
- IMPACT OF CONTRAST-INDUCED ACUTE KIDNEY INJURY AFTER CORONARY ANGIOGRAPHY OR PERCUTANEOUS CORONARY INTERVENTION ON LONG-TERM OUTCOMES: A POOLED ANALYSIS FROM THE HORIZONS-AMI AND ACUITY TRIALS (2014) (3)
- Poor mobility independently predicts mortality in TAVI: Are we closer to a universal definition for frailty? (2015) (3)
- Sex-related outcomes after drug-eluting stent: should we "never mind" or "mind" the gap? (2010) (3)
- Acute and 30-Day Outcomes in WomenAfter TAVR (3)
- Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry (2021) (3)
- 1-Year outcomes with COMBO stents in small vessel coronary disease: Subgroup analysis from the COMBO collaboration. (2020) (3)
- Abstract 2518: Clinical and Angiographic Outcomes after Percutaneous Revascularization of Chronic Total Occlusions with Bare-Metal and Drug-Eluting Stents: 3-year Follow-up Results from an International Multicenter CTO Registry (2008) (3)
- ONE MONTH DUAL ANTIPLATELET THERAPY IN HIGH BLEEDING RISK PATIENTS: PRIMARY RESULTS FROM THE ONYX ONE CLEAR STUDY (2020) (3)
- Clinical and angiographic outcomes in diabetic patients following single or multivessel stenting in the COSTAR II randomized trial. (2008) (3)
- Invasive Management of Coronary Artery Disease in Advanced Renal Disease (2021) (3)
- Impact of sex on long‐term cardiovascular outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes (2021) (3)
- Magnitude and impact of after hours treatment delay in patients undergoing primary angioplasty for acute myocardial infarction: The CADILLAC Trial (2003) (3)
- Prognostic Value of Corrected QT-Interval Prolongation in Patients With Unstable Angina Pectoris (2003) (3)
- Polymer-Based Versus Polymer-Free Stents in High Bleeding Risk Patients: Final 2-Year Results From Onyx ONE. (2022) (3)
- Final results from the multi-center trial of the angiosculpt scoring balloon catheter for the treatment of complex coronary artery lesions (2006) (3)
- Endothelial progenitor cells in coronary atherosclerosis and percutaneous coronary intervention: A systematic review and meta-analysis. (2022) (3)
- Impact of time to treatment on the effects of bivalirudin vs. glycoprotein IIb/IIIa inhibitors and heparin in patients undergoing primary percutaneous coronary intervention: insights from the HORIZONS-AMI trial. (2016) (3)
- Navigating the complexity of percutaneous coronary intervention in patients at high risk for bleeding. (2018) (3)
- Human immunodeficiency virus infection and high c-reactive protein correlates with increased in-stent restenosis rate (2003) (3)
- TCT-292 Evaluation of Neointimal Healing and Late luminal Loss of Endothelial Progenitor Cell Capturing Sirolimus-Eluting (COMBO) Stent by Optical Coherence Tomography: the EGO-COMBO Study (2012) (3)
- 1059-6 The multicenter evaluation of the everolimus-eluting stent for inhibition of neointimal hyperplasia: Results of the pooled FUTURE I and II trials (2004) (3)
- Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCI (2021) (3)
- Impact of an integrated treatment algorithm based on platelet function testing and clinical risk assessment: results of the TRIAGE Patients Undergoing Percutaneous Coronary Interventions To Improve Clinical Outcomes Through Optimal Platelet Inhibition study (2016) (3)
- Comparison of One-Year Outcomes in Patients >75 Versus ≤75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry). (2020) (3)
- Impact of diabetes mellitus on female subjects undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI international registry. (2020) (3)
- Drug-Coated Stents Versus Bare-Metal Stents in Academic Research Consortium-Defined High Bleeding Risk Patients. (2020) (3)
- Same or next day discharge: A new chapter in transcatheter aortic valve implantation (2016) (3)
- The DELTA 2 Registry (2021) (3)
- Off-label use of drug-eluting stents: assessing the risk (2007) (3)
- The Conundrum and Opportunity of Gender Equity For Evidence Generators. (2020) (3)
- What is the optimal antithrombotic strategy in primary percutaneous coronary intervention? (2012) (3)
- Sex differences in 1‐year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration (2020) (3)
- Effect of valve design and anticoagulation strategy on 30‐day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial (2017) (3)
- Outcomes from carotid artery stenting in over 1,000 cases from a single group of operators (2003) (3)
- Gender Differences in Medicare Payments Among Cardiologists. (2021) (3)
- PREDICTORS OF 1 YEAR NET ADVERSE CARDIOVASCULAR EVENTS (NACE) AMONG ACS PATIENTS UNDERGOING PCI WITH CLOPIDOGREL OR PRASUGREL: ANALYSIS FROM THE PROMETHEUS REGISTRY (2016) (2)
- Sex Differences in Cardiovascular Research: A Scientometric Analysis (2021) (2)
- Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Artery Revascularization (2016) (2)
- INCIDENCE, PREDICTORS AND IMPACT OF STROKE IN ACUTE CORONARY SYNDROME: INSIGHTS FROM THE ACUITY TRIAL (2012) (2)
- Aplicação clínica do ultra-som intracoronário (1997) (2)
- Performance of Prediction Models for Contrast-Induced Acute Kidney Injury after Transcutaneous Aortic Valve Replacement (2021) (2)
- TCT-78 Outcomes of Left Main Revascularization in the Elderly and Younger Patients: The EXCEL trial (2017) (2)
- INCREASED EXPRESSION OF OXIDATION-SPECIFIC EPITOPES AND APOPTOSIS ARE HAPTOGLOBIN GENOTYPE DEPENDENT: IMPLICATIONS FOR PLAQUE PROGRESSION IN HUMAN ATHEROSCLEROSIS (2011) (2)
- Impact of Chronic Kidney Disease on Revascularization and Outcomes in Patients with ST-Elevation Myocardial Infarction. (2021) (2)
- Impact of anticoagulation regimen prior to revascularization in patients with non‐ST‐segment elevation acute coronary syndromes: The ACUITY trial (2016) (2)
- Feasibility and Utility of a Cardiovascular Risk Screening Tool in Women Undergoing Routine Gynecology Evaluation. (2020) (2)
- Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus‐eluting stents (2020) (2)
- Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutancous coronary intervention: One year results from the randomized ACUITY trial (2007) (2)
- PHYSIOLOGIC IMPACT OF CHRONIC KIDNEY DISEASE ON WHOLE BLOOD CLOT KINETICS AND STRENGTH (2012) (2)
- TCT-292 Reduced Bleeding Complications and Increased Event-free Survival With Femoral Vascular Closure Device Use and Bivalirudin in STEMI Patients Undergoing Primary Angioplasty in the HORIZONS-AMI Trial (2013) (2)
- Seizure-related takotsubo cardiomyopathy in a patient with recurrent malignant meningioma (2014) (2)
- LONG-TERM OUTCOMES AFTER REVASCULARIZATION FOR STABLE ISCHEMIC HEART DISEASE: AN INDIVIDUAL PATIENT-LEVEL POOLED ANALYSIS OF 19 RANDOMIZED CORONARY STENT TRIALS (2020) (2)
- Influence of admission and discharge aspirin use on survival after primary coronary angioplasty for acute myocardial infarction. (2004) (2)
- Acute kidney injury: Prevention of contrast-induced AKI—the ongoing saga (2012) (2)
- Restenosis following percutaneous coronary interventions: a clinicalproblem (2005) (2)
- WHITE BLOOD CELL COUNT AND MAJOR ADVERSE CARDIOVASCULAR EVENTS AFTER PERCUTANEOUS CORONARY INTERVENTION IN THE CONTEMPORARY ERA: INSIGHTS FROM THE PARIS STUDY (2017) (2)
- Real-World Bioresorbable Vascular Scaffold Experience Compared With Second-Generation Metallic Drug-Eluting Stents in Complex Coronary Lesions. (2018) (2)
- Abstract 5608: Prognostic Impact of the Baseline White Blood Cell Count in Patients with Acute Myocardial Infarction Undergoing Primary PCI: Results from the HORIZONS-AMI trial (2008) (2)
- Procedural and Long-Term Clinical Outcomes After Percutaneous Coronary Intervention of Chronic Total Occlusions in Women: A Report From the Multinational Cto Registry (2011) (2)
- TCT-14 Invasive Versus Medical Management in Patients With Chronic Kidney Disease and Non–ST-Elevation Myocardial Infarction (2021) (2)
- FINAL TWO-YEAR RESULTS FROM THE RANDOMIZED ONYX ONE TRIAL IN HIGH BLEEDING RISK PATIENTS TREATED WITH 1-MONTH DAPT (2021) (2)
- TCT-224 Real world use of antithrombotic regimens after percutaneous coronary intervention in patients with atrial fibrillation. (2016) (2)
- TCT-59 Effect of Intracoronary Abciximab and Aspiration Thrombectomy on Microvascular Obstruction in Large Anterior Myocardial Infarction: The INFUSE-AMI MRI Substudy (2012) (2)
- TCT-467 Clinical Outcomes after Anterior ST-Elevation Myocardial Infarction According to LAD Lesion Location: The INFUSE-AMI Trial (2012) (2)
- ASSOCIATION OF STENT THROMBOSIS AND PATTERNS OF NON-ADHERENCE TO ANTI-PLATELET REGIMENS IN STENTED PATIENTS: SIX MONTH RESULTS OF THE PARIS REGISTRY (2012) (2)
- Favorable effect of γ‐radiation for in‐stent restenosis: Effect of diabetes on angiographic and clinical outcomes (2004) (2)
- A Biomarker‐Enhanced Model for Prediction of Acute Kidney Injury and Cardiovascular Risk Following Angiographic Procedures: CASABLANCA AKI Prediction Substudy (2022) (2)
- Angiographic Restenosis in Coronary Bifurcations Treatment with Regular Drug Eluting Stents and Dedicated Bifurcation Drug-Eluting BiOSS Stents: Analysis Based on Randomized POLBOS I and POLBOS II Studies (2020) (2)
- Effect of Chronic Kidney Disease in WomenUndergoing Percutaneous CoronaryIntervention With Drug-ElutingStents (2)
- Cre8™ Unique Technology in Challenging Daily Practice: Proceedings of a satellite symposium held at EuroPCR on 20th - 23rd May 2014 in Paris. (2014) (2)
- EFFECT OF THROMBOTIC AND BLEEDING RISK ACCORDING TO PLATELET REACTIVITY ON 2-YEAR MORTALITY: THE ADAPT-DES STUDY (2017) (2)
- Usefulness of Hyperglycemia in Predicting Renal and Myocardial Injury in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention (2004) (2)
- Coronary Artery Dissections, Perforations, and the No‐Reflow Phenomenon (2016) (2)
- Approach to patients with impaired renal function (2007) (2)
- Intravascular-ultrasound-guided percutaneous transluminal coronary angioplasty/provisional stent implantation strategy: impact on long-term clinical follow-up (2001) (2)
- Detection of peripheral arterial disease in patients presenting for coronary angiography and/or intervention patients study (PIPS) (2003) (2)
- Evolving Devices and Material in Transcatheter Aortic Valve Replacement: What to Use and for Whom (2022) (2)
- Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies (2021) (2)
- Use of prasugrel and clinical outcomes in African‐American patients treated with percutaneous coronary intervention for acute coronary syndromes (2019) (2)
- Invasive Versus Medical Management in Patients With Chronic Kidney Disease and Non–ST‐Segment–Elevation Myocardial Infarction (2022) (2)
- Prevalence and Professional Impact of Mental Health Conditions Among Cardiologists. (2022) (2)
- COMPARISON OF BLEEDING DEFINITIONS, BARC, GUSTO, TIMI AND VARC IN PATIENTS UNDERGOING BALLOON AORTIC VALVULOPLASTY: RESULTS FROM A TWO-CENTER REGISTRY (2012) (2)
- Cardiovascular Angiography and Interventions Association Task Force on Practice Guidelines and the Society for Report of the American College of Cardiology Foundation/American Heart 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention : A (2012) (2)
- Sex Differences in Outcomes After Percutaneous Coronary Intervention or Coronary Artery Bypass Graft for Left Main Disease: From the DELTA Registries (2022) (2)
- Adverse events in patients with high platelet reactivity following successful chronic total occlusion PCI: The Assessment of Dual AntiPlatelet Therapy with Drug‐Eluting Stents (ADAPT‐DES) study (2019) (2)
- Relationship between late loss, diameter stenosis and target lesion revascularization after stent implantation: An examination of surrogate endpoints from a pooled analysis of eight large randomized DES trials (2006) (2)
- Distribution of tissue growth in Palmaz-Schatz stents: Insights from a serial intravascular ultrasound study (1996) (2)
- Pharmacologic prevention of contrast-induced nephropathy (2005) (2)
- Current state-of-the-art antiplatelet and anticoagulation therapy in diabetic patients with coronary artery disease. (2021) (2)
- Temporal Trends in Gender of Principal Investigators and Patients in Cardiovascular Clinical Trials. (2023) (2)
- Why stronger radiation safety measures are essential for the modern workforce. A perspective from EAPCI Women and Women as One. (2020) (2)
- Current State and Future Perspectives of Artificial Intelligence for Automated Coronary Angiography Imaging Analysis in Patients with Ischemic Heart Disease (2022) (2)
- Women and Cardiac Disease: A Special Issue (2021) (2)
- Abstract 13255: RB006, a Direct Factor IX Inhibitor Results in Consistent and Near Complete Inhibition of Factor IX in Patients with Acute Coronary Syndromes: A RADAR Pharmacokinetic and Pharmacodynamic Substudy (2010) (2)
- RELATIONSHIP BETWEEN LENGTH OF HOSPITAL STAY AND 3-YEAR OUTCOMES AFTER LEFT MAIN REVASCULARIZATION: THE EXCEL TRIAL (2019) (2)
- The time dependence of antithrombin initiation in patients with non-ST-segment elevation acute coronary syndromes: subgroup analysis from the ACUITY trial. (2011) (2)
- Abstract 6088: Clinical and Angiographic Predictors of 30-Day and One-Year Cardiac Ischemic Events in Patients with Non-ST Elevation Acute Coronary Syndromes: Results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial (2008) (2)
- Derivation and External Validation of a Novel Risk Score for Prediction of 30-Day Mortality After Percutaneous Coronary Intervention. (2019) (2)
- TCT-111 Relationship between anemia, prasugrel use and clinical outcomes in contemporary percutaneous coronary intervention for acute coronary syndromes. (2016) (2)
- Antiplatelet therapy after drug-eluting stent implantation. (2015) (2)
- One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration (2021) (2)
- Impact of diabetes on coronary remodeling in patients with acute coronary syndromes: An intravascular ultrasound study (2003) (2)
- Impact of Small Valve Size on 1-Year Outcomes After Transcatheter Aortic Valve Implantation in Women (from the WIN-TAVI Registry). (2022) (2)
- Is the response to high pressure adjunct PTCA stent design specific? A sequential intravascular ultrasound study (1998) (2)
- Antiplatelets and AntithrombinsTCT-157 The Effect of Smoking Status on Platelet Reactivity and Long-Term Events after PCI. Does a Clopidogrel-related "Smoker's paradox" Exist? (2013) (2)
- Gamma radiation for in‐stent restenosis: effect of lesion length on angiographic and clinical outcomes (2004) (2)
- Acute and 30-day Outcomes in Women After TAVR : Results From the First Women in Transcatheter Aortic Valve Implantation ( WIN-TAVI ) Real World Registry (2016) (2)
- Conclusion (2010) (2)
- 1002-82 Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarction: The obesity paradox (2004) (2)
- Pursuit of perfection: three‐dimensional ct angiographic “objective quantification” of aortic valve structures for transcatheter aortic valve implantation (2013) (2)
- Two‐year clinical outcomes after successful transcatheter aortic valve implantation with balloon‐expandable versus self‐expanding valves: A subanalysis of the GALILEO trial (2022) (2)
- Impact of Chronic Total Occlusions on Revascularization Scores and Outcome Prediction. (2017) (2)
- Comparison of provisional 1-stent and 2-stent strategies in diabetic patients with true bifurcation lesions: the EES bifurcation study. (2014) (2)
- the Society for Cardiovascular Angiography and Interventions Foundation/American Heart Association Task Force on Practice Guidelines and Executive Summary : A Report of the American College of Cardiology 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: (2011) (2)
- Abstract 15919: Impact of Bivalirudin Therapy on Mortality in Patients With High Risk Features Undergoing PCI: A Patient-Level Pooled Analysis From the REPLACE-2, ACUITY and HORIZONS-AMI Trials (2011) (2)
- EVEN AFTER PERCUTANEOUS CORONARY INTERVENTION OF ANGIOGRAPHICALLY SIGNIFICANT LESIONS, IVUS-DEFINED HIGH-GRADE STENOSES ARE COMMON. A BASELINE IVUS ANALYSIS FROM THE PROSPECT TRIAL (2010) (2)
- Antiplatelet Therapy in Patients with Atrial Fibrillation: A Systematic Review and Metaanalysis of Randomized Trials. (2021) (2)
- Impact of the Presence and Extent of Incomplete Angiographic Revascularization After Percutaneous Coronary Intervention in Acute Coronary Syndromes: The ACUITY Trial (2012) (2)
- COMPLIANCE WITH DUAL ANTIPLATELET THERAPY AND SUBSEQUENT ADVERSE EVENTS IN PATIENTS WITH STEMI UNDERGOING STENT IMPLANTATION: ANALYSIS FROM THE HORIZONS-AMI TRIAL (2010) (2)
- Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: The cadillac trial (2003) (2)
- TCT-835 Validation of PARIS Risk Scores in Patients Treated With Everolimus-Eluting Stents for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial (2018) (2)
- Revascularization strategies in patients with Type 2 diabetes mellitus (2013) (2)
- DIFFERENCES AND LEVEL OF AGREEMENT IN SYNTAX SCORE ASSESSMENT BETWEEN SITE OPERATORS AND ANGIOGRAPHIC CORE LABORATORY READERS: INSIGHTS FROM THE EXCEL TRIAL (2017) (1)
- WHICH GLOMERULAR FILTRATION RATE EQUATION BEST PREDICTS POOR OUTCOMES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION UNDERGOING PRIMARY PCI: RESULTS FROM THE HORIZONS-AMI STUDY (2012) (1)
- The Role of Genetics in Acute Coronary Syndrome (2016) (1)
- Different mechanism of lumen enlargement during balloon angioplasty between focal and diffuse in-stent restenosis (2002) (1)
- IMPACT OF STENT DIAMETER ON OUTCOMES FOLLOWING PERCUTANEOUS CORONARY INTERVENTION WITH 2ND GENERATION DRUG ELUTING STENTS: RESULTS FROM A LARGE SINGLE-CENTER REGISTRY (2018) (1)
- Baseline features and clinical results in patients excluded from randomization from a large international trial of reperfusion strategies in acute myocardial infarction: The CADILLAC Registry (2003) (1)
- Contrast-induced Nephropathy in a High-risk Patient Population (2008) (1)
- Equal sex-based outcomes in unprotected left main PCI: No advantage for men. (2018) (1)
- TCT-5 Relationship Between High Platelet Reactivity on Clopidogrel and Outcomes After DES Implantation: Two-Year Results From the ADAPT-DES Study (2013) (1)
- TCT-221 Impact of prasugrel versus clopidogrel in smokers and non-smokers undergoing PCI for ACS: Results from the PROMETHEUS Study (2015) (1)
- The importance of the Heart Team evaluation before transcatheter aortic valve replacement: Results from the BRAVO‐3 trial (2020) (1)
- Drug-eluting balloons for side branch stenting during bifurcation percutaneous coronary intervention. (2013) (1)
- THE SAFETY AND TOLERABILITY OF MULTIPLE DOSE ADMINISTRATION OF CSL112, AN INTRAVENOUS FORMULATION OF PLASMA-DERIVED APOA-I, AMONG SUBJECTS WITH MODERATE RENAL IMPAIRMENT AFTER ACUTE MYOCARDIAL INFARCTION (2018) (1)
- Ticagrelor monotherapy in patients with diabetes mellitus undergoing percutaneous coronary interventions: insights from the TWILIGHT trial. (2020) (1)
- TCT-6 Prevalence and Impact of High Platelet Reactivity in Chronic Kidney Disease: Results from the ADAPT-DES Registry (2013) (1)
- SAFETY AND EFFICACY OF THE COMBO BIO-ENGINEERED STENT IN PATIENTS AT HIGH BLEEDING RISK: RESULTS FROM THE MASCOT POST-MARKETING REGISTRY (2018) (1)
- Long-Term Clinical Outcomes After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Ostial / Midshaft Lesions in Unprotected Left Main Coronary Artery From the DELTA Registry A Multicenter Registry Evaluating Percutaneous Coronary Intervention Versus Coronary Artery Bypas (1)
- P4569Rivaroxaban treatment strategies reduce costs associated with rehospitalizations due to bleeding and cardiovascular events: results from the PIONEER AF-PCI trial (2017) (1)
- Stick to the guidelines or clinical judgment: A toss up? (2021) (1)
- Acute myocardial infarction and multivessel disease: some vessels are more equal than others (2010) (1)
- PATTERNS OF ADHERENCE TO DUAL ANTIPLATELET THERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE UNDERGOING COMPLEX PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE PARIS REGISTRY (2015) (1)
- MYOCARDIAL BRIDGING DOES NOT AFFECT ATHEROSCLEROSIS IN ADJACENT CORONARY ARTERY SEGMENTS: AN ADAPT–DES IVUS SUB–STUDY (2013) (1)
- The SYNTAX Score Does Not Predict Risk of Adverse Events in Patients With Non-ST Elevation Acute Coronary Syndrome Who Undergo Coronary Artery Bypass Graft Surgery. (2017) (1)
- IMPACT OF GENDER AND RACE ON OUTCOMES AFTER COMPLEX PERCUTANEOUS CORONARY INTERVENTION WITH THE PLATINUM-CHROMIUM EVEROLIMUS-ELUTING STENT: A POOLED ANALYSIS OF THE PLATINUM DIVERSITY AND PROMUS ELEMENT PLUS POST-APPROVAL STUDIES (2019) (1)
- TCT-614 The Obesity Paradox Revisited: Body Mass Index and Long-Term Outcomes After PCI From a Large Pooled Patient-Level Database (2018) (1)
- IMPACT OF BIVALIRUDIN ON ACCESS AND NON-ACCESS RELATED BLEEDING IN PATIENTS UNDERGOING BALLOON AORTIC VALVULOPLASTY: RESULTS FROM A 2-CENTER REGISTRY (2012) (1)
- P6112Effect of procedure and lesion characteristics on bleeding and ischemic outcomes among atrial fibrillation patients undergoing percutaneous coronary intervention: results from the PIONEER AF-PCI trial (2017) (1)
- Abstract 4452: What are the Reasons for Clopidogrel Discontinuation after PCI? (2008) (1)
- TCT-57 Angiographic Reperfusion Indices Predict Infarct Size and Mortality: The INFUSE-AMI Trial (2012) (1)
- TCT-838 Prognostic Significance of a Previous Family History of Premature Coronary Artery Disease in Patients with Left Main Disease Undergoing PCI or CABG: Subgroup Analysis from EXCEL Trial (2017) (1)
- Arterial hypertension: A neglected risk for bleeding (2016) (1)
- Abstract 4690: Impact of Thrombus Aspiration in Patients With STEMI Undergoing Primary PCI: Analysis From the HORIZONS-AMI Trial (2009) (1)
- P3590Rivaroxaban strategies improve the number of days patients remain out of the hospital and event free: A PIONEER substudy (2017) (1)
- How to manage chronic total occlusions in the setting of acute myocardial infarction complicated by cardiogenic shock? (2018) (1)
- 1-year results after PCI with the COMBO stent in all-comers in Asia versus Europe: Geographical insights from the COMBO collaboration. (2020) (1)
- Creatine kinase-myocardial band isoenzyme elevation after percutaneous coronary intervention (2001) (1)
- Outcomes of Transcatheter Aortic Valve Implantation in Patients With Chronic and End-Stage Kidney Disease. (2021) (1)
- Sex-Related Differences in the Prevalence and Prognostic Value of the Academic Research Consortium for High Bleeding Risk Criteria (2021) (1)
- Feasibility of measuring patient-reported health status at time of percutaneous coronary intervention: Results from a single-center quality-improvement initiative (2020) (1)
- IMPACT OF PRIOR CHRONIC ANTIPLATELET THERAPY ON SHORT- AND LONG-TERM ADVERSE EVENTS IN PATIENTS PRESENTING WITH AN ACUTE CORONARY SYNDROME: INSIGHTS FROM THE ACUITY TRIAL (2010) (1)
- TCT-50 Angiographic Predictor of 2-Year Stent Thrombosis in Patients Receiving Drug-eluting Stents: Insights from the ADAPT-DES Study (2013) (1)
- Perioperative Management of P2Y12 Inhibitors in Patients Undergoing Cardiac Surgery within 1 Year of PCI. (2022) (1)
- Independence of Clinical Events Committees: A Consensus Statement from Clinical Research Organizations. (2022) (1)
- PROCEDURAL VARIATION IN THE PERFORMANCE OF PRIMARY PERCUTANEOUS CORONARY INTERVENTION FOR ST-ELEVATION MYOCARDIAL INFARCTION: A SURVEY STUDY OF US INTERVENTIONAL CARDIOLOGISTS (2012) (1)
- INCIDENCE OF ACUTE KIDNEY INJURY WITH BIVALIRUDIN OR UNFRACTIONATED HEPARIN FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT: RESULTS FROM THE BRAVO-3 RANDOMIZED TRIAL (2017) (1)
- TCT-447 Real World Generalizability Of Patients Enrolled In Clinical Trials Versus Those Not Enrolled (2015) (1)
- TCT-67 The First Establishment of Early Healing Profile, 9-month Neointimal Growth, and 24 Months Outcomes of the Dual Therapy Endothelial Progenitor Cell Capturing Sirolimus-eluting Stent as Assessed by Longitudinal Sequential Optical Coherence Tomography: The EGO-COMBO Study. (2013) (1)
- 291 Ticagrelor monotherapy after percutaneous coronary intervention in high-risk patients with prior myocardial infarction: a prespecified twilight substudy (2021) (1)
- COMMENT “ Capturing ” the Bene fi ts of Dual-Therapy Stent Technology Is This a Promise or Reality ? * (1)
- Outcomes of Vascular Closure Device Use After Transfemoral Coronary Intervention: Insights From the EXCEL Trial. (2021) (1)
- FREQUENCY, MECHANISMS AND IMPLICATIONS OF LATE PERI-STENT CONTRAST STAINING: ANALYSIS FROM THE HORIZONS-AMI TRIAL (2012) (1)
- TCT-509 Low Overall Rates of Angiographically Visible Distal Embolization in INFUSE-AMI: Possible Explanation for Lack of Efficacy of Manual Aspiration Thrombectomy (2012) (1)
- Should P2Y12 inhibitors be given for 12 months in acute coronary syndrome? (2014) (1)
- Evaluation of Cerebral Thromboembolism After Transcatheter Aortic Valve Replacement (EARTH TAVR): A Serial Magnetic Resonance Imaging Evaluation as Substudy of the GALILEO Trial. (2021) (1)
- Current controversies in PCI pharmacotherapy. (2015) (1)
- Polymer‐free stents in diabetic patients—not so sweet after all! (2014) (1)
- P4565Rivaroxaban treatment strategies reduce not only the first bleeding event, but all (including multiple) bleeding events: A PIONEER Substudy (2017) (1)
- TCT-476 Relationship Between Reference Vessel Diameter and the Incidence and Impact of Incomplete Coronary Revascularization Following PCI in ACS: The ACUITY Trial (2012) (1)
- TCT-486 Additive And Independent Impact Of Chronic Kidney Disease And Diabetes Mellitus On High Platelet Reactivity And Adverse Events Following PCI: Results From The ADAPT-DES Registry (2014) (1)
- TREATMENT OF LEFT MAIN CORONARY ARTERY DISEASE IN PATIENTS WITH DIABETES: 3-YEAR OUTCOMES COMPARING CABG AND PCI WITH EVEROLIMUS-ELUTING STENTS FROM THE EXCEL STUDY (2017) (1)
- Implications of Kidney Disease in the Cardiac Patient. (2020) (1)
- Pregnancy during cardiology training: a call to action (2021) (1)
- Drug-eluting stents and drug-eluting balloons are the best strategies to treat coronary in-stent restenosis (2016) (1)
- Favorable effect of gamma-radiation for in-stent restenosis: effect of diabetes on angiographic and clinical outcomes. (2004) (1)
- NT‐proBNP levels and cardiopulmonary function in children with sickle cell disease (2020) (1)
- IMPACT OF POINT-OF-CARE PLATELET FUNCTION TESTING AMONG DIABETIC AND NON-DIABETIC PATIENTS UNDERGOING PCI WITH DRUG-ELUTING STENTS: AN ADAPT-DES SUBSTUDY (2012) (1)
- IMPROVED PHARMACOLOGIC PROFILE OF A NOVEL, LIQUID ASPIRIN FORMULATION COMPARED WITH ENTERIC COATED ASPIRIN-A POOLED, PATIENT LEVEL ANALYSIS OF TWO RANDOMIZED CROSSOVER STUDIES (2020) (1)
- The Heart Team for Coronary Revascularization Decisions (2022) (1)
- TCT-52 Bivalirudin reduces cardiac mortality in patients with and without major bleeding: The HORIZONS-AMI trial (2012) (1)
- PLATELET REACTIVITY AND CLINICAL OUTCOMES AFTER CORONARY ARTERY IMPLANTATION OF DRUG-ELUTING STENTS IN SUBJECTS WITH PERIPHERAL ARTERIAL DISEASE: ANALYSIS FROM THE ADAPT-DES STUDY (2014) (1)
- Sex disparities continue to characterise the management of non‐ST‐elevation acute coronary syndrome (2021) (1)
- High Rates of Off-label Prescribing and the Urgent Need for a Randomized Clinical Trial. (2020) (1)
- Impact of vessel size after coronary vascular brachytherapy: a report of 990 patients (2002) (1)
- The randomised study of the double dose versus single dose sirolimus-eluting stent for the treatment of diabetic patients with de novo coronary lesions. (2006) (1)
- Cardiac safety and tolerability of angiographic contrast media (2004) (1)
- TCT-597 Two-Year Ischemic and Bleeding Outcomes After Coronary Intervention of Calcified vs. Non-Calcified Lesions Treated With Drug-eluting Stents: The ADAPT-DES Study (2015) (1)
- Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1‐month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear study (2021) (1)
- IMPACT ON TWO-YEAR OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION COMPLEXITY AND PLATELET REACTIVITY AMONG PATIENTS WITH STABLE CORONARY ARTERY DISEASE: INSIGHT FROM THE ADAPT-DES STUDY (2015) (1)
- Complete Revascularization in Patients Undergoing a Pharmacoinvasive Strategy for ST-Segment–Elevation Myocardial Infarction (2021) (1)
- Abstract 1715: Necrotic Core and its Ratio to Dense Calcium are Predictors of High-risk Non-ST-Elevation Acute Coronary Syndromes: Results from the Prospective, Multi-center, Global VH-IVUS Registry (2007) (1)
- TCT-516 Microvascular Obstruction Detected by MRI is a Predictor of Recovery from Myocardial Stunning: The INFUSE-AMI Trial (2012) (1)
- Comparison of catheterization laboratory initiated abciximab and eptifibatide during percutaneous coronary intervention in acute coronary syndromes (an ACUITY substudy). (2010) (1)
- IMPACT OF SINGLE VERSUS DUAL ANTI PLATELET THERAPY ON EARLY OUTCOMES IN WOMEN UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT: FROM THE WIN-TAVI REGISTRY (2017) (1)
- TRENDS IN INCIDENCE AND MORTALITY ASSOCIATED WITH ACUTE KIDNEY INJURY IN PATIENTS UNDERGOING PCI FOR ACUTE CORONARY SYNDROME (2017) (1)
- Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation: Insights From the PIONEER AF-PCI Trial. (2019) (1)
- Carotid Artery Stenting in Patients with High-Risk Anatomy for Carotid Endarterectomy (2001) (1)
- Abstract 17531: Two-Year Clinical Results Comparing Abciximab vs. Eptifibatide in Combination With 600mg vs. 300mg Clopidogrel Loading Dose in Patients With ST-Elevation Myocardial Infarction: Results from the HORIZONS-AMI Trial (2010) (1)
- Representation of Women in Internal Medicine Specialties in North America, the United Kingdom, and Australasia: Cardiology's Outlier Status and the Importance of Diversity. (2022) (1)
- Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index. (2022) (1)
- Classification and patterns of bifurcation in-stent restenosis (BISR) in the second generation drug eluting stent era. (2017) (1)
- Oral rapamycin for the prevention of in-stent restenosis (2003) (1)
- Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing PCI. (2022) (1)
- Predictors of intimal hyperplasia accumulation within Palmaz-Schatz stents: a serial quantitative angiographic and intravascular ultrasound study (1998) (1)
- Comparison of Age (<75 Years Vs ≥75 Years) and Platelet Reactivity to the Risk of Thrombotic and Bleeding Events After Successful Percutaneous Coronary Intervention With Drug-Eluting Stents (from the ADAPT-DES Study). (2019) (1)
- Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKD. (2022) (1)
- Effect of Baseline Anemia on Outcomes After Left Main Coronary Revascularization. (2020) (1)
- TCT-271 Sex-related differences in outcomes after percutaneous coronary intervention (PCI) in patients with diabetes presenting with acute coronary syndrome (ACS): Results from the PROMETHEUS study. (2016) (1)
- Takotsubo cardiomyopathy mimics an acute coronary syndrome in postmenopausal women. (2009) (1)
- Directional Coronary Atherectomy in Acute Myocardial Infarction (1998) (1)
- 830-5 The impact of myocardial blush grade on clinical outcomes of patients treated with saphenous vein grafts and thrombotic native coronary arteries: Analysis from the X-TRACT trial (2004) (1)
- CLINICAL UTILITY OF BIOMARKERS TO PREDICT STENT THROMBOSIS AFTER STEMI TREATED WITH DES: A HORIZONS-AMI SUBSTUDY WITH 3-YEAR FOLLOW-UP (2011) (1)
- CULPRIT LESION MORPHOLOGY IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI): THE HORIZONS-AMI TRIAL VH-IVUS SUBSTUDY (2011) (1)
- Hope for the best, prepare for the worst: How to manage coronary perforations (2019) (1)
- IS PLATELET REACTIVITY ASSOCIATED WITH ISCHEMIC EVENTS FOLLOWING SUCCESSFUL CHRONIC TOTAL OCCLUSION PERCUTANEOUS CORONARY INTERVENTION (2017) (1)
- Aspirin-free strategies: a framework to reassess the role of dual antiplatelet therapy after percutaneous coronary intervention. (2021) (1)
- Contrast-induced nephropathy: prevention and management of high-risk patients. (2008) (1)
- Patient-tailored Drug-eluting Stent Choice - A Solution for Patients with Diabetes: Proceedings of Two Satellite Symposia Held at EuroPCR in May 2015 in Paris. (2015) (1)
- The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent. (2021) (1)
- DIFFERENCES IN CORONARY PLAQUE COMPOSITION AND MORPHOLOGY IN PATIENTS WITH AND WITHOUT CHRONIC KIDNEY DISEASE PRESENTING WITH ACUTE CORONARY SYNDROMES: INSIGHTS FROM THE PROSPECT STUDY (2011) (1)
- Chronic kidney disease is associated with increased mortality, bleeding, and ischemic events in moderate and high-risk patients with acute coronary syndromes: An ACUITY substudy (2007) (1)
- TCT-472 Prognosis of Patients Presenting with Non ST-Segment Elevation Myocardial Infarction and Non-obstructive Coronary Artery Disease: Propensity Score Matched Cohort from the ACUITY Trial (2012) (1)
- IMPACT OF WEIGHT ON THE ANTIPLATELET EFFECTS OF ASPIRIN-RESULTS OF A POOLED ANALYSIS OF TWO RANDOMIZED CROSSOVER STUDIES COMPARING A LIQUID ASPIRIN FORMULATION WITH ENTERIC COATED ASPIRIN (2020) (1)
- INDEPENDENT AND COMBINED IMPACT OF DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE ON PLATELET REACTIVITY (2011) (1)
- Periprocedural anticoagulation in non-ST-segment elevation acute coronary syndrome: time to reassess? (2020) (1)
- IMPACT OF CHRONIC KIDNEY DISEASE ON LONG-TERM OUTCOMES IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS TREATED WITH PRIMARY PERCUTANEOUS CORONARY INTERVENTION AND ALTERNATIVE ANTITHROMBOTIC TREATMENT STRATEGIES: A HORIZONS-AMI SUBSTUDY (2011) (1)
- HIGH BLEEDING RISK AFTER PERCUTANEOUS CORONARY INTERVENTION: IMPACT OF RACE/ETHNICITY (2020) (1)
- Aspirin-free antithrombotic management following coronary stenting. Myth or reality? (2019) (1)
- New paradigms of care for STEMI focusing on mortality and attributable death analysis: what do device and drug trials teach us? (2009) (1)
- IMPACT OF CHRONIC KIDNEY DISEASE ON MYOCARDIAL BLUSH AND ST-SEGMENT RESOLUTION FOLLOWING PRIMARY PERCUTANEOUS CORONARY INTERVENTION: THE HORIZONS-AMI TRIAL (2012) (1)
- TCT-2 Two-Year Outcomes in High Bleeding Risk Patients With Bifurcations After Percutaneous Coronary Intervention and One Month of Dual Antiplatelet Therapy (2022) (1)
- ARE VULNERABLE PLAQUES WIDELY DISSEMINATED OR FOCAL? A BASELINE 3-VESSEL IVUS ANALYSIS FROM THE PROSPECT TRIAL (2010) (1)
- Impact of anemia on short‐term outcomes after TAVR: A subgroup analysis from the BRAVO‐3 randomized trial (2021) (1)
- TCT-670 Impact of Moderate and Severe Coronary Calcification on 1-Year Outcomes after PCI with DES: A Pooled Analysis of 11,651 Patients from 14 Randomized Trials (2012) (1)
- DOES STUDY SUBJECT RACE, ETHNICITY OR SEX INFLUENCE CARDIOLOGY RESEARCH SITE PERFORMANCE (2020) (1)
- TCT-365 Pregnancy-Induced Disorders Identify High-Risk Women who Benefit from Cardiovascular Screening: Results from the Women's Heart Health Initiative, an OB/GYN Screening Pilot Program (2012) (1)
- Interventional cardiology in 2012: We are 'shocked', 'frozen', and 'freed' by new data (2013) (1)
- Reply: Risk Scores From PARIS Registry: Are They Useful in a Contemporary Cohort of ACS Patients? (2016) (1)
- TCT-662 Age-related Effect of Smoking on Coronary Artery Disease Assessed by Grayscale and Virtual histology Intravascular Ultrasound (2013) (1)
- LONG-TERM CLINICAL IMPACT OF CONTRAST-ASSOCIATED ACUTE KIDNEY INJURY FOLLOWING PCI AN ADAPT-DES SUB-STUDY (2021) (1)
- Examining the role of diabetes mellitus in ST‐elevation myocardial infarction (2019) (1)
- P6114Characteristics and clinical outcomes in patients undergoing PCI by levels of high-density lipoproteins (2017) (1)
- Revascularization or optimal medical therapy for stable ischemic heart disease: A Bayesian meta-analysis of contemporary trials. (2021) (1)
- IMPACT OF CORONARY ARTERY CALCIFICATION IN PATIENTS UNDERGOING REVASCULARIZATION FOR LEFT MAIN CORONARY ARTERY DISEASE: INSIGHTS FROM THE EXCEL TRIAL (2019) (1)
- Response to Letter Regarding Article, "Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study". (2016) (1)
- Gold-coated versus uncoated stents: an intravascular ultrasound volumetric analysis showing an increase in intimal hyperplasia in gold-coated stents (2002) (1)
- Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft (2021) (1)
- QUANTIFICATION AND IMPACT OF UNTREATED CORONARY ARTERY DISEASE AFTER PCI: THE RESIDUAL SYNTAX SCORE (2012) (1)
- COMPARING PCI OUTCOMES IN THE VERY ELDERLY: DOES AGE MATTER? A REPORT FROM OUTCOMES OF SEPTUAGENARIANS, OCTOGENARIANS AND NONAGENARIANS AFTER PCI (2017) (1)
- Predictors of treatment delay in patients with acute myocardial infarction undergoing primary angioplasty: An analysis from the CADILLAC trial (2003) (1)
- Intravascular ultrasound predictors of late recurrence after stent implantation in small coronary arteries (2003) (1)
- TCT-153 Clinical, social, and behavioral predictors of the increased risk of cardiac events after PCI in minority women: A subanalysis of the PLATINUM Diversity study (2017) (1)
- Revascularization of unprotected left main coronary artery disease with percutaneous coronary intervention: the role of drug-eluting stents. (2008) (1)
- The fine balance of quality and quantity: The time has come to define quality of PCI! (2011) (1)
- SYNERGISTIC IMPACT OF CORONARY CALCIFICATION AND BIFURCATION TARGET LESIONS ON ADVERSE CARDIOVASCULAR EVENTS FOLLOWING PCI: INSIGHTS FROM A LARGE SINGLE-CENTER PCI REGISTRY (2019) (1)
- Contributors, Mar. 1979 (1979) (1)
- MKL1 C–184>T AND CYP3A5 A–6986>G POLYMORPHISMS ARE ASSOCIATED WITH CONTRAST INDUCED ACUTE KIDNEY INJURY AFTER PCI (2013) (1)
- P2068Incidence, determinant and temporal impact of definite stent thrombosis on mortality in women: from the WIN-DES collaborative patient-level pooled analysis (2017) (1)
- TCT-68 Influence of Final Kissing Balloon Inflation on Long-Term Outcomes After PCI of Distal Left Main Bifurcation Lesions: Analysis From the EXCEL Trial (2019) (1)
- TCT-482 "Resistant" In-Stent Restenosis in the Drug-Eluting Stent Era: An Angiographic Description and Outcomes (2013) (1)
- Predicting Risk of Ischemic or Bleeding Events After Percutaneous Coronary Intervention. (2016) (1)
- Safety of very early sheath removal in patients treated with REG1 for acute coronary syndromes: insights from the RADAR trial. (2013) (1)
- Individualizing dual antiplatelet therapy (DAPT) duration based on bleeding risk, ischemic risk, or both: An analysis from the DAPT Study (2022) (1)
- PREDICTORS OF MAJOR BLEEDING POST BALLOON AORTIC VALVULOPLASTY: RESULTS FROM THE BRAVO (EFFECT OF BIVALIRUDIN ON AORTIC VALVE INTERVENTION OUTCOMES) STUDY (2012) (1)
- Femoral Vascular Closure Devices and Bleeding, Hemostasis, and Ambulation Following Percutaneous Coronary Intervention (2022) (1)
- Impact of the ACUITY and TIMI major bleeding definitions on one-year mortality in patients with acute coronary syndromes (2007) (1)
- USE OF POTENT P2Y12 INHIBITORS IN AFRICAN-AMERICAN PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES (2017) (1)
- DOES STUDY SUBJECT DIVERSITY INFLUENCE CARDIOLOGY RESEARCH SITE PERFORMANCE?: INSIGHTS FROM 2 U.S. NATIONAL CORONARY STENT REGISTRIES. (2021) (1)
- The year in cardiovascular medicine 2021: interventional cardiology (2022) (1)
- TCT-110 Smoker’s Paradox: A Statistical Artifact Patient-Level Pooled Analysis of 18 Randomized Controlled Trials (2014) (1)
- Association of Eptifibatide and Acute Profound Thrombocytopenia (2001) (1)
- Anhedonia Predicts Major Adverse Cardiac Events and Mortality in Patients 1 Year After Acute Coronary Syndrome (2011) (1)
- The HEP@NET study: an internet-based registry examining the efficacy of heparin coating in patients undergoing coronary stent implantation (2002) (1)
- Coronary Artery Dissection and Perforation (2011) (1)
- The Opportunity of Women as One (2020) (1)
- Anaemia and transfusion (2021) (1)
- Rationale and design of the Japan-USA harmonized assessment by randomized, multicenter study of OrbusNEich's combo StEnt (Japan-USA HARMONEE): Assessment of a novel DES platform for percutaneous coronary revascularization in patients with ischemic coronary disease and non-ST-elevation acute coronary (2017) (1)
- GENETIC RISK, ADHERENCE TO A HEALTHY LIFESTYLE, AND RISK OF CORONARY ARTERY DISEASE (2017) (1)
- MAJOR VASCULAR COMPLICATIONS IN PATIENTS UNDERGOING TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT WITH BIVALIRUDIN OR UNFRACTIONATED HEPARIN: FROM THE EFFECT OF BIVALIRUDIN ON AORTIC VALVE INTERVENTION OUTCOMES (BRAVO) TRIAL (2016) (1)
- IMPACT OF PACLITAXEL-ELUTING STENTS IN DIABETIC PATIENTS WITH ACUTE MYOCARDIAL INFARCTION UNDERGOING PRIMARY ANGIOPLASTY: ANALYSIS FROM THE HORIZONS AMI TRIAL (2010) (1)
- Ticagrelor vs Prasugrel in a Contemporary Real-World Cohort Undergoing Percutaneous Coronary Intervention. (2022) (1)
- The OPERA study: The tenor or baritone of shorter duration of DAPT? (2014) (1)
- 1006-56 Virtual histology of intravascular ultrasound images: Feasibility and clinical correlations in humans (2004) (1)
- Impact of chronic kidney disease on carotid atherosclerotic plaque prevalence and morphology: results from the high-risk plaque bioimage study (2013) (1)
- IMPACT OF RESIDUAL INFLAMMATORY RISK IN PATIENTS WITH LOW LDL-CHOLESTEROL UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHT FROM A LARGE SINGLE-CENTER REGISTRY (2019) (1)
- Prevalence and prognostic impact of hsCRP elevation are age‐dependent in women but not in men undergoing percutaneous coronary intervention (2020) (1)
- Sexual Harassment, Victim Blaming, and the Potential Impact on Women in Cardiology (2021) (1)
- Nutritional supplementation to prevent and slow the progression of chronic kidney disease: focus on bicarbonate (2010) (1)
- TCT-453 Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. (2016) (1)
- 1-Year COMBO stent outcomes stratified by the PARIS bleeding prediction score: From the MASCOT registry (2020) (1)
- PROCEDURAL AND ONE-YEAR OUTCOMES IN PATIENTS TREATED WITH ROTATIONAL VERSUS ORBITAL ATHERECTOMY WITH MECHANISTIC INSIGHTS USING OPTICAL COHERENCE TOMOGRAPHY (2018) (1)
- MORTALITY, LENGTH OF STAY, AND COST IMPLICATIONS OF PROCEDURAL BLEEDING AFTER CONTEMPORARY PERCUTANEOUS INTERVENTIONS INVOLVING LARGE-BORE CATHETERS (2017) (1)
- TCT CONNECT-307 Long-Term Outcomes After Coronary Intervention With Drug Eluting Stents for Unprotected Left Main Coronary Artery Stenosis According to Diabetes Mellitus Status (2020) (1)
- First and recurrent events in the ISCHEMIA trial: two sides of the same coin. (2021) (1)
- Gender differences in clinical outcomes after percutaneous coronary intervention in small coronary arteries (2002) (1)
- TCT-288 Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Intervention: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaborative Patient-Level Pooled Analysis. (2016) (1)
- INTRACORONARY ABCIXIMAB AND ASPIRATION THROMBECTOMY DURING PRIMARY PCI FOR ANTERIOR STEMI: ONE–YEAR RESULTS FROM THE RANDOMIZED INFUSE–AMI TRIAL (2013) (1)
- ETIOLOGY, TIMING AND IMPACT OF DUAL ANTIPLATELET THERAPY DISCONTINUATION AFTER DRUG-ELUTING STENT IMPLANTATION: INSIGHTS FROM THE ADAPT-DES STUDY (2016) (1)
- Short-term statin therapy for prevention of contrast induced-acute kidney injury in patients with diabetes and chronic kidney disease (2013) (1)
- TCT-20 IVUS Predictors of Stent Thrombosis: Results From the Prospective, Multicenter ADAPT-DES Study (2012) (1)
- “CIN” No More: The Use of Contrast Volume to e‐GFR Ratio to Predict and Prevent Contrast‐Induced Acute Kidney Injury (2012) (1)
- Direct stenting improves target lesion revascularization in saphenous vein graft lesions: an intravascular ultrasound-guided study (2002) (1)
- TCT-479 The Increased Risk of Stent Thrombosis in Acute Coronary Syndromes is Confined to the First 30 days After PCI: Results from the Multicenter ADAPT-DES Study (2014) (1)
- Dual pathway inhibition in patients with atherosclerotic disease: pharmacodynamic considerations and clinical implications (2022) (1)
- Elderly patients with acute myocardial infarction: Targeted or complete revascularization? (2022) (1)
- Role and relevance of risk stratification models in the modern-day management of non-ST elevation acute coronary syndromes (2022) (1)
- The new European Society of Cardiology/European Association for Cardio-Thoracic Surgery recommendations for transcatheter aortic valve intervention are too restrictive. (2022) (1)
- Efficacy and Safety of P2Y12 Inhibitor Monotherapy After Complex PCI: A Collaborative Systematic Review and Meta-Analysis. (2022) (1)
- Edge‐to‐edge percutaneous mitral repair for functional ischaemic and non‐ischaemic mitral regurgitation: a systematic review and meta‐analysis (2022) (1)
- Pre-procedural oral anticoagulant use is associated with cardiovascular events in women after transcatheter aortic valve replacement: An analysis from the WIN-TAVI cohort. (2022) (1)
- Abbreviated dual antiplatelet therapy after PCI in patients at high bleeding risk: a collaborative meta-analysis of randomized trials (2022) (1)
- Best Practices for Designing Informative Trials Including Women (2022) (1)
- Subjective angina or myocardial ischaemia to justify PCI? Never mistake the finger for the moon. (2022) (1)
- Recent Advances in Antiplatelet Therapy in Complex Percutaneous Coronary Intervention. (2022) (1)
- Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke: A Post Hoc Analysis From the AUGUSTUS Trial. (2022) (1)
- Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study. (2022) (1)
- Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease (2023) (1)
- Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular Therapies. (2022) (1)
- Troponin in Stable Patients Undergoing Coronary Angiography: Should It Be Routinely Assessed? (2022) (1)
- Abstract 19034: Safety and Efficacy of Non-Vitamin K Antagonist Oral Anticoagulants During Transcatheter Ablation of Atrial Fibrillation (2017) (0)
- OralBleeding and the Hazards of AnticoagulationTCT-89 Tradeoff between Myocardial Infarction and Bleeding in Relation to Bleeding Risk: insights from PARIS registry (2017) (0)
- the and impact of risk scores on long-term outcomes in CKD patients. MitraClip in High- Versus Low-Volume Centers (2018) (0)
- TCT-330 Risk phenotype and clinical outcomes of patients with stable coronary artery disease treated with PCI stratified by baseline LDL cholesterol. (2016) (0)
- TCT-471 Impact of New- versus Early-Generation Drug Eluting Stents in Women according to Age: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. (2016) (0)
- Abstract 18932: Safety and Efficacy of New- vs. Early-Generation Drug-Eluting Stents in Elderly Women: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration (2017) (0)
- White blood cell count and clinical outcomes after left main coronary artery revascularization: insights from the EXCEL trial (2021) (0)
- TCT-243 Which Intraprocedural Thrombotic Events Impact Clinical Outcomes Following Percutaneous Coronary Intervention in ACS? A Pooled Analysis of the HORIZONS-AMI and ACUITY Trials (2013) (0)
- TCT-225 Impact of Age on the Disruption of Dual Antiplatelet Therapy: Analysis from the PARIS (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented) Patients Registry (2015) (0)
- RELATIONSHIP BETWEEN VESSEL SIZE, PLATELET REACTIVITY, AND STENT THROMBOSIS AFTER DRUG-ELUTING STENT PERCUTANEOUS CORONARY ARTERY INTERVENTION (2016) (0)
- TRANSRADIAL VS. TRANSFEMORAL APPROACH FOR PRIMARY ANGIOPLASTY IN ACUTE MYOCARDIAL INFARCTION: ANALYSIS FROM THE HORIZONS-AMI TRIAL. (2010) (0)
- TCT-221 Predictors of optimal medical therapy on discharge after percutaneous coronary intervention for acute coronary syndrome: An analysis of the PROMETHEUS registry. (2016) (0)
- Abstract 3220: Bivalirudin Monotherapy Provides Similar One-Year Survival Compared to Heparin plus GP IIb/IIIa Inhibitors in Diabetic Patients with Acute Coronary Syndromes: Results from the Randomized ACUITY Trial (2007) (0)
- Women leaders: transforming the culture in cardiology (2022) (0)
- TEMPORAL TRENDS, DETERMINANTS AND IMPACT OF HIGH-INTENSITY LIPID LOWERING THERAPY IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2018) (0)
- The Role of New Antiplatelet Agents in Percutaneous Coronary Intervention (2009) (0)
- Comprar Handbook of Chronic Total Occlusions | Moses Jeffrey | 9781841846248 | Informa Healthcare (2007) (0)
- TCT-155 The Interaction Between Clopidogrel and Calcium Channel Blockers on Platelet Reactivity and Long-Term Events after PCI (2013) (0)
- TCT-607 Neointimal Transformation and Late Stent Failure from 2 months to 2 years of the New Dual Therapy Endothelial Progenitor Cell Capturing Sirolimus-eluting COMBO Stent by Longitudinal Sequential OCT: The EGO-COMBO Study (2015) (0)
- PREDICTORS OF ANTIPLATELET CESSATION IN A REAL-WORLD PATIENT POPULATION WITH CORONARY STENTS UNDERGOING NONCARDIAC SURGERY (2022) (0)
- Impact of Cigarette Smoking on Extent of Coronary Artery Disease and Prognosis of Patients With Non – ST-Segment Elevation Acute Coronary Syndromes An Analysis From the ACUITY Trial (Acute (0)
- FREQUENCY AND IMPACT OF SINGLE VERSUS DUAL ANTIPLATELET CESSATION ON ADVERSE CARDIAC EVENTS: RESULTS FROM THE PARIS REGISTRY (2013) (0)
- RESIDUAL INFLAMMATORY RISK IN PATIENTS WITH CHRONIC KIDNEY DISEASE UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2019) (0)
- TCT-341 The SYNTAX Score Predicts Acute Kidney Injury After PCI for NSTEACS: Analysis from the ACUITY Trial (2013) (0)
- GENDER DIFFERENCES IN CARDIAC SYMPTOMS 30 DAYS AFTER PRIMARY PCI FOR ANTERIOR MYOCARDIAL INFARCTION: INSIGHTS FROM INFUSE–AMI (2013) (0)
- TCT-313 Lens Changes Associated with Radiation in the Cardiac Catheterization Laboratory: An Update from the IC-CATARACT (CATaracts Attributed to Radiation in the CaTh Lab) Study (2017) (0)
- INCIDENCE AND PREDICTORS OF FUNCTIONALLY SIGNIFICANT SIDE BRANCH STENOSES IN CALCIFIED CORONARY LESIONS AFTER ROTATIONAL ATHERECTOMY AND CUTTING BALLOON ANGIOPLASTY: THE RANDOMIZED ORBID-FFR TRIAL (2020) (0)
- Abstract 5593: Long-term Follow-up of Patients with Unstable Angina Treated with Drug-Eluting Stents: Pooled Analysis from 14 Clinical Trials (2008) (0)
- ASSOCIATION BETWEEN CORONARY CALCIFICATION AND BLEEDING AFTER PCI IN ACS: POOLED ANALYSIS FROM HORIZONS-AMI AND ACUITY TRIALS (2013) (0)
- Does genetic polymorphism for platelet glycoprotein illa impact early and long-term outcomes after elective percutaneous coronary interventions? (2003) (0)
- IMPACT OF SMOKING AND ALTERNATIVE ANTITHROMBOTIC STRATEGIES ON OUTCOMES OF PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: ANALYSIS FROM THE HARMONIZING OUTCOMES WITH REVASCULARIZATION AND STENTS IN ACUTE MYOCARDIAL INFARCTION (HORIZONS-AMI) TRIAL (2010) (0)
- TCT-314 Inpatient Versus Outpatient PCI in Patients With Left Main Disease: Analysis From the EXCEL Trial (2019) (0)
- Coronary Stenting in Patients With Small Coronary Arteries at High Risk of Bleeding: Onyx ONE Clear (2022) (0)
- REVASCULARIZATION OF CALCIFIED TARGET LESIONS IN PATIENTS PRESENTING WITH ACUTE CORONARY SYNDROMES: ANALYSIS FROM THE ACUITY TRIAL (2014) (0)
- In-stent restenosis in the drug-eluting stent era (2018) (0)
- Predictors of radiation failure after treatment of in-stent restenosis with gamma vascular brachytherapy: pooled analysis from GAMMA I, II, and SCRIPPS III studies (2002) (0)
- TCT-803 Clinical Outcomes After TAVR in Patients With and Without Peripheral Arterial Disease: Results From the BRAVO-3 Randomized Trial (2019) (0)
- Adverse Cardiac Events , and Infarct Size In Anterior Myocardial Infarction : An Analysis of INFUSE-AMI RCT # NCT 00976521 (2014) (0)
- TCT-422 Pre-procedural white matter lesion burden predicts MRI outcomes in transcatheter aortic valve replacement (TAVR): The Sentinel Trial (2017) (0)
- Impact of Major Adverse Cardiac Events and Major Bleeding on Overall Mortality in Patients with Acute Myocardial Infarction: Results from the HORIZONS-AMI Trial (2008) (0)
- P1661Evaluation of transradial versus transfemoral procedures in all-comers patients treated with the dual-therapy stent (2018) (0)
- Reperfusion in women with STEMI: a date not to be late! (2015) (0)
- TCT-481 Treatment of "resistant" in-stent restenosis in the drug-eluting era: comparison of repeat stent versus balloon only strategy (2013) (0)
- TCT-62 Impact of Atrial Fibrillation in Patients with STEMI Before and After Primary PCI: Insights from the HORIZONS-AMI Trial (2012) (0)
- Abstract 5598: Angiographic Evidence of Early Coronary Artery Disease and Inceased Risk of Mortality in Smokers with Non-ST-Segment Elevation Acute Coronary Syndromes: An Analysis of the ACUITY Trial (2008) (0)
- 2927Sex-related differences in patients undergoing complex coronary interventions in the era of 2nd generation DES (2017) (0)
- Transplantation of autologous endothelial cells induces angiogenesis in a sheep model of chronic ischemia (2003) (0)
- 830-6 Relationship between embolic material retrieval and adverse events with different distal protection devices during saphenous vein graft stenting (2004) (0)
- TCT-34 Effect of Baseline Anemia on Outcomes After PCI and CABG in Patients With Left Main Disease: The EXCEL Trial (2018) (0)
- COMPARATIVE INCIDENCE AND COSTS ASSOCIATED WITH 30-DAY READMISSION FOR RECURRENT MI VERSUS MAJOR BLEEDING AMONG PATIENTS HOSPITALIZED WITH ACUTE MI IN THE UNITED STATES: A POPULATION-BASED COHORT STUDY (2020) (0)
- TCT-237 Outcomes After Successful PCI of Severely Calcified Lesions Using Rotational Atherectomy, Cutting Balloon, or Balloon Angioplasty only Before Second-Generation Drug-Eluting Stent Implantation. (2016) (0)
- Abstract 2651: Major Bleeding is Associated with Increased Short-Term Mortality and Ischemic Complications in Non-ST Elevation Acute Coronary Syndromes: The ACUITY Trial (2006) (0)
- 1061-100 Predictors of reinfarction after ST elevation myocardial infarction and glycoprotein receptor blockade: Analysis from the CADILLAC trial (2004) (0)
- P1389Impact of peripheral arterial disease on provision of discharge pharmacotherapy and longitudinal outcomes in patients with stable angina undergoing percutaneous coronary interventions (2017) (0)
- Readmission in Patients With ST-Elevation Myocardial Infarction in 4 Age Groups (<45, >45 to <60, 60 to <75, and >75). (2022) (0)
- PATIENT REFUSAL, SURGICAL INELIGIBILITY AND MORTALITY IN PATIENTS WITH MULTIVESSEL CORONARY ARTERY DISEASE UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2023) (0)
- Abstract 16705: Lower Education Level is Associated with Non-Adherence to Dual Antiplatelet Therapy After PCI: 6-Month Results from PARIS (2012) (0)
- DYNAMIC NATURE OF NON-CULPRIT CORONARY ARTERY LESION MORPHOLOGY IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION PATIENTS: A SERIAL VIRTUAL HISTOLOGY-INTRAVASCULAR ULTRASOUND ANALYSIS FROM THE HORIZONS-ACUTE MYOCARDIAL INFARCTION TRIAL (2011) (0)
- TCT-315 White Blood Cell Count and 4-Year Clinical Outcomes After Left Main Coronary Artery Revascularization: Insights From the EXCEL Trial (2019) (0)
- TCT-200 Correlation of Admission Heart Rate With Angiographic and Clinical Outcomes by Culprit Coronary Artery in Patients With STEMI Undergoing Primary PCI: The HORIZONS-AMI Trial. (2016) (0)
- TCT-244 Radiation Dose Reduction in Percutaneous Coronary Intervention Using a Dedicated Protocol (2022) (0)
- Abstract 18402: Impact of the Use of Different Bleeding Scales on the Rate of 6-Month Bleeding After PCI: Results from the PARIS Registry (2012) (0)
- CABG Beats Vintage PCI: Does Contemporary PCI Stand a Chance to EXCEL? (2016) (0)
- IMPACT OF HEMODIALYSIS AND HIGH PLATELET REACTIVITY ON OUTCOMES FOLLOWING PERCUTANEOUS CORONARY INTERVENTION WITH DRUG-ELUTING STENTS: AN ADAPT-DES SUBSTUDY (2014) (0)
- Predictors of antiplatelet cessation in a real-world patient population undergoing non-cardiac surgery after PCI. (2022) (0)
- TCT-105 Prevalence of prasugrel use and associations between type of acute coronary syndrome and 1-year clinical outcomes. (2016) (0)
- P5139Identification of atrial fibrillation patients who are at high bleeding risk after undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial (2018) (0)
- Marcadores de riesgo negativos para eventos cardiovasculares en ancianos (2020) (0)
- ASSOCIATIONS BETWEEN DUAL ANTIPLATELET THERAPY CESSATION AND MACE DUE TO STOPPING ONE OR BOTH DRUGS: INSIGHTS FROM THE PARIS REGISTRY (2014) (0)
- SAFETY AND EFFICACY OF 1-MONTH VERSUS 3-MONTH DUAL ANTIPLATELET THERAPY IN HIGH BLEEDING RISK PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS WITH AN EVEROLIMUS ELUTING STENT: INSIGHTS FROM THE XIENCE SHORT DAPT PROGRAM (2021) (0)
- RELATIONSHIP BETWEEN BIOMARKERS AND SUBSEQUENT ADVERSE ISCHEMIC AND BLEEDING EVENTS AFTER ST-ELEVATION MYOCARDIAL INFARCTION: A HORIZONS-AMI SUBSTUDY (2011) (0)
- IS SAME DAY DISCHARGE SAFE IN ELECTIVE PCI? RESULTS FROM A RANDOMIZED CONTROLLED STUDY (2011) (0)
- TCT-260 Which is the Ideal Revascularization Strategy in Patients Presenting with Acute Coronary Syndrome and Proximal LAD Stenosis? Results from the ACUITY Study (2013) (0)
- TCT-849 Radiation-Associated Lens Changes in the Cardiac Catheterization Laboratory: the IC-CATARACT (CATaracts Attributed to Radiation in the CaTh Lab) Initiative. (2016) (0)
- Determinants of Seattle Angina Questionnaire in multivessel disease patients undergoing percutaneous coronary intervention: Insights from a single-center study. (2023) (0)
- Characterisation of Access Site Versus Non-Access Site Bleeding After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation (2018) (0)
- Abstract 2217: Impact of the ACUITY and TIMI Major Bleeding Definitions on One-Year Mortality in Patients with Acute Coronary Syndromes (2007) (0)
- TCT-237 Efficacy and Safety of Routine Thrombus Aspiration in Patients with ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: an updated Systematic Review and Meta-Analysis of Randomized Controlled Trials (2015) (0)
- Bivalirudin versus heparin in PCI: Is the pendulum swinging again in favor of heparin? (2021) (0)
- TCT-468 Predictors Of Stent Thrombosis After Primary Percutaneous Coronary Intervention And Risk for 30-Day Mortality: Analysis from the HORIZONS-AMI and EUROMAX trials (2014) (0)
- P6435Impact of persistent high C-reactive protein levels on all-cause mortality in patients after percutaneous coronary interventions (2018) (0)
- Single antiplatelet therapy after transcatheter aortic valve implantation: clarity on existing data. (2021) (0)
- Acute Coronary Syndrome (2014) (0)
- 1155-78 Implications and prevention of large periprocedural myocardial infarction after percutaneous intervention of diseased saphenous vein grafts and thrombotic native coronary lesions (2004) (0)
- TCT-199 Incidence, Predictors, and Outcomes of High-Grade Atrioventricular Block in Patients With STEMI Undergoing Primary PCI: The HORIZONS-AMI Trial. (2016) (0)
- Relationship of the degree of procedural anticoagulation to outcomes after stent implantation (2002) (0)
- TCT CONNECT-66 Ischemic and Bleeding Outcomes in Patients With Versus Without Atrial Fibrillation: Analysis From the Onyx ONE Month DAPT Program (2020) (0)
- CORRELATION AND PROGNOSTIC UTILITY BETWEEN LEFT VENTRICULAR END-DIASTOLIC PRESSURE AND LEFT VENTRICULAR EJECTION FRACTION IN PATIENTS WITH STEMI UNDERGOING PRIMARY PCI: THE HORIZONS-AMI TRIAL (2011) (0)
- COMPLEMENTARY PREDICTIVE VALUE OF MYOCARDIAL BLUSH GRADE AND ST–SEGMENT RESOLUTION AFTER PRIMARY PCI: AN ANALYSIS FROM HORIZONS–AMI (2013) (0)
- TCT-108 Debris heterogeneity across different valve types captured by a cerebral protection system during TAVR (2017) (0)
- Ticagrelor in Patients With Cancer (2020) (0)
- TCT-313 Incidence and Impact of Major Bleeding Events After PCI or CABG for Left Main Coronary Artery Disease: The EXCEL Trial (2019) (0)
- Dear colleagues: enough with the men-only author panels (2022) (0)
- TCT-222 Reperfusion Success, Infarct Size and Clinical Outcomes in Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Anterior Myocardial Infarction (2013) (0)
- TCT-236 Clinical Profile And Impact Of A Family History Of Premature Coronary Artery Disease On Long-term Clinical Ischemic Events In Patients Undergoing PCI For STEMI: Analysis From The HORIZONS-AMI Trial. Revascularization And Stents In Acute Myocardial Infarction) Trial. (2013) (0)
- Stenting in acute myocardial infarction in patients with chronic renal failure: predictors of in-hospital and long-term outcome (2002) (0)
- Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease: 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), Association for Acute CardioVascular Care (ACVC) and European Association of Pr (2023) (0)
- The optimal approach to coronary bifurcations: Systematic rather than simplified? (2012) (0)
- A-13 | One Month DAPT in High Bleeding Risk ACS Patients: 2-year Subgroup Analysis from Onyx ONE Clear (2022) (0)
- P2646COMBO PCI outcomes in patients categorized by baseline PARIS bleeding risk score: from the global MASCOT registry (2018) (0)
- SYNERGISTIC IMPACT OF CHRONIC KIDNEY DISEASE AND DIABETES MELLITUS ON PERIPHERAL VASCULAR ATHEROSCLEROTIC PLAQUE NEOVASCULARIZATION AND INFLAMMATION (2012) (0)
- Long-term outcomes of patients with acute coronary syndromes and chronic renal insufficiency undergoing percutaneous coronary intervention and being treated with bivalirudin vs heparin plus a glycoprotein IIb/IIIa inhibitor: Results from the randomized ACUITY Trial (2007) (0)
- Balance of Ischemia and Bleeding in Selecting an Antithrombotic Regimen. (2013) (0)
- TCT-736 Prevalence and Impact of Bleeding Determinants on Risks for out-of-hospital bleeding and coronary thrombosis in patients undergoing percutaneous coronary intervention: Results from a large single-center PCI Registry (2018) (0)
- IMPACT OF INTRAVENOUS HEPARIN ADMINISTERED PRIOR TO PRIMARY PERCUTANEOUS CORONARY INTERVENTION: ANALYSIS FROM THE HORIZONS-AMI TRIAL (2010) (0)
- TCT-420 Derivation and External Validation of a Novel Risk Score for Prediction of 30-Day Mortality After Percutaneous Coronary Intervention (2019) (0)
- TCT CONNECT-300 Rates and Impact of Stroke After Revascularization for Left Main Coronary Artery Disease: The EXCEL Trial (2020) (0)
- PCI Considerations in Women: Gender-Specific Outcomes and Challenges (2014) (0)
- TCT-263 Left anterior descending artery that wraps around the apex is associated with apical remodeling and subsequent heart failure in patients with anterior ST-Elevation MI: An INFUSE-AMI sub-study (2013) (0)
- LAD WRAPPING AROUND THE LV APEX PREDICTS ADVERSE CARDIAC OUTCOMES IN ANTERIOR STEMI- A HORIZONS-AMI SUB-STUDY (2014) (0)
- TCT-831 Identification of High-Risk Plaques by Coronary Angiography: Confirmation of Computational Fluid Dynamics by Optical Coherence Tomography (2019) (0)
- RISKS AND BENEFITS OF POST–PROCEDURAL ANTICOAGULATION IN PATIENTS WITH STEMI UNDERGOING PRIMARY PCI: ANALYSIS FROM THE HORIZONS–AMI TRIAL (2013) (0)
- NAC and CIN prevention: Mounting evidence of inefficacy (2012) (0)
- P3100 | BEDSIDE Endothelial dysfunction versus early atherosclerosis: a study with high resolution imaging (2015) (0)
- A-54 | Efficacy and Safety of P2Y12 Inhibitor Monotherapy After Complex PCI: A Collaborative Systematic Review and Meta-Analysis (2022) (0)
- 1460Effect of the INR stability characteristics on bleeding events among atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial (2018) (0)
- IMPACT OF PACLITAXEL-ELUTING STENTS IN PATIENTS WITH ANTERIOR MYOCARDIAL INFARCTION UNDERGOING PRIMARY ANGIOPLASTY COMPARED WITH BARE METAL STENTS: ANALYSIS FROM THE HORIZONS AMI TRIAL (2010) (0)
- Abstract 15180: Impact of the Everolimus-Eluting Stent on Stent Thrombosis According to Baseline Risk of Study Population (2011) (0)
- PROGNOSTIC UTILITY OF MYOCARDIAL BLUSH GRADE AFTER PCI IN PATIENTS WITH NSTEMI: ANALYSIS FROM THE ACUITY TRIAL (2011) (0)
- Abstract 11971: Gender Differences in Industry Payments Among Cardiologists (2019) (0)
- Abstract 5213: Correlations Between Reciprocal ST-segment Depression on the Baseline Electrocardiogram, Angiographic Findings and Clinical Outcomes in Patients With STEMI Treated With Primary PCI (2009) (0)
- ADDITIVE EFFECT OF MULTIPLE HIGH BLEEDING RISK CRITERIA IN PATIENTS UNDERGOING PCI (2020) (0)
- INCIDENCE, PATTERNS AND ASSOCIATIONS BETWEEN DUAL ANTIPLATELET THERAPY CESSATION AND RISK FOR ADVERSE EVENTS IN HIGH-RISK PATIENTS: INSIGHTS FROM THE PARIS REGISTRY (2018) (0)
- IMPACT OF HIGH DOSE ASPIRIN IN MEN VS. WOMEN AFTER ACUTE MYOCARDIAL INFARCTION: RESULTS FROM THE HORIZONS-AMI TRIAL (2012) (0)
- TRENDS IN PUBLICATION OF WOMEN AUTHORS IN CARDIOLOGY OVER A DECADE (2022) (0)
- TCT-35 One-Month Dual Antiplatelet Therapy After PCI With Resolute Onyx DES: Final 2-Year Results From Onyx ONE Clear (2021) (0)
- Abstract 2525: Two Year Outcome in Patients with Unprotected Left Main Coronary Artery Stenosis Treated with Drug-Eluting Stent Implantation: Milan and New York Experience (2008) (0)
- IMPACT OF CHRONIC THROMBOCYTOPENIA ON CLINICAL OUTCOMES AFTER TAVR: INSIGHTS FROM THE BRAVO-3 RANDOMIZED TRIAL (2022) (0)
- Limitations of Current Risk Scoring in Real World Populations: The Importance of External Validation. (2019) (0)
- EVALUATION OF THE ACADEMIC RESEARCH CONSORTIUM HIGH BLEEDING RISK DEFINITION IN PATIENTS TREATED WITH DRUG-COATED STENTS AND BARE-METAL STENTS FROM THE LEADERS FREE I & II TRIALS (2020) (0)
- Abstract 18677: The ACEF Risk Score Exhibits Superior Predictive Ability for Adverse Clinical Outcomes in Women Undergoing PCI (2012) (0)
- USE OF CLOPIDOGREL VERSUS PRASUGREL IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: FACTORS INFLUENCING REAL-WORLD THERAPEUTIC DECISION-MAKING (2016) (0)
- Reply: Last Nail in the Coffin for Propensity Scores in Observational Cardiovascular Studies? (2017) (0)
- SCAI Expert Consensus Statement on Sex-Specific Considerations in Myocardial Revascularization—A Powerful Reminder and Call to Action (2022) (0)
- Ticagrelor With or Without Aspirin in High-Risk Patients With Anemia Undergoing Percutaneous Coronary Intervention: a subgroup analysis of the TWILIGHT trial. (2023) (0)
- TCT-649 Long-Term Prognosis of Elderly Patients With Additional High Bleeding Risk Factors: A Pooled Analysis From 4 Post-Approval XIENCE Studies (2019) (0)
- P511Incidence and patterns of dual antiplatelet therapy cessation among patients with peripheral arterial disease after percutaneous coronary intervention: insights the PARIS registry (2017) (0)
- TCT CONNECT-57 Clinical Outcomes According to Lesion Complexity in Patients With High Bleeding Risk Treated With 1-Month Dual Antiplatelet Therapy Following PCI: Analysis From the Onyx ONE Clear Study (2020) (0)
- TCT-472 Impact of Excess Dosing of Eptifibatide During PCI for ACS: A Pooled Analysis from the HORIZONS-AMI and ACUITY Trials (2014) (0)
- Women in Interventional Cardiology: Past, Present, and Future-Small Numbers, Growing Impact. (2018) (0)
- Abstract 17007: Does Age Modify Gender-based Differences in Clinical Outcomes Following Percutaneous Coronary Intervention (PCI) (2014) (0)
- TCT-467 The SYNTAX Score And Risk Of Stent Thrombosis In Patients Undergoing PCI For NSTE-ACS: An ACUITY Trial PCI Cohort Analysis (2013) (0)
- IMPACT OF ADMISSION BLOOD GLUCOSE LEVEL ON BLEEDING AND ISCHEMIC COMPLICATIONS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION: ANALYSIS FROM THE HARMONIZING OUTCOMES WITH REVASCULARIZATION AND STENTS IN ACUTE MYOCARDIAL INFARCTION TRIAL (2010) (0)
- STEMI with multivessel disease: An ongoing battle for the optimal treatment strategy (2016) (0)
- This is a repository copy of Antithrombotic therapy after acute coronary syndrome or PCI (2019) (0)
- OUTCOMES AND PROGNOSIS OF PATIENTS WITH KNOWN, NEWLY DIAGNOSED AND WITHOUT DIABETES MELLITUS PRESENTING WITH ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: FROM THE HORIZONS-AMI STUDY (2016) (0)
- Intracoronary Imaging, Cholesterol Efflux, and Transcriptomics after Intensive Statin Treatment in Diabetes (2017) (0)
- Abstract 19512: Characterization of Access vs. Non-Access Site Bleeding Following PCI in Patients With Atrial Fibrillation (2017) (0)
- Carotid artery stenting 19991 (2000) (0)
- Letter to the EditorReply from the Authors (2005) (0)
- 869-1 Relationship between time to reperfusion, ST-segment resolution, myocardial blush scores and mortality with primary percutaneous coronary intervention for acute myocardial infarction: Results from the CADILLAC trial (2004) (0)
- Minding the Microcirculation: Is it Worth the Effort? (2019) (0)
- Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding. (2023) (0)
- The History of Clinical Research Workshop at CIT: A Ten Year Perspective (2018) (0)
- Acute coronary syndromes: Antithrombotics in ACS—moving beyond unfractionated heparin (2011) (0)
- Meta-Analysis of Brief Dual-Antiplatelet Therapy Duration After Percutaneous Coronary Intervention. (2022) (0)
- TCT-8 Impact of Aspirin Resistance on Outcomes after Coronary Events. (2016) (0)
- Treatment Options for Coronary Revascularization (1999) (0)
- Acute coronary syndromes Prasugrel plus bivalirudin vs . clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction (0)
- TCT-174 Baseline hemoglobin level, anemia and adverse events in patients with acute coronary syndromes; Lessons from ACUITY and HORIZONS-AMI (2015) (0)
- OC10_02 Impact of Diabetes Mellitus on Patients With Human Immunodeficiency Virus Undergoing Percutaneous Coronary Intervention: Results From a Large, Single Center Registry (2016) (0)
- TCT-119 Association Among Degree of Coronary Artery Calcification, Clinical Presentation, and Adverse Clinical Outcomes After PCI: A Patient-Level Pooled Analysis of 11 Randomized Trials (2021) (0)
- Abstract 5610: Bivalirudin in Patients with Acute Coronary Syndromes Undergoing Saphenous Vein Graft Percutaneous Coronary Intervention: A Subgroup Analysis from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) Trial (2008) (0)
- TCT-469 Frequency, Timing and Implications of Reinfarction after Primary Stenting in ST-Segment Elevation Myocardial Infarction: The HORIZONS-AMI trial (2012) (0)
- Complex PCI: When the going gets tough the tough gets going (2015) (0)
- TRENDS IN UPTAKE AND IN-HOSPITAL OUTCOMES WITH 2ND GENERATION DRUG ELUTING STENTS BETWEEN MEN AND WOMEN UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM THE CATHPCI REGISTRY (2014) (0)
- TCT-745 Insights Into Sex Differences in Transfemoral Transcatheter Aortic Valve Implantation From 2007–2018: From the CENTER Collaboration, A Global Patient-Level Analysis of 12,381 Patients (2019) (0)
- TCT-150 Prognostic Value of Different Definitions of Contrast Induced Acute Kidney Injury in STEMI: Analysis from the HORIZONS-AMI Trial (2012) (0)
- TCT-166 Correlates and Prognostic Impact of New-Onset Heart Failure after ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Insights from the INFUSE-AMI Trial. (2016) (0)
- ATHEROSCLEROTIC PLAQUE MORPHOLOGY IN RESPONSE TO HIGH INTENSITY LIPID LOWERING THERAPY BY MULTIMODALITY IMAGING AMONG WOMEN AND MEN: A YELLOW-II SUB-STUDY (2017) (0)
- Diabetes mellitus in transfemoral transcatheter aortic valve implantation: a propensity matched analysis (2022) (0)
- Pharmacologic Agents for Prevention of Contrast-Induced Nephropathy (2008) (0)
- TCT-211 Incidence and Impact of Dual Antiplatelet Therapy Cessation on Clinical Outcomes in Patients with Renal Dysfunction: Insights from the PARIS Registry. (2016) (0)
- LONG-TERM CLINICAL OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION FOR CHRONIC TOTAL OCCLUSIONS IN PATIENTS WITH AND WITHOUT DIABETES MELLITUS: FIVE-YEAR OUTCOMES FROM A 1,791 PATIENT MULTI-NATIONAL REGISTRY (2011) (0)
- TCT-304 Long term clinical outcomes in acute coronary syndrome patients at high bleeding risk undergoing PCI with implantation of everolimus-eluting stents: Results from the Patient-Level Pooled Analysis of EES Post Approval Studies. (2018) (0)
- Impact of body mass index on outcomes in patients undergoing percutaneous coronary intervention for in-stent restenosis (2022) (0)
- Antiplatelets and Antithrombotics The Role of New Antiplatelet Agents in Percutaneous Coronary Intervention (2009) (0)
- TCT-479 Impact of Angiographic Patterns (Focal vs. Diffuse) of Resistant In-stent Restenosis on Clinical Outcomes (2013) (0)
- TCT-476 Antithrombotic Therapy In Patients With Chronic Kidney Disease And Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Results From The AVIATOR Registry (2014) (0)
- THE IMPACT OF ELECTROCARDIOGRAPHIC LEFT VENTRICULAR HYPERTROPHY ON MORTALITY IN PATIENTS WITH STEMI UNDERGOING PRIMARY PCI: ANALYSIS FROM THE HORIZONS–AMI TRIAL (2013) (0)
- Factor XI Inhibitors in Early Clinical Trials: A Meta-analysis (2022) (0)
- Abstract 18702: Obesity Paradox in Women Undergoing Percutaneous Coronary Intervention With Drug-eluting Stents: Results From a Patient-level Pooled Analysis of Randomized Controlled Trials (2015) (0)
- Ticagrelor Reduces Platelet Reactivity in Troponin Negative Patients With ACS Undergoing Non-Urgent PCI (2015) (0)
- PROGNOSTIC VALUE OF HIGH SENSITIVITY C-REACTIVE PROTEIN AMONG CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2022) (0)
- ASSOCIATION BETWEEN ORBITAL OR ROTATIONAL ATHERECTOMY AND CLINICAL OUTCOMES AMONG PATIENTS WITH CALCIFIC CORONARY ARTERY DISEASE: INSIGHTS FROM THE CLINICAL ASSESSMENT, REPORTING AND TRACKING (CART) PROGRAM (2020) (0)
- TCT-858 Residual inflammatory status in patients with stable coronary artery disease undergoing percutaneous coronary intervention (2018) (0)
- TCT-838 Prognostic Value of High-Sensitivity C-Reactive Protein in Percutaneous Coronary Intervention According to Body Mass Index (2019) (0)
- Sex-based Differences in Percutaneous Coronary Intervention Outcomes in Patients With Ischemic Heart Disease (2023) (0)
- IMPACT OF DIABETES MELLITUS ON LONG-TERM OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION WITH DRUG-ELUTING STENT IN A HIGH-BLEEDING RISK POPULATION: OUTCOMES FROM THE POOLED XIENCE REGISTRY (2019) (0)
- TCT-795 Prognostic Impact of Race in Patients Undergoing PCI: Analysis of 22,638 Patients from 10 Randomized Coronary Stent Trials (2018) (0)
- Evaluation of paclitaxel eluting stents in single and multivessel coronary artery disease using established and novel stent platforms: An interim analysis of the randomized, blinded COSTAR II trial (2006) (0)
- STENT EXPANSION AND ENDOTHELIAL SHEAR STRESS IN BIFURCATION LESION: COMPARISON OF KISSING BALLOON INFLATION AND PROXIMAL OPTIMIZING TECHNIQUE (2019) (0)
- ST-segment elevation resolution as a predictor of mortality in patients with thrombolysis in myocardial infarction III flow in the infarct artery after primary angioplasty: The CADILLAC trial (2003) (0)
- TCT-501 Dual Antiplatelet Therapy Interruption For Surgery: Insights From The PARIS (Patterns Of Non-adherence To Anti-Platelet Regiments In Stented Patients) Registry (2014) (0)
- TCT-231 Comparison of Revascularization Strategies in Patients with Prior CABG Presenting with Acute Coronary Syndromes (2013) (0)
- TCT-66 Effects of dual antiplatelet therapy cessation among patients with diabetes mellitus after PCI with DES. (2016) (0)
- TCT-265 Impact of Platelet Count on Myocardial Infarct Size and Adverse Events in Anterior ST-Elevation Myocardial Infarction: Results from the INFUSE-AMI Trial (2015) (0)
- On‐Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two‐Year Results From ADAPT‐DES (2022) (0)
- IMPACT OF ANTITHROMBOTIC REGIMEN AND TROPONIN STATUS ON OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION IN ACUTE CORONARY SYNDROMES: THE ACUITY TRIAL (2010) (0)
- Impact of Chronic Kidney Disease on Periprocedural Anticoagulation and Short-Term Outcomes after TAVR: A BRAVO-3 Trial Subanalysis (2021) (0)
- Ticagrelor or prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention for chronic coronary syndromes. (2023) (0)
- Efficacy of gamma vascular brachytherapy for ostial versus nonostial in stent restenotic lesions (2002) (0)
- TCT-59 The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality after DES: The ADAPT-DES study (2015) (0)
- IMPACT OF MAJOR BLEEDING AFTER CARDIAC SURGERY ON SUBSEQUENT MORTALITY: THE ACUITY TRIAL (2011) (0)
- THE IMPACT OF LEFT VENTRICULAR FUNCTION ON MORTALITY IN PATIENTS WITH ST-SEGMENT ELEVATION ACUTE MYOCARDIAL INFARCTION: ANALYSIS OF THE HARMONIZING OUTCOMES WITH REVASCULARIZATION AND STENTS IN ACUTE MYOCARDIAL INFARCTION (HORIZONS-AMI) STUDY (2010) (0)
- Coronary artery disease burden and long-term outcomes in patients with human immune deficiency virus (HIV) undergoing percutaneous coronary intervention: results from a single-center registry (2013) (0)
- One‐year clinical outcomes in patients with chronic kidney disease treated with COMBO stents: From the COMBO collaboration (2020) (0)
- A pioneering Argentinean study to better understand the regional gender differences on patients with Acute Coronary Syndromes. (2013) (0)
- TCT-27 Ticagrelor Versus Prasugrel in an All-Comer Patient Cohort Undergoing Percutaneous Coronary Intervention (2022) (0)
- EFFECT OF BIVALIRUDIN VERSUS UNFRACTIONATED HEPARIN IN TRANSCATHETER AORTIC VALVE REPLACEMENT WITH SELF-EXPANDING VALVES: FROM THE BRAVO-3 RANDOMIZED TRIAL (2017) (0)
- REGULATE-PCI Trial: Safety Concerns Cause Early Termination (2015) (0)
- Abstract 4757: Attenuated Plaque Identified by Intravascular Ultrasound Predicts No-Reflow After Stenting in Acute Myocardial Infarction: The HORIZONS-AMI Trial (2009) (0)
- TCT-72 Impact of Gender on Adverse Cardiovascular Events Following Percutaneous Coronary Intervention: Pooled Analysis from the SPIRIT II, III and IV trials (2012) (0)
- Abstract 16507: Complex Percutaneous Coronary Intervention Features Worsen Prognosis in Diabetic Patients: Insights From a Large Single-center Registry (2020) (0)
- TCT-149 Impact of Chronic Kidney Disease on Myocardial Infarct Size and Adverse Events in ST-Elevation Myocardial Infarction: Results from the INFUSE-AMI Trial (2012) (0)
- TCT-47 Impact of Pre-procedural Cardiopulmonary Instability in Patients with Acute Myocardial Infarction Undergoing Primary PCI: Insights from the HORIZONS-AMI trial (2014) (0)
- IMPACT OF CHRONIC KIDNEY DISEASE ON OUTCOMES IN PATIENTS UNDERGOING TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT WITH BIVALIRUDIN OR UNFRACTIONATED HEPARIN: FROM THE EFFECT OF BIVALIRUDIN ON AORTIC VALVE INTERVENTION OUTCOMES (BRAVO) TRIAL (2016) (0)
- Prevalence and impact of TWILIGHT criteria in all-comer patients undergoing percutaneous coronary intervention (2022) (0)
- TCT-541 Validation of the Academic Research Consortium–High Bleeding Risk Criteria for Patients Undergoing Percutaneous Coronary Intervention (2019) (0)
- Impact of lesion length on vascular brachytherapy failure: a comparison of beta (b) versus gamma (g) irradiation in 990 patients (2002) (0)
- IMPACT OF INCOMPLETE CORONARY REVASCULARIZATION ON ONE-YEAR OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION IN ACUTE CORONARY SYNDROMES: THE ACUITY TRIAL (2012) (0)
- Abstract 15502: Clinical Outcomes in Patients Undergoing Non-cardiac Surgery Within 1 Year of Pci (2020) (0)
- TCT-2 Incidence and Impact of Totally Occluded Culprit Arteries in Patients with Non-ST-segment Elevation (2014) (0)
- Abstract 13942: Do Geographic Trends in Aspirin Discharge Dose Alter Outcomes After STEMI and Primary PCI: Results From the HORIZONS-AMI Trial (2011) (0)
- 808-2 Creatine kinase-MB elevation after coronary stenting in lesions with ruptured plaque (2004) (0)
- TCT-379 Independent and Combined Effect of Chronic Kidney Disease and Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents: Results from a Patient-Level Pooled Analysis of Randomized Controlled Trials (2015) (0)
- Abstract 2001: Clinical and Angiographic Predictors of 30-Day and One-Year Ischemic Cardiac Events in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: An ACUITY Substudy (2008) (0)
- Abstract 4368: Impact of Baseline Thrombus on Acute Tissue Protrusion and Late Neointimal Formation After Stent Implantation in Acute Myocardial Infarction: An Intravascular Ultrasound Substudy From the HORIZONS-AMI Trial (2009) (0)
- TCT CONNECT-305 Impact of Lesion Location on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents for Unprotected Left Main Coronary Artery Stenosis (2020) (0)
- SAFETY AND EFFICACY OF THE BIOABSORBABLE POLYMER EVEROLIMUS ELUTING STENTS COMPARED TO THE 2ND GENERATION DURABLE POLYMER EVEROLIMUS ELUTING STENTS IN COMPLEX CORONARY LESIONS (2019) (0)
- Complications related to radiation and contrast media exposure (2007) (0)
- TCT-746 Outcomes by Total Stent Length in ACS PCI with Second Generation Drug-Eluting Stents: Results from the PROMETHEUS Study (2017) (0)
- REGULATE-PCI trial – Author's reply (2016) (0)
- THE RELATIONSHIP BETWEEN LESION SEVERITY AND VULNERABLE PLAQUE MORPHOLOGY: LESSONS FROM THE PROSPECT STUDY (2012) (0)
- TCT-577 Early- Versus New-Generation Drug-Eluting Stents in Women at High Risk for Atherothrombosis: Results froma Patient-Level Pooled Analysis of Randomized Controlled Trials (2015) (0)
- Antithrombotic strategy variability in atrial fibrillation and obstructive coronary disease revascularised with percutaneous coronary intervention: primary results from the AVIATOR 2 international registry. (2022) (0)
- P3283Predictors of pacemaker implantation in women undergoing contemporary transcatheter aortic valve replacement: Results from the WIN-TAVI registry (2017) (0)
- TIMING AND ALGORITHM OF PERMANENT PACEMAKER IMPLANTATION AFTER TAVR (2017) (0)
- Inclusion of women in cardiovascular clinical trials: A path forward. (2022) (0)
- TCT-620 Shift Of Patient Selection For Balloon Aortic Valvuloplasty After Introduction Of Transcatheter Aortic Valve Replacement: Insights From A Single-center Registry (2015) (0)
- TCT-120 Long-term Outcomes in Women and Men Following Percutaneous Coronary Intervention: An individual patient data pooled analysis from 21 randomized trials (2018) (0)
- TCT-446 Outcomes Among Patients Enrolled Versus Not Enrolled In Interventional Cardiovascular Clinical Trials: Insights From A Single-center Analysis (2015) (0)
- THE RELATIONSHIP BETWEEN PERICARDIAL ADIPOSE TISSUE VOLUME, ATHEROSCLEROTIC PLAQUE TYPE AND CARDIOVASCULAR RISK: A HIGH RISK PLAQUE BIOIMAGE SUB-STUDY (2017) (0)
- CONTEMPORARY PRACTICE PATTERNS RELATED TO THE RISK OF ACUTE KIDNEY INJURY IN THE CATHETERIZATION LABORATORY: RESULTS FROM AN INTERNATIONAL SURVEY OF SOCIETY OF CARDIOVASCULAR ANGIOGRAPHY AND INTERVENTION (SCAI) CARDIOLOGISTS (2016) (0)
- TCT-4 Dual Antiplatelet Therapy for 1 Versus 3 Months in Women and Men at High Bleeding Risk Undergoing Drug-Eluting Stent Implantation (2022) (0)
- Radiation protection for healthcare professionals working in catheterisation laboratories during pregnancy: an EAPCI position statement in collaboration with EHRA, EACVI, the ESC Regulatory Affairs Committee and Women as One. (2022) (0)
- Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial (2022) (0)
- PREDICTORS OF NET ADVERSE CLINICAL EVENTS POST BALLOON AORTIC VALVULOPLASTY: RESULTS FROM THE BRAVO (EFFECT OF BIVALIRUDIN ON AORTIC VALVE INTERVENTION OUTCOMES) STUDY (2012) (0)
- Primary stent deployment for obstructive lesions of the subclavian or innominate artery (1998) (0)
- IMPACT OF RENAL FUNCTION IN PATIENTS WITH HIGH BLEEDING RISK WHO UNDERWENT PERCUTANEOUS CORONARY INTERVENTION WITH XIENCE: A PATIENT-LEVEL POOLED ANALYSIS FROM FOUR XIENCE POST-APPROVAL TRIALS (2019) (0)
- TCT-474 Triple vs. Dual Antithrombotic Therapy In Patients With Atrial Fibrillation And Acute Coronary Syndromes: The AVIATOR Registry (2014) (0)
- Heroism in the Face of the COVID-19 Pandemic. (2020) (0)
- INCIDENCE, PREDICTORS AND IMPACT OF MAJOR BLEEDING IN PATIENTS UNDERGOING TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT WITH BIVALIRUDIN OR UNFRACTIONATED HEPARIN: FROM THE EFFECT OF BIVALIRUDIN ON AORTIC VALVE INTERVENTION OUTCOMES (BRAVO) TRIAL (2016) (0)
- Management of Patients With Kidney Disease in Need of Cardiovascular Catheterization: A Scientific Workshop Cosponsored by the National Kidney Foundation and the Society of Cardiovascular Angiography and Interventions (2022) (0)
- Different mechanism of lumen enlargement in lesions with stent underexpansion after balloon angioplasty for in-stent restenosis compared to those with optimal stent expansion: an intravascular ultrasound study (2002) (0)
- TCT-489 Stent Thrombosis after primary PCI for STEMI in relation to non-usage of dual antiplatelet therapy over time: Results of the HORIZONS-AMI trial (2012) (0)
- INCIDENCE, PREDICTORS AND IMPACT OF STROKE AFTER PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES: RESULTS FROM THE PROMETHEUS REGISTRY (2016) (0)
- INCIDENCE AND RISK FACTORS FOR CONTRAST-INDUCED NEPHROPATHY IN PRIMARY PERCUTANEOUS CORONARY INTERVENTION: AN ANALYSIS FROM THE HARMONIZING OUTCOMES WITH REVASCULARIZATION AND STENTS IN ACUTE MYOCARDIAL INFARCTION TRIAL (HORIZONS-AMI) (2011) (0)
- BASELINE INFLAMMATORY BIOMARKERS PREDICT LONG-TERM ISCHAEMIC RISK IN PATIENTS AT HIGH BLEEDING RISK UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS: RESULTS FROM A PROSPECTIVE REGISTRY (2023) (0)
- MINIMUM STENT AREA IS AN INDEPENDENT PREDICTOR OF ANGIOGRAPHIC RESTENOSIS AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN STEMI: A HORIZONS-AMI IVUS SUBSTUDY (2011) (0)
- P1664Clinical outcomes by potency of P2Y12 inhibitor following COMBO DTS PCI: From the COMBO collaboration (2018) (0)
- C-57 | Prevalence and Outcomes of Early Menopause in Women undergoing Transcatheter Aortic Valve Replacement: Insights from the WIN-TAVI Registry (2022) (0)
- Abstract 20415: Incidence of Post-Procedural Myocardial Infarction and Risk of Recurrent Cardiac Events After Coronary Stenting (2016) (0)
- New Criteria to Identify Patients at Higher Risk for Cardiovascular Complications After Percutaneous Coronary Intervention. (2022) (0)
- PRELIMINARY ANGIOGRAPHIC RESULTS OF THE NOVEL POLYMER-FREE BIOLIMUS-A9 COATED STENTS FOR THE TREATMENT OF CORONARY ARTERY LESIONS - FOUR-MONTH ANGIOGRAPHIC FOLLOW-UP OF THE PROSPECTIVE, RANDOMIZED, MULTICENTER BIOFREEDOM TRIAL (2010) (0)
- Abstract 15958: Internal Elastic Lamellar Disruption is Associated With Smooth Muscle and Myofibroblast Cell Hyperplasia in Restenotic Peripheral Vascular Disease (2011) (0)
- COMPLETE REVASCULARIZATION IN PATIENTS UNDERGOING A PHARMACOINVASIVE STRATEGY FOR STEMI (2021) (0)
- Racial Disparities in First Authorship of Cardiology Editorials (2022) (0)
- TCT-747 Associations between Stent Diameter and Clinical Outcomes in ACS PCI Using Second Generation Drug-Eluting Stents: From the PROMETHEUS Study (2017) (0)
- Abstract 4589: Anti-thrombotic Strategies in Patients with Elevated Biomarkers Undergoing PCI: Results from the ACUITY Trial (2008) (0)
- TCT-96 Validation of the UK-BCIS CHIP-PCI Score in a Large Single-Center Registry (2022) (0)
- IMPACT OF ANTICOAGULATION REGIMEN IN PATIENTS WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROMES UNDERGOING AN EARLY INVASIVE STRATEGY INDEPENDENT OF REVASCULARIZATION: THE ACUITY TRIAL (2010) (0)
- Relationship between time to treatment, electrocardiographic ST-segment resolution, and outcomes with primary percutaneous coronary intervention for acute myocardial infarction: Results from the CADILLAC trial (2003) (0)
- TCT-630 The Impact of Diabetes Mellitus in Patients Undergoing Percutaneous Coronary Intervention With a Drug Eluting Stent for Unprotected Left Main Stenosis (2019) (0)
- PROGNOSTIC UTILITY OF THE SYNTAX SCORE IN PATIENTS WITH SINGLE VS. MULTIVESSEL DISEASE UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE ACUITY TRIAL (2011) (0)
- IMPACT OF TROPONIN ELEVATION ON OUTCOMES OF PATIENTS WITH ACUTE CORONARY SYNDROMES AND CHRONIC RENAL INSUFFICIENCY (2010) (0)
- Iconographies supplémentaires de l'article : Comparison of Outcomes of Patients With ST-Segment Elevation Myocardial Infarction With Versus Without Previous Coronary Artery Bypass Grafting (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] (2013) (0)
- Hostile Work Environment in Cardiology: The Global Prevalence of Emotional Harassment, Discrimination, and Sexual Harassment and Their Impact on Healthcare (2020) (0)
- In saphenous vein grafts bigger is not significantly better: an intravascular ultrasound study (2002) (0)
- Abstract 16422: Development and Validation of a Stent Thrombosis Risk Score in Patients With Acute Coronary Syndromes (2011) (0)
- Positive geometric remodelling of native denovo coronary lesions predicts clinical restenosis after stent implantation (1999) (0)
- Bivalirudin plus a high-dose infusion versus Heparin in patients with acute coronary syndrome. (2023) (0)
- Chest Pain in Women: Evaluation and Management (2015) (0)
- TCT-156 Patterns of Therapy Cessation in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Insights From the AVIATOR-2 International Registry (2019) (0)
- TCT-71 Predictors, incidence and outcomes of patients undergoing transcatheter aortic valve implantation complicated by stroke – From the CENTER-Collaboration (2018) (0)
- TCT-419 Effects of Body Mass Index on the Comparative Effectiveness of PCI Versus CABG for Left Main Coronary Artery Disease: Insights From the EXCEL Trial (2018) (0)
- ARE “NEW GENERATION” DES SUPERIOR TO “OLD GENERATION” DES IN REDUCING ADVERSE CLINICAL OUTCOMES AT LONG–TERM FOLLOW–UP: INSIGHTS FROM REAL (REGISTRO REGIONALE ANGIOPLASTICHE DELL'EMILIA–ROMAGNA) MULTICENTER REGISTRY (2013) (0)
- 869-2 Impact of intravenous beta-blockade during primary percutaneous intervention on convalescent left ventricular function (2004) (0)
- Reducing the cost of managing patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting. (2020) (0)
- TCT-105 Determinants of Seattle Angina Questionnaire in Multivessel Disease Patients Undergoing Percutaneous Coronary Intervention: Insights From a Single-Center Study (2022) (0)
- TCT-156 Patterns of Therapy Cessation in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Insights From the AVIATOR-2 International Registry (2019) (0)
- Abstract 12129: Public Reporting of PCI Outcomes and Provider Risk Aversion: The Results of a Survey of Interventional Cardiologists in Massachusetts and New York (2017) (0)
- PROGNOSTIC VALUE OF ELEVATED C-REACTIVE PROTEIN AMONG DIABETIC PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2021) (0)
- RACIAL DIFFERENCES IN PREVALENCE OF CAROTID ATHEROSCLEROSIS: RESULTS FROM THE PLAQUE BIOIMAGE STUDY (2013) (0)
- TCT-658 Neurologic Outcomes with Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. (2016) (0)
- Contents (2020) (0)
- IMPACT OF LEFT VENTRICULAR FUNCTION ON MORTALITY IN PATIENTS WITH ACUTE CORONARY SYNDROMES: ANALYSIS OF THE ACUTE CATHETERIZATION AND URGENT INTERVENTION TRIAGE STRATEGY (ACUITY) TRIAL (2010) (0)
- TCT-479 Impact of Left Ventricular Dysfunction and Multi-Vessel Disease After Primary Percutaneous Coronary Intervention: Three-Year Outcomes from the HORIZONS-AMI Trial (2012) (0)
- TCT-65 Comparative Efficacy and Safety of Coronary Stents in Diabetic Patients With and Without Insulin Treatment: A pooled patient level analysis from 17 randomized trials. (2016) (0)
- Abstract 4678: Surgical versus Percutaneous Revascularization for the Treatment of Patients With Multivessel Disease in the Setting of Acute Coronary Syndromes: Analysis From the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) Trial (2009) (0)
- Importance of gender differences in the diagnosis and management of patients with Acute Coronary Syndromes: The GRACE study in an Argentine Population (2013) (0)
- The Smart(est) Choice for Dual Antiplatelet Therapy is a Patient-Directed One. (2022) (0)
- TCT-346 Race and Outcomes after PCI for ACS: A Pooled Analysis of the HORIZONS-AMI and ACUITY Trials (2013) (0)
- TCT-692 Impact of Drug-Eluting Stent Generation in Elderly Patients Undergoing PCI: Five-Year Follow-up From a Patient-Level Analysis of 19 Randomized Trials (2018) (0)
- PREDICTION OF ACUTE KIDNEY INJURY IN PATIENTS UNDERGOING CORONARY INTERVENTION USING CALCULATION OF SERUM OSMOLALITY (2017) (0)
- ~ Ba!!oons PTCA Is to Stenta In Patlente Equivalent With Small Coronaries: A Comparative Retrospective Matching Study (1998) (0)
- Abstract 18793: Impact of Chronic Kidney Disease on Outcomes in Patients Undergoing Balloon Aortic Valvuloplasty: Results from the BRAVO Study (2012) (0)
- Miscellaneous Coronary InterventionTCT-57 Impact Of Coronary Artery Calcification On Clinical Events In Patients Undergoing Coronary Artery Bypass Grafting: Analysis From The ACUITY (Acute Catheterization And Urgent Intervention Triage Strategy) Trial (2013) (0)
- The 70/30 Rule Between Men and Women-Disparity or Opportunity?-Reply. (2020) (0)
- Extending the aspirin-free paradigm to patients with acute coronary syndrome: is it time to change guidelines? (2020) (0)
- Representation of Women in Cardiology Academic Faculty Ranks. (2023) (0)
- TCT-1 Bleeding in Patients With Atrial Fibrillation and Acute Coronary Syndrome or PCI Treated With Antithrombotic Therapy: Insights From the AUGUSTUS Trial (2022) (0)
- TCT-615 Percutaneous Coronary Intervention for Patients with Ischemic Cardiomyopathy Is Associated with Low Mortality and Improves Ejection Fraction: A Meta-Analysis of 3,844 Patients (2018) (0)
- Abstract 4487: Clopidogrel Resistance in Patients Undergoing Percutaneous Coronary Intervention: One Year Outcome (2008) (0)
- TCT-750 Can the Rate of Acute Stent Thrombosis with Bivalirudin Anticoagulation During Primary PCI in STEMI be Reduced with Modified Pharmacologic Regimens? (2012) (0)
- Antiplatelets in patients with atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials (2021) (0)
- TCT-403 Impact of Bifurcation Lesion Treatment with DES on Clinical Outcomes: Results from the Prospective, Multicenter ADAPT-DES Study (2013) (0)
- Corrigendum to "Gender-related differences after acute myocardial infarction: A major global health challenge" [International Journal of Cardiology Volume 311 (2020), 18-19 / DOI: https://doi.org/10.1016/j.ijcard.2020.04.023]. (2021) (0)
- Improving Outcomes in High-Risk Percutaneous Coronary Interventions and Newer-Generation Drug-Eluting Stents: Good, But Not Good Enough (2017) (0)
- CLINICALLY-BASED PATIENT RISK SCORES AND THE ‘TARGET LESION REVASCULARIZATION PARADOX’ IN PATIENTS WITH MULTI-VESSEL CAD UNDERGOING PCI (2012) (0)
- Abstract 84: Impact of Education on Dual Antiplatelet Therapy Adherence (2012) (0)
- Treatment of Acute Infarction With PCI Outcomes of Optimal or “ Stent-Like ” Balloon Angioplasty in Acute Myocardial Infarction : The CADILLAC Trial (2016) (0)
- TCT-477 Major Adverse Cardiovascular Events And Bleeding Risk Analysis In Elderly Afibrillation Patients Undergoing Percutaneous Coronary Intervention: The AVIATOR Registry (2014) (0)
- TCT-63 Impact of Chronic Total Occlusions on Revascularization Scores and Outcome Prediction. (2016) (0)
- Artificial Intelligence – Advisory or Adversary? (2023) (0)
- TCT-294 Clinical Outcomes in Women and Minorities According to the Urgency of Percutaneous Coronary Intervention (2019) (0)
- Stents farmacológicos eluidores de everolimus na prática no mundo real: [editorial] (2011) (0)
- Abstract 18868: Ethnic and Gender Differences in the Occurrence and Outcomes in Patients With Diabetes: Results of the Platinum Diversity Study (2017) (0)
- Bleeding Complications in Patients Undergoing Percutaneous Coronary Intervention: Prognostic Implications and Prevention (2010) (0)
- Overlapping paclitaxel elating stents: Early outcomes in the COSTAR II study (2006) (0)
- TCT-196 Outcomes of Radial Compared with Femoral Artery Access in Patients Undergoing PCI for Left Main Disease: Analysis from the EXCEL Trial (2017) (0)
- FEMALE-AUTHORED RESEARCH PUBLICATIONS IN HIGH-IMPACT CARDIOLOGY JOURNALS RECEIVE LESS ONLINE ATTENTION BASED ON ALTMETRIC SCORES (2022) (0)
- RISK-TREATMENT PARADOX IN PREVALENCE AND DETERMINANTS OF POTENT P2Y12 INHIBITOR USE IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM A LARGE SINGLE-CENTER REGISTRY (2016) (0)
- SEX-SPECIFIC PREDICTORS OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH PREMATURE CORONARY ARTERY DISEASE UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2023) (0)
- IMPACT OF EARLY AND LATE STENT MALAPPOSITION ON LONG-TERM CLINICAL OUTCOMES: THREE-YEAR FOLLOW-UP FROM THE HORIZONS-AMI IVUS SUBSTUDY (2012) (0)
- P6138Quality of clinical trial evidence on devices and drugs approved to treat coronary artery disease (2019) (0)
- TCT-833 Inflammatory Risk Status Is Age-Dependent in Women but Not in Men Undergoing Percutaneous Coronary Intervention (2019) (0)
- MULTIVESSEL VERSUS CULPRIT-ONLY PCI IN PATIENTS WITH NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION AND MULTIVESSEL DISEASE: RESULTS FROM THE PROMETHEUS STUDY (2017) (0)
- Outcomes After Transcatheter Aortic Valve Implantation in Men Versus Women. (2022) (0)
- EFFECT OF BIVALIRUDIN VERSUS HEPARIN IN A CONTEMPORARY TAVR POPULATION OF WOMEN: RESULTS FROM THE BRAVO 3 RANDOMIZED TRIAL (2016) (0)
- SPATIAL CORONARY ARTERIAL DISTRIBUTION OF NON-CULPRIT LESION ATHEROSCLEROTIC EVENTS: ANALYSIS FROM THE PROSPECT TRIAL. (2010) (0)
- Efficacy of Long Radiation Treatment in Native In-Stent Restenosis: A Subanalysis From the RENO Registry (2002) (0)
- Can manual thrombus aspiration improve myocardial reperfusion? (2006) (0)
- TCT-320 Impact of Pre-Procedural High-Sensitivity C-Reactive Protein, LDL-C and SYNTAX Score on Outcomes Following Percutaneous Coronary Intervention (2018) (0)
- Predictors and outcomes of acute, sub-acute and early stroke following transcatheter aortic valve implantation (2022) (0)
- DIFFERENTIAL IMPACT OF HIGH PLATELET REACTIVITY ON CLOPIDOGREL IN WOMEN AND MEN FOLLOWING PERCUTANEOUS CORONARY INTERVENTION (PCI) WITH DES (2015) (0)
- Impact of different antiplatelet therapy cessation modes on outcomes in patients treated with ticagrelor with or without aspirin after PCI: the twilight-antiplatelet cessation study (2022) (0)
- FEASIBILITY AND VALIDITY OF MEASURING PATIENT-REPORTED HEALTH STATUS AT TIME OF PCI: RESULTS FROM A SINGLE-CENTER QUALITY IMPROVEMENT INITIATIVE (2018) (0)
- Gender Peculiarities (0)
- PATIENTS WITH IVUS-DEFINED HIGH-GRADE STENOSES LEFT BEHIND AFTER PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROME HAVE MORE FIBROATHEROMAS AND WORSE CLINICAL OUTCOMES DESPITE A LOWER OVERALL PLAQUE BURDEN: ANALYSIS FROM THE PROSPECT TRIAL (2011) (0)
- TCT-487 Temporal Associations Between Myocardial Infarction, Major Bleeding and Mortality Risk in ACS Patients Undergoing PCI: Insights from the PROMETHEUS Cohort (2015) (0)
- DRUG-ELUTING VERSUS BARE-METAL STENTS IN TREATMENT OF DIABETIC PATIENTS WITH ACUTE CORONARY SYNDROMES: ANALYSIS FROM THE RANDOMIZED ACUITY TRIAL (2010) (0)
- Intravascular Ultrasound Analysis Bifurcation Coronary Lesions Treated With the "Crush" Technique: An (2011) (0)
- TCT-542 Impact of Baseline Anemia and Thrombocytopenia on 1-Year Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention (2019) (0)
- Comparison of upstream tirofiban and eptifibatide use in patients with moderate and high risk acute coronary syndromes: An ACUITY substudy (2007) (0)
- P4554Impact of the presence of chronic kidney disease on 1-year target lesion failure in patients treated with a dual-therapy stent (2018) (0)
- THE EFFECT OF STATIN USE PRIOR TO ANGIOGRAPHY ON THE PREVENTION OF CONTRAST INDUCED NEPHROPATHY: A META-ANALYSIS OF 16 RANDOMIZED TRIALS (2014) (0)
- -2. Clinical Research Design: From Observational Research to Clinical Trials (2005) (0)
- Gender-related differences after acute myocardial infarction: A major global health challenge. (2020) (0)
- Patterns of dual anti platelet therapy cessation in left main and proximal left anterior descending artery PCI: Results from the PARIS registry (2015) (0)
- The Use of Bivalirudin in ST-Segment Elevation Myocardial Infarction: Advantages and Limitations. (2012) (0)
- Does vessel size have an impact on recurence rates following gamma vascular brachytherapy: acute and nine-month results from SCRIPPS III registry (2002) (0)
- (cadillac) trial abciximab and device investigation to lower late angioplasty complications primary percutaneous coronary intervention: Analysis from the controlled Impact of anemia in patients with acute myocardial infarction undergoing (2011) (0)
- INTRAVASCULAR ULTRASOUND COMPARISON BETWEEN CAUCASIAN AND ASIAN LEFT MAIN CORONARY ARTERY DISEASE (2011) (0)
- Perspectives of Female Cardiology Trainees on Interventional Cardiology Training and Careers: A Canadian Nationwide Survey. (2022) (0)
- Contrast-Induced Nephropathy Redefined; Impact of Any Acute Kidney Injury on Clinical Outcomes in Patients with ACS undergoing Angiography: Results from the ACUITY Trial (2008) (0)
- The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial (2022) (0)
- Is bivalirudin a safe alternative to heparin during carotid stenting? A case matched study (2003) (0)
- TCT-166 Correlates of High Platelet Reactivity on Clopidogrel in 8,533 Patients: An ADAPT-DES Substudy (2013) (0)
- 1101-41 Intravascular ultrasound assessment of lesions with sirolimus-eluting stent failure (2004) (0)
- The fork in the road: A dedicated turn or a provisional one? (2011) (0)
- DIFFERENTIAL IMPACT OF FEMALE GENDER ON MORTALITY BY PRESENCE OR ABSENCE OF CHRONIC KIDNEY DISEASE FOLLOWING PCI: RESULTS FROM A SINGLE–CENTER REGISTRY WITH 15,990 PATIENTS (2013) (0)
- TCT-844 Long term risk for major bleeding and ischemic events after PCI with implantation of everolimus-eluting stents: A Pooled-level Analysis of 8,020 Patients (2018) (0)
- Impending savior: Impella 2.5 circulatory support system in high‐risk PCI (2012) (0)
- ANGIOGRAPHIC PHENOTYPE AND CLINICAL OUTCOMES OF PATIENTS WITH MALIGNANCY UNDERGOING PCI (2017) (0)
- Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of glassy and twilight. (2023) (0)
- TCT-112 Impact of Race/Ethnicity On 30 Day Readmission After Percutaneous Coronary Intervention: Results From a Multiethnic, Single Center Registry (2014) (0)
- Triple Antiplatelet Therapy and Combinations with Oral Anticoagulants After PCI (2016) (0)
- TCT-180 Efficacy and Safety of Rotational Atherectomy in Patients With Non ST Elevation - Acute Coronary Syndromes (2022) (0)
- Clinical Pharmacokinetics and Pharmacodynamics of CSL112 (2023) (0)
- P2331Association between serum osmolality and acute kidney injury after percutaneous coronary intervention: a simple tool for acute kidney injury prediction (2017) (0)
- The Final Word: Current Strategies for the Lifetime Management of Patients with Aortic Valve Stenosis (2022) (0)
- OUTCOMES OF PCI VERSUS CABG IN LEFT MAIN DISEASE ACCORDING TO SYNTAX SCORE BY SITE VERSUS ANGIOGRAPHIC CORE LABORATORY ASSESSMENT: INSIGHTS FROM THE EXCEL TRIAL (2017) (0)
- TCT-201 Incidence and Implications of Presentation With Ventricular Tachycardia or Fibrillation in Patients With STEMI Undergoing Primary PCI: The HORIZONS-AMI Trial. (2016) (0)
- RISK AND IMPACT OF DIABETES MELLITUS ON ISCHEMIC EVENTS IN FEMALES AND MALES AFTER PERCUTANEOUS CORONARY INTERVENTION (2017) (0)
- FIVE-YEAR FOLLOW-UP OF POLYTETRAFLUOROETHYLENE-COVERED STENTS COMPARED WITH BARE METAL STENTS IN AORTOCORONARY SAPHENOUS VEIN GRAFTS: THE RANDOMIZED BARRICADE TRIAL (2011) (0)
- TCT-6 Simultaneous Impact of Thrombotic and Bleeding Risks on Use of Novel P2Y12 inhibitors in Contemporary PCI: Results from a Large Single-Center Registry. (2016) (0)
- Clinical and Angiographic Predictors of Death or Myocardial Infarction in Diabetics with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: An ACUITY Subanalysis (2009) (0)
- 518 DUAL ANTIPLATELET THERAPY DE-ESCALATION MODALITIES IN ACUTE CORONARY SYNDROME PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2022) (0)
- Coronary Artery Disease in Women: Shyly Bold? (2012) (0)
- Chronic Total Occlusion Recanalization A Call for a Randomized Trial Reply (2012) (0)
- Use of Bivalirudin for Anticoagulation in Interventional Cardiovascular Procedures (2018) (0)
- TCT-117 Impact of Discharge Location After Transcatheter Aortic Valve Replacement On 1-Year Outcomes In Women: Results From The WIN-TAVI Registry (2017) (0)
- Abstract 16973: Prevalence, Determinants, and Impact of Target Lesion Calcification in Patients Undergoing Percutaneous Coronary Intervention With Newer Generation Drug Eluting Stents: Findings From a Large Multiethnic Registry (2015) (0)
- TCT-86 Quantification and Impact of the Proportion of Coronary Disease Burden Treated by Percutaneous Coronary Intervention: The SYNTAX Revascularization Index (2014) (0)
- 1043-48 Impact of cerebrovascular and peripheral arterial disease on outcomes after percutaneous coronary interventions (2004) (0)
- Abstract 5606: Outcomes of Patients With Acute Coronary Syndromes and Chronic Renal Insufficiency: Prognostic Importance of Troponin Elevation and Role of Adjunctive Antithrombotic Therapy (Analysis From the Acuity Trial) (2009) (0)
- TCT CONNECT-162 Predictors of Adverse Events in Patients Undergoing Cardiac Surgery Within 1 Year of PCI (2020) (0)
- TCT-230 Impact of Delay to reperfusion on Infarct Size and Clinical Outcomes in Patients with STEMI: The INFUSE-AMI Trial (2013) (0)
- Device and Procedure Relatedness: Viewpoint From Members of the ARC Steering Group. (2022) (0)
- INCOMPLETE THREE-VESSEL INTRAVASCULAR IMAGING IN THE PROSPECT TRIAL: IMPLICATIONS FOR PRE-EMPTIVE VULNERABLE PLAQUE DETECTION (2010) (0)
- TCT-798 Evaluation of sex-differences in one-year clinical outcomes among patients treated with the dual-therapy COMBO stent: From the COMBO Collaboration (2018) (0)
- TCT-662 Patients Who Do Not Receive Drug-Eluting Stent for In-Stent Restenosis: Characteristics and Outcomes (2019) (0)
- Transfemoral TAVR in Nonagenarians (0)
- , Catheterization and Urgent Intervention Triage Strategy ( ACUITY ) Trial Percutaneous Coronary Intervention in Acute Coronary Syndromes : The Acute Impact of the Presence and Extent of Incomplete Angiographic Revascularization After (2012) (0)
- TCT CONNECT-379 Adverse Outcomes in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease (2020) (0)
- Comparison of Quality-of-Life Measures after Radial versus Femoral Artery Access for Cardiac Catheterization in Women: Results of the SAFE-PCI for Women Quality-of-Life Substudy Short title: Hess et al.: QOL in SAFE-PCI for Women (2015) (0)
- Relative Impact of MACE and Varying Definitions of Major Bleeding on Mortality: Results from the HORIZONS-AMI Trial (2008) (0)
- TCT-237 Revascularization Options for Women With Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials (2019) (0)
- PLATELET REACTIVITY AND OUTCOMES AFTER PCI OF LESIONS WITH AND WITHOUT IN-STENT RESTENOSIS: THE ADAPT-DES STUDY (2017) (0)
- TCT-500 Prognostic Implications of Reduced Pre-procedural TIMI Flow in Patients with Non–ST-Segment Elevation Acute Coronary Syndromes Undergoing PCI (2018) (0)
- Predictors of target lesion revascularization in diabetic patients treated with Palmaz-Schatz stents (1998) (0)
- Delayed time course of target lesion revascularization following saphenous vein graft angioplasty (1998) (0)
- ROMA-Women: Innovative Approaches for the First Cardiac Surgery Trial in Women. (2023) (0)
- PROGNOSTIC UTILITY OF LEFT VENTRICULAR END-DIASTOLIC PRESSURE MEASUREMENT IN PATIENTS WITH STEMI UNDERGOING PRIMARY PCI: THE HORIZONS-AMI TRIAL (2011) (0)
- TCT-268 Impact of diabetes on outcomes after percutaneous coronary intervention in patients according to race/ethnicity. (2016) (0)
- TCT-99 Clinical Outcomes in Patients With High Bleeding Risk and Bifurcations After Percutaneous Coronary Intervention With Resolute Onyx and 1-Month Dual Antiplatelet Therapy (2021) (0)
- TCT-3 Outcomes in STEMI patients treated with clopidogrel or prasugrel: A propensity adjusted analysis from the INFUSE-AMI Trial (2013) (0)
- mpact of Bivalirudin Therapy in High-Risk atients With Acute Myocardial Infarction (0)
- TCT-163 Do Patients with Paroxysmal Atrial Fibrillation in Sinus Rhythm during PCI Require Triple Therapy? Results from a Multicenter Center Study (2013) (0)
- Potential Clinical Advantages of Drug-Coated Balloon in Specific Clinical Settings (2019) (0)
- Pharmacology/PharmacotherapyTCT-220 Effect of prasugrel versus clopidogrel in ACS patients with high or low BMI undergoing PCI: Results from the PROMETHEUS Study (2015) (0)
- 801-3 Anemia worsens prognosis after primary angioplasty in acute myocardial infarction: Analysis from the CADILLAC trial (2004) (0)
- 31. Bleeding Definitions (2014) (0)
- A sensitive and cost-effective intravascular ultrasound model to study anti-restenosis strategies in vivo (1996) (0)
- Survival benefit with PCI for chronic total occlusions: The Jury is still out (2012) (0)
- Antiplatelets and AntithrombinsTCT-156 Impact of Clopidogrel Hyporesponsiveness on Clinical Outcomes in Patients Receiving Drug-eluting Stents for Stable Coronary Disease in the ADAPT-DES Study (2013) (0)
- Stent apposition in late and very late stent thrombosis (2013) (0)
- Predictors and prognostic values of CK-MB cardiac enzyme elevation after coronary intervention with radiation treatment in in-stent restenosis (2002) (0)
- A NOVEL APPROACH TO IDENTIFY WOMEN WITH CARDIOVASCULAR RISK FACTORS: RESULTS FROM THE OB/GYN SCREENING PILOT PROGRAM (2012) (0)
- Gamma vascular brachytherapy neutralizes the negative impact of diabetes mellitus on clinical outcomes after PCI for in-stent restenosis: pooled data from Gamma I, Gamma II, and SCRIPPS III trials (2002) (0)
- Guest Editorial A Brave New World for Non-vitamin K Antagonist Oral Anticoagulants: Have We seen the Last of Warfarin? (2017) (0)
- ROTATIONAL VERSUS ORBITAL ATHERECTOMY FOR TREATMENT OF DIFFUSE CORONARY IN-STENT RESTENOSIS (2020) (0)
- TCT-445 Patients with 3-vessel Coronary Artery Disease and Impaired LVEF undergoing PCI with Impella 2.5 Hemodynamic Support Have Improved 90-Day Outcomes Compared to Intra-Aortic Balloon Pump: A Substudy of The PROTECT II Trial (2013) (0)
- TEMPORAL ASSOCIATIONS BETWEEN TIME AFTER PERCUTANEOUS CORONARY INTERVENTION, DUAL ANTIPLATELET THERAPY CESSATION AND STENT THROMBOSIS IN THE CONTEMPORARY PCI ERA: INSIGHTS FROM THE PARIS REGISTRY (2014) (0)
- IMPACT OF BODY SURFACE AREA ON OUTCOMES IN WOMEN AND MEN UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2023) (0)
- Interventional Cardiology Frequency and Predictors of Stent Thrombosis After Percutaneous Coronary Intervention in Acute Myocardial Infarction (2011) (0)
- Impact of Blood Transfusion and Other Bleeding Measures on Subsequent Mortality Among Patients Undergoing Primary PCI for Acute Myocardial Infarction: The HORIZONS-AMI Trial (2008) (0)
- TCT-228 Prasugrel or Clopidogrel in Patients With Acute Coronary Syndromes With Multivessel Disease: Results From the PROMETHEUS Study (2021) (0)
- Abstract 20664: Is Aspirin Needed as an Antiplatelet Therapy in Patients With Atrial Fibrillation Undergoing Coronary Intervention? (2017) (0)
- A rocky road to LV recovery post TAVI (2015) (0)
- TCT-249 Differential Impact Of Diabetes Mellitus On Safety And Efficacy Of New Versus First Generation Drug-eluting Stents Among Women: A Patient-level Pooled Analysis Of 26 Randomized Trials (2014) (0)
- Safety of Intracoronary g -Radiation on Uninjured Reference Segments During the First 6 Months After Treatment of In-Stent Restenosis A Serial Intravascular Ultrasound Study Brief Rapid Communication (2000) (0)
- P493Impact of prior cerebrovascular diseases on treatment strategies and clinical outcomes after percutaneous coronary interventions (2017) (0)
- NOVEL HIGH-POTENCY ORAL ANTIPLATELET DRUGS VERSUS CLOPIDOGREL IN PATIENTS WITH DIABETES MELLITUS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM A LARGE SINGLE-CENTER ALL-COMERS REGISTRY (2015) (0)
- TCT-540 Incidence, Predictors, and Impact of Post-Discharge Gastrointestinal Bleeding After Coronary Drug-Eluting Stents Implantation: The ADAPT-DES Study (2018) (0)
- TCT-443 Outcomes in Patients With Peripheral Vascular Disease Undergoing Transcatheter Aortic Valve Implantation (2022) (0)
- Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention AF-PCI (2018) (0)
- Given the Same Dose of Heparin as Nondiabetics During Percutaneous Coronary Intervention (2003) (0)
- TCT CONNECT-64 Impact of DAPT Cessation in High Bleeding-Risk Patients Undergoing PCI: Insights From the PARIS Registry (2020) (0)
- TCT-417 Influence of Thrombotic and Bleeding Risk on P2Y12 Receptor Inhibitor Choice in ACS After PCI: Insights From a Large Single-Center Registry (2019) (0)
- TCT-327 Rotational angiography with 3D reconstruction following motion field estimation for evaluation of geometry of the implanted Medtronic Corevalve frame: comparison with MSCT (2016) (0)
- Abstract 19548: Detection, Correlation and Prediction of Systemic Vascular Disease using 3D volumetric Carotid Ultrasound: Results from the High Risk Plaque Initiative (2012) (0)
- P1663COMBO stent PCI for elderly patients: one year clinical outcomes and DAPT cessation patterns from the global MASCOT registry (2018) (0)
- LONG-TERM ADVERSE ISCHEMIC OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION AMONG PATIENTS WITH VERSUS WITHOUT PRIOR CORONARY ARTERY BYPASS GRAFTING: ANALYSIS FROM 17 RANDOMIZED TRIALS (2017) (0)
- IMPACT OF ANEMIA IN MEN AND WOMEN WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: THE HORIZONS-AMI TRIAL (2010) (0)
- Ticagrelor with or without Aspirin after PCI. Reply. (2020) (0)
- Safety of metformin continuation in diabetic patients undergoing invasive coronary angiography: the NO-STOP single arm trial (2023) (0)
- Causes of death in patients with atrial fibrillation and a recent acute coronary syndrome or percutaneous coronary intervention: insights from the AUGUSTUS trial (2022) (0)
- TCT-733 Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After PCI: Analysis from the ADAPT-DES study (2017) (0)
- Abstract 4601: Prognostic Significance of Thrombus in Patients With Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes; ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Subanalysis (2009) (0)
- Long‐Term Ticagrelor in Stable Patients With Prior Myocardial Infarction: Bleeding Avoidance First and Foremost (2021) (0)
- Drug‐eluting stents in diabetic patients: Are we still treading water? (2020) (0)
- Towards a standardized classification of cardiogenic shock: Will the new SCAI staging system translate into better clinical practice and research? (2020) (0)
- Antiplatelet Therapy in Patients Undergoing Elective Percutaneous Coronary Intervention (2022) (0)
- Outcomes in Patients With Early Menopause Who Underwent Transcatheter Aortic Valve Implantation. (2023) (0)
- IMPACT OF ARTERIAL ACCESS SITE ON RISK FOR ACUTE KIDNEY INJURY IN PATIENTS UNDERGOING PCI: RESULTS FROM A LARGE SINGLE-CENTER PCI REGISTRY (2015) (0)
- Timing of Stent Thrombosis After 1-Month Discontinuation of Dual Antiplatelet Therapy. (2022) (0)
- ARE ALL NON-CULPRIT LESIONS THAT CAUSE EVENTS SIMILAR? A PROSPECT SUBSTUDY ANALYSIS (2011) (0)
- Comparison of catheterization lab initiated abciximab and double-bolus eptifibatide during percutaneous coronary intervention in acute coronary syndromes: an ACUITY substudy (2007) (0)
- Abstract 4365: Delayed Strut Coverage in a Diabetic Population Treated With Paclitaxel Eluting and Bare Metal Stents: Sub-analysis of the Horizons-OCT Trial (2009) (0)
- Impact of High-Density Lipoprotein Levels on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention with Drug Eluting Stents. (2020) (0)
- TCT-30 Clinical Predictors and Long-term Impact of Enzymatic Infarct Size After Primary PCI in STEMI: The HORIZONS-AMI Trial (2014) (0)
- TREATMENT OF BIFURCATION LESIONS ifurcation Coronary Lesions reated With the “ Crush ” Technique n Intravascular Ultrasound Analysis (2016) (0)
- IMPACT OF AGE ON THE MODES OF DUAL ANTIPLATELET THERAPY CESSATION: ANALYSIS FROM THE PARIS (PATTERNS OF NON-ADHERENCE TO ANTI-PLATELET REGIMENS IN STENTED PATIENTS) REGISTRY (2015) (0)
- Abstract 18591: Anatomically- Versus Clinically-derived Risk Scores Have Markedly Differing Predictive Abilities Following PCI For Multivessel CAD: The "TLR Paradox" (2012) (0)
- Prognostic role of troponin T and troponin I in patients with acute coronary syndromes: Meta-analysis of 20 studies (2003) (0)
- TCT-109 Ischemic Outcomes after Coronary Intervention of Calcified Lesions with Drug-eluting Stent: Insight from ADAPT DES study (2014) (0)
- Fatal, ischemic and bleeding risk of patients meeting the selection criteria of the TWILIGHT trial: insights from a large PCI registry. (2023) (0)
- CORRELATION OF THROMBUS AREA WITH ANGIOGRAPHIC AND CLINICAL OUTCOMES IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION UNDERGOING PRIMARY PCI: ANALYSIS FROM THE HORISONS-AMI TRIAL (2010) (0)
- TCT-35 Impact of Cardiovascular Rehospitalizations Following PCI vs. CABG For Left Main Coronary Artery Disease: A Sex-Specific Analysis From the EXCEL Trial (2018) (0)
- Interventional Management of Diabetic Coronaropathy and Diffuse Coronary Artery Disease (2015) (0)
- TCT-584 Long-Term Impact of Improving Drug-Eluting Stent Technology in Patients Undergoing Multilesion Intervention: A Patient-Level Analysis of 19 Randomized Trials (2018) (0)
- Is bigger better with vascular brachytherapy (VBT) for in-stent restenosis? Impact of optimal final angiographic results and predictors of restenosis in 990 VBT patients (2002) (0)
- Side branch fractional flow reserve after provisional stenting of calcified bifurcation lesions: The ORBID‐FFR study (2020) (0)
- TCT-38 Ticagrelor With and Without Aspirin in Patients With Previous Coronary Artery Bypass Graft Undergoing Percutaneous Coronary Intervention: The TWILIGHT-CABG Subanalysis (2021) (0)
- PREVALENCE AND PROGNOSTIC IMPACT OF HIGH BLEEDING RISK STATUS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR LEFT MAIN CORONARY ARTERY DISEASE (2021) (0)
- SYNERGISTIC EFFECTS OF CORONARY CALCIFICATION AND INFLAMMATION ON RISKS FOR ADVERSE CARDIOVASCULAR EVENTS AFTER PCI: RESULTS FROM A LARGE SINGLE-CENTER REGISTRY (2017) (0)
- BLEEDING RISK IN ELDERLY PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2021) (0)
- TCT-178 Everolimus-Eluting Stents versus Coronary Artery Bypass Graft Surgery for Left Main Coronary Artery Disease in Patients with and without Chronic Kidney Disease (2017) (0)
- In vivovalidation of lesion length measurements using motorized pullback of intravascular ultrasound transducers (1996) (0)
- EFFECT OF APIXABAN VERSUS VITAMIN K ANTAGONIST AND ASPIRIN VERSUS PLACEBO ON DAYS ALIVE AND OUT OF HOSPITAL IN THE AUGUSTUS RANDOMIZED CONTROLLED TRIAL (2021) (0)
- Safety of an early discharge strategy following primary intervention with adjunctive glycoprotein IIb/IIIa inhibition: The CADILLAC trial (2003) (0)
- Moving from dual antiplatelet therapy to monotherapy based on P2Y12 receptor blockade—why it could be a novel paradigm? (2021) (0)
- COMPARISON OF LONG TERM CLINICAL PROGNOSIS AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION ACCORDING TO THE PRESENCE OF IN-HOSPITAL MAJOR BLEEDING EVENTS: 3 YEAR FOLLOW-UP RESULT OF HORIZONS-AMI (2011) (0)
- Effect of aspirin discontinuation according to individualised patient bleeding and ischemic risks after PCI: a TWILIGHT trial sub-analysis (2022) (0)
- Sex-differences in outcomes after percutaneous coronary intervention of chronic total occlusions: insights from a large single-center registry (2021) (0)
- Bleeding Associated with Angiography and Percutaneous Coronary Intervention (2018) (0)
- Abstract 3438: Impact of Different Pre-dilatation Strategies on Stent Expansion: An Intravascular Ultrasound Study (2006) (0)
- TCT-217 Efficacy of Dual Antiplatelet Therapy in Women with Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2015) (0)
- Abstract 19521: Impact of Procedural Complications on Survival in Patients with Severe Aortic Stenosis Treated with Balloon Aortic Valvuloplasty: Results from the BRAVO Study (2012) (0)
- Outcomes of bivalirudin in moderate and high risk patients with acute coronary syndromes and renal insufficiency: An ACUITY substudy (2007) (0)
- TCT-397 Edoxaban versus Standard of Care and their Effects on Clinical Outcomes in Patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation – Rationale and Design of the ENVISAGE-TAVI AF Trial (2017) (0)
- Abstract 15109: Racial Variability in Severity of Coronary Calcification Among Patients Undergoing Percutaneous Coronary Intervention: Results From a Single-Center Multiethnic Registry (2019) (0)
- Rationale and Technique for Percutaneous Coronary Intervention of Chronic Total Occlusions (2015) (0)
- TCT-844 Very Late (>1 Year) Stent-Related Adverse Cardiovascular Events: Individual Patient Data and Network Meta-Analyses From 19 Randomized Clinical Trials (2019) (0)
- CLINICAL OUTCOMES BY SEX AND ETHNICITY AFTER PERCUTANEOUS CORONARY INTERVENTION (2018) (0)
- on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions the American College of Cardiology Foundation/American Heart Association Task Force 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention : A Report of (2012) (0)
- Abstract 1145: Drug-Eluting Stents in the Treatment of Intermediate Lesions: Pooled Analysis from 14 Randomized Clinical Trials (2008) (0)
- TCT-110 Incidence, predictors, and outcomes of DAPT disruption due to non-compliance versus bleeding after PCI: insights from the PARIS Registry (2018) (0)
- Access routes in transcatheter aortic valve replacement: All roads lead to Rome but only one is paved (2021) (0)
- ASSOCIATIONS BETWEEN VALVE TYPE AND OUTCOMES IN WOMEN UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT: RESULTS FROM THE WIN-TAVI REGISTRY (2018) (0)
- TCT-181 Temporal Differences in Ischemic and Bleeding Risks after Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction. (2016) (0)
- TCT-261 Safety and efficacy of Bivalirudin monotherapy in patients with non-ST segment elevation myocardial infarction undergoing PCI: Results from the ACUITY Study (2013) (0)
- Reply: Drug-Eluting Stents Are Effective in Women: Only Part of the Story? (2016) (0)
- TCT-400 Platelet Reactivity and Risk of Stent Thrombosis After Coronary Drug-Eluting Stent Implantation in Patients Treated With Oral Anticoagulation: The ADAPT-DES Study (2019) (0)
- Undersizing the Stents in Saphenous Vein Grafts: By How Much? (2010) (0)
- The Optimal Duration of Dual Antiplatelet Therapy After PCI (2016) (0)
- Abstract 5212: Resolution of Pathological Q-waves is Associated With Improved Outcomes After Primary PCI for Acute Myocardial Infarction (2009) (0)
- TCT-218 Balancing The Risk Between Myocardial Infarction and Clinically Significant Bleeding With Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation (2015) (0)
- Optimal Stent Expansion: An Intrsvasculsr Ultrasound Study (2013) (0)
- TCT-485 Effect of Gender on Clinical Outcomes in Patients With or Without Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Results from a Large Single Center Registry (2015) (0)
- The kidney and percutaneous coronary interventions (2007) (0)
- TCT-307 Vascular Closure Device Use After PCI for Left Main Disease: Analysis From the EXCEL Trial (2019) (0)
- Abstract 12961: Prognostic Significance of Post-Procedural Sustained Ventricular Tachycardia or Fibrillation in Patients Undergoing Primary Percutaneous Coronary Intervention: Insights from the HORIZONS AMI Trial (2010) (0)
- Mechanismsand Resultsof Balloon Angioplasty for the Treatmentof In-Stent Restenosis (1996) (0)
- Overview of drug-eluting stent registries (2006) (0)
- IMPACT OF HEMODYNAMIC SUPPORT WITH IMPELLA ON SUBSEQUENT ACUTE KIDNEY INJURY RELATIVE TO PREDICTED RISK IN PATIENTS UNDERGOING HIGH-RISK PERCUTANEOUS CORONARY INTERVENTION: AN ANALYSIS FROM THE PROSPECTIVE CVAD STUDY (2019) (0)
- TCT-546 Performance of the Dual AntiPlatelet Therapy (DAPT) Score in the ADAPT-DES Study. (2017) (0)
- Sex Difference in Bleeding Risk With P2Y12 Inhibitor Agents After Percutaneous Coronary Intervention-Reply. (2022) (0)
- CLOPIDOGREL WITH AND WITHOUT PROTON PUMP INHIBITOR USE: A PARIS REGISTRY ANALYSIS (2014) (0)
- TCT-543 Clinical and Procedural Risk Predictors of Acute Kidney Injury Following Transcatheter Aortic Valve Replacement: Findings From a Real-World Registry (2022) (0)
- TCT-539 Left Main Percutaneous or Surgical Revascularization and Subsequent Risk of Acute Kidney Injury: Insights From the LUCKY Registry (2022) (0)
- TCT-285 Stent Diameter and Clinical Outcomes After PCI: From the COMBO MASCOT and REMEDEE Collaboration (2019) (0)
- TCT-1 Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting With Everolimus-Eluting Stents: Analysis From the EXCEL Trial (2018) (0)
- Sex Differences Among Patients Receiving Edoxaban vs Vitamin K Antagonist for Atrial Fibrillation After Transcatheter Aortic Valve Replacement (2023) (0)
- TCT-791 Impact of Clinical Judgement on Risk Stratification of Patients at High Risk for TAVR: A BRAVO-3 Subgroup Analysis (2017) (0)
- Reply: P2Y12 Inhibitor-Based Monotherapy: Optimal Duration and Ideal Agent. (2020) (0)
- Abstract 3347: Sirolimus Eluting Stents In Single Vessel Versus Multi-vessel Percutaneous Coronary Intervention: Results From The Matrix Registry (2007) (0)
- P1966Impact of coronary artery calcification on long-term outcomes after implantation of first and second-generation drug-eluting stents: a patient-level analysis of 18 randomized trials (2019) (0)
- utcomes With the Paclitaxel-Eluting tent in Patients With Acute Coronary Syndromes (2005) (0)
- IMPACT OF INCOMPLETE REVASCULARIZATION OF THE LEFT ANTERIOR DESCENDING ARTERY VERSUS OTHER CORONARY ARTERIES AFTER PCI: INSIGHTS FROM THE RIVER-PCI TRIAL (2020) (0)
- Short dual antiplatelet therapy duration in high bleeding risk patients undergoing PCI for non-ST-elevation acute coronary syndrome (2022) (0)
- Combined and independent impact of coronary artery calcification and inflammation on risk for adverse cardiovascular events after percutaneous coronary intervention: Results from a large single‐center registry (2020) (0)
- TCT-13 Ticagrelor Monotherapy in Patients With Peripheral Artery Disease Undergoing PCI (2022) (0)
- The Optimal Duration of Dual Combination Antiplatelet Therapy After Stent Implantation and Perioperative Management Issues. (2013) (0)
- TCT-386 Long-Term Outcomes After Left Main PCI: An Individual Patient-Data Pooled Analysis of 21 Randomized Controlled Trials (2019) (0)
- Biological basis and proposed mechanism of action of CSL112 (Apolipoprotein A-I [Human]) for prevention of major adverse cardiovascular events in patients with myocardial infarction. (2021) (0)
- TCT-206 Tailoring the Intensity of Antiplatelet Pharmacotherapy to Ischemic and Bleeding Risk: A Cost Optimizing Simulation From PARIS. (2016) (0)
- TCT-388 Impact of main branch selection on clinical outcomes after percutaneous coronary intervention for unprotected left main coronary artery disease: a substudy from the DELTA registry. (2013) (0)
- Abstract 11826: Association of Bleeding, Mortality and Gender in Acute Coronary Syndromes: The "Gender Triangle" . A Gender-based Prospective Observational Study From Real Registry (2012) (0)
- TCT-238 Impact of Smoking on Infarct Size and Adverse Events in Patients With Anterior ST-Elevation Myocardial Infarction: Results From the INFUSE-AMI Trial (2015) (0)
- 801-2 Predictors of survival after primary percutaneous coronary intervention: The impact of myocardial perfusion grade in female patients (2004) (0)
- Outcomes of Patients with Acute Coronary Syndromes and Non-obstructive Coronary Artery Disease: Analysis from the Randomized ACUITY Trial (2009) (0)
- PLATELET REACTIVITY AND OUTCOMES AFTER PCI OF SAPHENOUS VEIN GRAFTS VERSUS NATIVE CORONARY ARTERIES: THE ADAPT-DES STUDY (2017) (0)
- Benefits of optimising coronary flow before stenting in primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from INFUSE-AMI. (2013) (0)
- Beta versus gamma radiation for treatment of in-stent restenosis: angiographic predictors and outcomes in 630 patients (2002) (0)
- TCT-39 Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index: TWILIGHT-BMI Analysis (2021) (0)
- TCT-496 Differences in quantitative coronary angiographic (QCA) characteristics of coronary artery disease between Human Immunodeficiency Virus (HIV) patients presenting with acute coronary syndrome (ACS) and stable angina pectoris (SAP) undergoing percutaneous coronary intervention (PCI). (2016) (0)
- IMPACT OF VASCULAR CLOSURE WITH THE PRE-CLOSURE TECHNIQUE ON ADVERSE EVENTS IN PATIENTS UNDERGOING TRANSFEMORAL BALLOON AORTIC VALVULOPLASTY: RESULTS FROM A 2-CENTER registry (2012) (0)
- LONG TERM RESULTS FOR THE DIVERGE TRIAL: 1 AND 2 YEAR CLINICAL OUTCOMES FOR THE AXXESS BIOLIUMS A9 ELUTING SELF EXPANDING STENT FOR THE TREATMENT OF DE NOVO BIFURCATION LESIONS (2010) (0)
- TCT-352 Proportion of Ischemic Risk After PCI Mediated by High Platelet Reactivity on Clopidogrel: Analysis From the ADAPT-DES Study. (2016) (0)
- Predictors and sequalae of subacute thrombosis after percutaneous intervention in acute myocardial infarction: The CADILLAC trial (2003) (0)
- TCT-205 Incidence and clinical outcomes associated with DAPT discontinuation in complex PCI patients: From the PARIS registry. (2016) (0)
- TCT-20 Relative Benefit of Double Versus Triple Antithrombotic Therapy in Patients With Atrial Fibrillation Randomized Earlier Versus Later After Index Coronary Event: Insights From the AUGUSTUS Trial (2022) (0)
- 830-3 Impact of vessel size on outcomes of different distal protection devices during saphenous vein graft intervention: A FIRE trial substudy (2004) (0)
- Clopidogrel pretreatment versus clopidogrel exposure prior to PCI in the ACUITY Trial: Does it really matter? (2007) (0)
- INDIVIDUALIZING DURATION OF DUAL ANTIPLATELET THERAPY BASED ON BLEEDING RISK, ISCHEMIC RISK, OR BOTH: AN ANALYSIS FROM THE DUAL ANTIPLATELET THERAPY (DAPT) STUDY (2021) (0)
- Relative Prognostic Utility of Different Bleeding Scales Among Patients Undergoing Primary Angioplasty for Acute Myocardial Infarction: The HORIZONS-AMI Trial (2008) (0)
- TCT-225 Relationship Between the SYNTAX Score and Major Bleeding after PCI: Analysis from the ACUITY Trial (2013) (0)
- Target lesion failure with BRS? good old DES to the rescue (2016) (0)
- IMPACT OF DIABETES MELLITUS ACROSS GENDER AND RACE ON OUTCOMES AFTER EVEROLIMUS-ELUTING STENT IMPLANTATION: FROM THE PLATINUM DIVERSITY AND THE PROMUS ELEMENT PLUS POST-APPROVAL STUDIES (2019) (0)
- TCT-56 Validation of PARIS Risk Scores in a Large Multi-Ethnic PCI Cohort: Results from a Large Single-Center Registry. (2016) (0)
- British Cardiovascular Interventional Society Consensus: a Huge Step Towards Standardised Care for Out-of-hospital Cardiac Arrest in the UK (2022) (0)
- TCT CONNECT-56 Prolonged Dual Antiplatelet Therapy in Patients With or Without Prior Myocardial Infarction: An Updated Systematic Review and Meta-Analysis (2020) (0)
- TCT-219 Impact of prasugrel versus clopidogrel in ACS patients undergoing PCI with short or long stents: Results from the PROMETHEUS Study (2015) (0)
- TCT-400 Everolimus-Eluting Stent and Dedicated 2-Stent Strategy in Complex 'True' Bifurcation Lesion with Major Side Branch Involvement (2013) (0)
- Association between proton pump inhibitor and ischemic stroke risk remains controversial (2019) (0)
- PROGNOSTIC VALUE OF THE ACADEMIC RESEARCH CONSORTIUM FOR HIGH BLEEDING RISK CRITERIA IN PATIENTS WITH DIABETES MELLITUS UNDERGOING PCI (2021) (0)
- GENOTYPE-DEPENDENT IMPAIRMENT OF HEMOGLOBIN CLEARANCE INCREASES OXIDATIVE STRESS AND INFLAMMATION LEADING TO ACCELERATED NEOVASCULARIZATION IN HUMAN DIABETIC ATHEROSCLEROSIS (2011) (0)
- Depression and ischemic heart disease. (2022) (0)
- B-TYPE NATRIURETIC PEPTIDE AND THE RISK OF CONTRAST INDUCED NEPHROPATHY IN STEMI: ANALYSIS FROM THE HORIZONS-AMI TRIAL (2012) (0)
- 4284Impact of coronary artery disease and PCI on Long-term outcomes of women undergoing transcatheter aortic valve replacement: insights from the multi-center WIN-TAVI registry (2018) (0)
- DISCHARGE MEDICATION USE IN PATIENTS WHO EXPERIENCE BLEEDING COMPLICATIONS AFTER PRIMARY PCI: ANALYSIS FROM HORIZONS-AMI (2011) (0)
- Aortic and coronary aneurysms: Are they really distinct entities? (2015) (0)
- Do multiple prior interventions for in-stent restenosis impact the success of gamma brachytherapy? (2002) (0)
- VALIDATION OF A RISK SCORE TO PREDICT CONTRAST-INDUCED ACUTE KIDNEY INJURY AFTER PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ACS: RESULTS FROM THE ACUITY TRIAL (2010) (0)
- TCT-36 Complete Revascularization Versus Culprit Lesion–Only PCI in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease: A Subgroup Analysis of the COMPLETE Trial (2022) (0)
- TCT-834 Risk Stratification Using the ACEF Score in Patients Undergoing Percutaneous or Surgical Left Main Revascularization: Insights From the EXCEL Trial (2018) (0)
- Long-term clinical results and predictors after successful stent implantation in saphenous vein grafts (1998) (0)
- TICAGRELOR MONOTHERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION IN HIGH-RISK PATIENTS WITH OR WITHOUT HISTORY OF MYOCARDIAL INFARCTION. A PRESPECIFIED TWILIGHT SUBSTUDY (2021) (0)
- Bivalirudin for patients with ST-elevation myocardial infarction – Authors' reply (2011) (0)
- TCT-475 Effect of Stent Diameter in Women Undergoing Percutaneous Coronary Intervention with Early- and New-Generation Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. (2016) (0)
- Side branch FFR after provisional stenting: simplified approach based on OCT frame count (2020) (0)
- TCT-451 Incidence, Correlates and impact of left ventricular ejection fraction improvement on short- and long-term clinical outcome of patients undergoing high-risk percutaneous coronary intervention. A single center experience (2018) (0)
- Abstract 16570: Systemic Inflammation Alters the Bleeding-Ischemic Balance in High-Bleeding Risk Patients Undergoing Percutaneous Coronary Interventions (2020) (0)
- THE IMPACT OF NON–FIBROATHEROMA LESION PHENOTYPE ON LONG–TERM CLINICAL OUTCOMES: A SUBSTUDY ANALYSIS FROM PROSPECT (2013) (0)
- TCT-94 Safety and Efficacy of the Combo Bio-Engineered Stent in an All-Comer PCI Cohort: Results from the MASCOT Post-Marketing Registry (2017) (0)
- ONE- VERSUS THREE-MONTH DAPT IN OLDER PATIENTS AT HIGH BLEEDING RISK UNDERGOING PCI: INSIGHTS FROM THE XIENCE SHORT DAPT GLOBAL PROGRAM (2023) (0)
- STROKE AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION: INCIDENCE AND TEMPORAL TRENDS BETWEEN 2007 AND 2022 (2023) (0)
- A HYBRID APPROACH TO AUTOMATE QUANTITATIVE CORONARY ANGIOGRAPHY VIA DEEP LEARNING (2021) (0)
- TCT-278 Clinical Outcomes of All-Comer Patients Presenting With Acute Coronary Syndrome Treated With the COMBO Stent: From the MASCOT and REMEDEE Registry (2019) (0)
- Predictors of contrast induced nephropathy after percutaneous coronary intervention in patients with and without chronic renal failure (2002) (0)
- Vascular brachytherapy for ostial in-stent restenotic lesions (2002) (0)
- TCT-452 Predictors of Prolonged Hospitalization After Transcatheter Aortic Valve Implantation (2022) (0)
- 1063-64 Predilatation before distal protection device placement is associated with increased procedure-related myocardial infarction: Analysis from the FIRE trial (2004) (0)
- Dual antiplatelet therapy for 1 versus 3 months in high bleeding risk patients with or without oral anticoagulant therapy after coronary stenting (2022) (0)
- Reply: Chronic Kidney Disease and Antiplatelet Therapy: A Worrying Gap Between Evidence Based Medicine and Clinical Practice. (2018) (0)
- TCT-5 Risks and Benefits of Dual Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery: Insights from the ACUITY trial. (2016) (0)
- Future Perspectives on Percutaneous Coronary Interventions in Women. (2012) (0)
- Rethinking the Role of Impaired Renal Function in Multivessel PCI or CABG. (2022) (0)
- Percutaneous coronary interventions in octogenarians with use of glycoprotein GP llb/llla inhibitors: Similar major adverse cardiac events but higher hemorrhagic stroke rate than younger patients (2003) (0)
- Interplay between PCI access site, anticoagulant agent, and bleeding: Insights from the REGULATE-PCI randomized trial. (2020) (0)
- TCT-886 Predictors of Vascular complications in patients undergoing Balloon Aortic Valvuloplasty (2012) (0)
- Abstract 20362: Gender Differences in Percutaneous Coronary Intervention for Chronic Total Occlusions: a Report from the 1,781 Patient Multinational CTO Registry (2010) (0)
- ASSOCIATIONS BETWEEN DIABETES MELLITUS AND OUTCOMES WITH THE COMBO BIO-ENGINEERED STENT: FROM THE MASCOT POST-MARKETING REGISTRY (2018) (0)
- Abstract 4556: Incidence and Mechanisms of Acute and Late Stent Malapposition After Stent Implantation in Patients With Acute Myocardial Infarction: An Intravascular Ultrasound Substudy of the HORIZONS-AMI Trial (2009) (0)
- TCT-438 Impact of concomitant coronary artery disease on risk for short-term MACCE in patients after TAVR (2017) (0)
- Antiplatelet Therapy in High-Bleeding Risk Patients Undergoing PCI: Walking a Tightrope (2022) (0)
- CHANGES IN LV EJECTION FRACTION AND OUTCOMES AFTER PCI IN PATIENTS WITH SEVERE ISCHEMIC CARDIOMYOPATHY (2023) (0)
- Reply: Research and Therapeutic Nihilisms in Chronic Kidney Disease. (2017) (0)
- TCT-513 Simple Measures of ST-Segment Resolution Predict Infarct Size: The INFUSE-AMI Trial (2012) (0)
- TCT-159 Balloon-Expandable or Self-Expandable Valves in Valve-in-Valve Transcatheter Aortic Valve Implantation? (2021) (0)
- TCT-326 The Occupational Effects of Interventional Cardiology Results from the WIN for Safety Survey (2012) (0)
- Abstract 19106: Diabetes Induced Actin S-glutathiolation Increases Vein Graft Accelerated Atherosclerosis Through Delayed Endothelial Regeneration (2014) (0)
- Intravascular ultrasound guidance decreases target lesion revascularization in long-diffuse coronary lesions (2002) (0)
- TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy Versus Ticagrelor Plus Aspirin Beginning at 3 Months in High-risk Patients Undergoing Percutaneous Coronary Intervention (2019) (0)
- TCT-463 Does Routine Post-Procedural Anticoagulation Reduce Acute Stent Thrombosis after Bivalirudin Anticoagulation During Primary PCI? The HORIZONS-AMI Trial (2014) (0)
- Abstract 16974: Gender Differences in Patients Undergoing Transcatheter Aortic Valve Replacement: a Single Center Experience (2014) (0)
- TCT-35 Effects of Complete Revascularization According to Age in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel: Insights From the COMPLETE Trial (2022) (0)
- IMPELLA OR INTRA-AORTIC BALLOON PUMP SUPPORT IN PATIENTS UNDERGOING HIGH RISK PERCUTANEOUS CORONARY INTERVENTION: A REAL WORLD SINGLE CENTER EXPERIENCE (2017) (0)
- The REVIVED–BCIS2 trial: lessons and outcomes (2022) (0)
- CRT-100.06 Differences in Quantitative Coronary Angiographic (QCA) Characteristics of Coronary Artery Disease and Clinical Outcomes Between Statin Pre-treated and Statin-Naïve Human Immunodeficiency Virus (HIV) Patients Undergoing Percutaneous Coronary Intervention (PCI) (2017) (0)
- 760 IMPACT OF COMORBIDITIES AND PATIENTS PREFERENCE ON THE CHOICE BETWEEN PERCUTANEOUS OR SURGICAL REVASCULARIZATION FOR LEFT MAIN CORONARY ARTERY DISEASE (2022) (0)
- TWELVE MONTH FOLLOW-UP DATA FROM THE ONYX CORE TRIAL: ANGIOGRAPHIC AND CLINICAL PERFORMANCE OF NEXT GENERATION RESOLUTE ONYX DRUG-ELUTING STENT (2017) (0)
- THE ROLE OF FEMALE SEX IN THE CONTEMPORARY TREATMENT OF THE LEFT MAIN CORONARY ARTERY INSIGHTS FROM THE W– DELTA (WOMEN– DRUG ELUTING STENT FOR LEFT MAIN CORONARY ARTERY DISEASE) REGISTRY (2013) (0)
- DUAL ANTIPLATELET THERAPY AND LONG-TERM CLINICAL OUTCOMES AFTER PRIMARY PCI: THE HORIZONS-AMI TRIAL (2012) (0)
- The impact of switching P2Y12 receptor inhibitor therapy during index hospitalization: a systematic review (2015) (0)
- TCT-732 Relationship Between Stent Diameter, Platelet Reactivity, and Adverse Events After PCI: Analysis from the ADAPT-DES study. (2017) (0)
- B-25 | Two-Year Outcomes in Patients with Bifurcation Lesions treated with Resolute ONYX ZES: Final Results from the RESOLUTE ONYX Bifurcation Study (2022) (0)
- Percutaneous Coronary intervention in Small Coronary Arteries (2002) (0)
- TCT-55 Risk-Benefit Analysis of Upstream Antithrombotic Therapy in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes Prior to Coronary Angiography. (2016) (0)
- TCT-401 Associations Between Baseline Atrial Fibrillation And Risk Of 1-Year Outcomes After Transcatheter Aortic Valve Replacement: Results From The WIN-TAVI Registry (2017) (0)
- DUAL ANTIPLATELET THERAPY (DAPT) CESSATION AND CARDIOVASCULAR RISK IN RELATION TO AGE: ANALYSIS FROM THE PARIS (PATTERNS OF NON-ADHERENCE TO ANTI-PLATELET REGIMENS IN STENTED PATIENTS) REGISTRY (2019) (0)
- Effects of Body Mass Index on ClinicalOutcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents (2017) (0)
- TCT-67 Predictors and Outcomes After Stent Failure Is Treated With Either CABG or PCI: An Individual Patient-Data Pooled Analysis From 32,880 Patients (2019) (0)
- Abstract 16790: Myocardial Injury is an Independent Predictor of Mortality in Patients With COVID-19 (2020) (0)
- TCT-353 Underweight Status, Platelet Reactivity, and 2-Year Clinical Outcomes in Patients Undergoing PCI With DES: An ADAPT-DES Study Analysis. (2016) (0)
- Abstract 13657: The REG1 Anticoagulation System Allows for Early Arterial Sheath Removal After Cardiac Catheterization Without Increases in Time to Hemostasis or Bleeding Complications: An Analysis From the RADAR Clinical Trial. (2011) (0)
- Antiplatelet therapy for coronary artery disease in 2023: current status and future prospects. (2023) (0)
- ASSOCIATIONS BETWEEN DIFFERENT MODES OF DAPT CESSATION AND MAJOR ADVERSE EVENTS AT 6 MONTHS AND BEYOND: INSIGHTS FROM THE PARIS REGISTRY (2014) (0)
- Abstract 15867: Contemporary Percutaneous Treatment of In-Stent Restenosis in the United States: Insights From a Large Single-Center Registry (2018) (0)
- TCT-322 Utility of the Residual SYNTAX Score In Patients With Diabetes Mellitus After Percutaneous Coronary Intervention (2013) (0)
- TCT-366 Impact of gender on adverse cardiac events in patients with large anterior myocardial infarction: Results from the INFUSE-AMI trial (2012) (0)
- Meta-Analysis of Anticoagulation Therapy for the Prevention of Cardiovascular Events in Patients with Peripheral Arterial Disease. (2021) (0)
- Impact of Bivalirudin Monotherapy on 30-day Outcomes in Patients with Acute Coronary Syndromes and Complex Coronary Stenoses Undergoing Percutaneous Coronary Intervention (2009) (0)
- TCT-444 Diabetes Mellitus in Transfemoral Transcatheter Aortic Valve Implantation: A Propensity Matched Analysis (2022) (0)
- Geographic miss is not associated with restenosis or the edge phenomenon in the INHIBIT trial (2002) (0)
- IMPACT OF BIVALIRUDIN AND PACLITAXEL-ELUTING STENTS IN PATIENTS WITH STEMI UNDERGOING PRIMARY PCI OF THE LEFT ANTERIOR DESCENDING ARTERY: THE HORIZONS-AMI TRIAL (2012) (0)
- Usefulness of Serial Echocardiographic Parameters for Predicting the Subsequent Occurrence of Atrial Fibrillation (2001) (0)
- The effect of height on vascular events after percutaneous intervention (1998) (0)
- Abstract 21306: Impact of Insulin Treated Diabetes Mellitus on 1 Year Outcomes After Contemporary PCI (2017) (0)
- TCT-414 Dedicated 2-stent versus 1-Stent Strategy in Diabetic Patients with Complex 'True' Bifurcation Lesion PCI using Everolimus-Eluting Stent (2013) (0)
- Outcomes in patients requiring bail-out abciximab during primary intervention in acute myocardial infarction: Analysis from the CADILLAC trial (2003) (0)
- Dangas bivalirudin heparin TAVR BRAVO 3 appendix JACC 12 2015 (2015) (0)
- Utility of the ACC/AHA Lesion Classification to Predict Outcomes After Contemporary DES Treatment: Individual Patient Data Pooled Analysis From 7 Randomized Trials (2022) (0)
- Abstract 2649: Bivalirudin Monotherapy Improves 30 Day Clinical Outcomes In Diabetics With Acute Coronary Syndrome (ACS). Report From The ACUITY Trial (2006) (0)
- CRT-100.52 Clinical Outcomes of PCI With a Zotarolimus-Eluting Stent Followed by One-Month DAPT in High-Bleeding-Risk Patients With Small (≤2.5 mm) Coronary Arteries: One-Year Analysis From the Onyx ONE Clear Study (2022) (0)
- Antithrombotic Strategies after Transcatheter Valve Implant Transcatheter Aortic Valve Replacement (2018) (0)
- CORONARY ARTERY DISEASE BURDEN AND CLINICAL OUTCOMES IN PATIENTS WITH HUMAN IMMUNE DEFICIENCY VIRUS (HIV) UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM A SINGLE-CENTER REGISTRY (2014) (0)
- LBT-8 Impact Of Calcification On Percutaneous Coronary Intervention Outcomes: Insights From The MACE Study (2017) (0)
- Abstract 11314: Inverse Relationship Between Body Mass Index and Coronary Artery Calcification in Older Patients with Clinically Significant Coronary Lesions (2011) (0)
- TCT-296 Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Implantation Is Associated With Increased Mortality (2021) (0)
- Marked mortality risk of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction (2003) (0)
- TWO-YEAR CLINICAL OUTCOMES OF SECOND GENERATION VERSUS FIRST GENERATION CORONARY DRUG-ELUTING STENTS: AN ANALYSIS FROM ADAPT-DES (2014) (0)
- PATIENTS ADMITTED WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION AND A NORMAL OR NEAR NORMAL CORONARY ANGIOGRAM HAVE A FAVORABLE PROGNOSIS: ANALYSIS FROM HORIZONS-AMI TRIAL (2010) (0)
- TCT-399 Long-Term Cardiovascular Outcomes According to the Antiplatelet Agent Discontinued After Coronary Stenting: Insights From 4 Xience V Post-Approval Studies (2019) (0)
- IMPACT OF GENDER IN HIGH BLEEDING RISK PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION WITH XIENCE EVEROLIMUS ELUTING STENT: A PATIENT-LEVEL POOLED ANALYSIS FROM FOUR XIENCE POST-APPROVAL TRIALS (2019) (0)
- Stent Expansion and Endothelial Shear Stress in Bifurcation Lesions. (2019) (0)
- TCT-718 Predictors of vascular complications in women undergoing contemporary transcatheter aortic valve replacement: A report from the WIN-TAVI registry. (2016) (0)
- IMPACT OF ACUTE KIDNEY INJURY ON OUTCOMES IN PATIENTS UNDERGOING BALLOON AORTIC VALVULOPLASTY (2013) (0)
- Low stroke rates during carotid artery stenting with neuroprotection (2003) (0)
- 761 PRASUGREL OR CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES AT DIFFERENT THROMBOTIC RISK: RESULTS FROM THE PROMETHEUS STUDY (2022) (0)
- TCT-219 Influence Of Anemia On Physician-Recommended DAPT Discontinuation After Percutaneous Coronary Intervention. (2016) (0)
- Comparison of Quality-of-Life Measures after Radial versus Femoral Artery Access for Cardiac Catheterization in Women : Results of the SAFE-PCI for Women Quality-of-Life Substudy (2015) (0)
- The “pathology” of Renal Artery Stenosis: An Intravascular Ultrasound Study (1998) (0)
- TCT CONNECT-41 Impact of Chronic Kidney Disease on Coronary Revascularization and In-Hospital Outcomes in Patients With Acute ST-Segment Elevation Myocardial Infarction (2020) (0)
- TCT-655 Outcomes of high-risk patients undergoing percutaneous coronary interventions in the ambulatory versus in-hospital setting (2012) (0)
- IVUS PREDICTORS OF EARLY STENT THROMBOSIS AFTER PRIMARY PERCUTANEOUS INTERVENTION IN ACUTE MYOCARDIAL INFARCTION: A HORIZONS-AMI SUBSTUDY (2010) (0)
- TCT-565 Long-term Outcomes and Predictors Of Adverse Events After Successful Saphenous Vein Graft Intervention. Results from A Large Single-Center (2017) (0)
- Onyx ONE: outcomes in patients with acute coronary syndrome (2020) (0)
- TEMPORAL TRENDS IN TRANSRADIAL ACCESS DURING PCI IN RELATION TO BLEEDING RISK: INSIGHTS FROM A LARGE SINGLE-CENTER REGISTRY (2020) (0)
- TCT-578 Predictive Factors of Early, Late and Very Late Atherothrombotic Events in Women Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents: Results from a Patient-Level Pooled Analysis of Randomized Controlled Trials (2015) (0)
- Impact of smoking habit on clinical outcomes after percutaneous coronary intervention (2002) (0)
- Abstract 15664: Prior Oral Anticoagulant Status and Outcomes in Patients With Atrial Fibrillation With an Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention: Insights From the Augustus Trial (2020) (0)
- Duration of Dual Antiplatelet Therapy AfterDrug-Eluting Stent Implantation (0)
- ARC-HBR criteria and TAVR: not all high bleeding risk patients look alike. (2022) (0)
- P2069Multivessel PCI versus culprit-vessel only PCI in patients with acute myocardial infarction and multivessel disease (2017) (0)
- PREDICTORS OF HIGH INTENSITY STATIN USE AFTER PERCUTANEOUS CORONARY INTERVENTIONS (2017) (0)
- Clinical Outcomes Following Stent Thrombosis Occurring In-Hospital Versus Out-of-Hospital (2012) (0)
- MYOCARDIAL ISCHEMIA AND INFARCTION RELATIONSHIP BETWEEN BIOMARKERS AND SUBSEQUENT MAJOR ADVERSE CARDIOVASCULAR EVENTS AFTER ST-ELEVATION MYOCARDIAL INFARCTION: A HORIZONS-AMI SUBSTUDY (2011) (0)
- TCT CONNECT-378 Sex Disparities Among Patients Undergoing Complex Percutaneous Coronary Intervention (PCI): Insights From a Single-Center Large-Volume PCI Registry (2020) (0)
- TCT-6 The CENTER-Collaboration: Outcomes in patients undergoing transfemoral transcatheter aortic valve implantation with balloon-expandable valves versus self-expandable valves. (2018) (0)
- Percutaneous Coronary Intervention for Acute Myocardial Infarction Prognostic Implications of Creatine Kinase Elevation After Primary (2011) (0)
- TCT-58 Effects of Mechanical Thrombectomy and Intracoronary Abciximab on Coronary Flow and Infarct Size During Primary PCI: Analysis from the INFUSE-AMI Trial (2012) (0)
- TCT-111 Gender Differences In The Burden Of Coronary Artery Disease In Patients With Human Immunodeficiency Virus Infection Undergoing Percutaneous Coronary Intervention (2014) (0)
- TCT-398 Associations Between Atrial Fibrillation and Clinical Outcomes Among Patients Undergoing Transcatheter Aortic Valve Replacement With Self-Expanding Devices: Results From the United States STS/ACC TVT Registry (2017) (0)
- Acute angiographic and clinical results of the NIR w/SOX stent. (2002) (0)
- CLINICAL OUTCOMES ASSOCIATED WITH IMPELLA VERSUS IABP USE IN STABLE PATIENTS UNDERGOING HIGH RISK PERCUTANEOUS CORONARY INTERVENTION (2017) (0)
- Acute myocardial infarction: early strategies to optimize results. (2005) (0)
- PREDICTORS OF MORTALITY AND CONDUCTION DISTURBANCES IN WOMEN UNDERGOING TAVR: A CT SUB-ANALYSIS OF THE WIN-TAVI REGISTRY (2018) (0)
- SMALL-VESSEL PERCUTANEOUS CORONARY INTERVENTION WITH PLATINUM CHROMIUM EVEROLIMUS ELUTING STENTS: INSIGHTS FROM THE POOLED PLATINUM DIVERSITY AND PROMUS ELEMENT PLUS POST APPROVAL STUDIES (2019) (0)
- IMPACT OF ASPIRIN DOSE ON LONG TERM CLINICAL OUTCOMES AFTER STENTING FOR ACUTE MYOCARDIAL INFARCTION: 3-YEAR FOLLOW-UP DATA FROM THE HORIZONS-AMI TRIAL (2011) (0)
- Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trial. (2022) (0)
- When Can Strut Thickness Really Matter in Percutaneous Coronary Intervention? (2019) (0)
- TCT-217 Predictors of Dyspnea in Patients Receiving Ticagrelor After PCI: Insights From the Twilight Trial (2021) (0)
- TCT-528 Use of guideline directed medical therapy and outcomes in patients with high risk of bleeding undergoing percutaneous coronary intervention in contemporary clinical practice (2017) (0)
- Abstract 1762: Relationship Between Leucocyte Count, Myonecrosis, Myocardial Perfusion and Outcomes Following Primary Angioplasty (2006) (0)
- TCT-198 Final Results of the IC-CATARACT (CATaracts Attributed to Radiation in the CaTh Lab) Study: Lens Changes Associated With Radiation in the Cardiac Catheterization Laboratory (2019) (0)
- Abstract 2640: Long-Term Clinical Follow-up of Patients with De Novo Coronary Bifurcation Lesions Treated with the Nitinol Self-Expanding Biolimus A9-Eluting "AXXESS" Stent - Results from the Prospective, Multicenter Axxess Plus Trial (2006) (0)
- Angiography and QCA (TCT-84 to TCT-93)TCT-87 Frequency And Impact Of Intraprocedural Thrombotic Events During Percutaneous Coronary Intervention In Women Compared To Men: Pooled Analysis From The ACUITY And HORIZONS-AMI Trials (2014) (0)
- TCT-123 Incidence and Impact of Acute Kidney Injury in Patients with Acute Coronary Syndromes Treated with CABG: Insights from ACUITY/HORIZONS-AMI (2014) (0)
- PREDICTIVE ABILITY OF THE PARIS RISK SCORE IN ALL-COMERS PATIENTS UNDERGOING PCI WITH DRUG ELUTING STENTS: EXTERNAL VALIDATION IN THE GLOBAL LEADERS STUDY (2019) (0)
- Comparison of heparin plus IIb/IIIa inhibition versus bivalirudin with or without IIb/IIIa inhibition in patients with acute coronary syndromes undergoing percutaneous coronary intervention: The ACUITY trial (2006) (0)
- TCT-127 Incidence, Predictors, and Prognostic Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention (2014) (0)
- Prevention and Management of Stroke After Transcatheter Aortic Valve Replacement: The Mount Sinai Stroke Initiative. (2023) (0)
- Chapter 52 – Heart Disease in Women (2018) (0)
- TCT-277 Global Differences in Predictors of Long-Term Outcomes After Percutaneous Coronary Intervention: Insights From the XIENCE Pooled Registry (2019) (0)
- Patients With Diabetes at High Bleeding Risk With 1-Month Dual Antiplatelet Therapy: Onyx ONE Clear Results (2022) (0)
- Angiographic findings after minimally invasive coronary bypass operation: an angiographic study (1998) (0)
- Comparison of effect of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions on risk of hemorrhagic stroke in patients ≥75 years of age vs. those <75 years of age (2004) (0)
- Rationale and design of the Onyx ONE global randomized trial: A randomized controlled trial of high-bleeding risk patients after stent placement with 1â• ̄month of dual antiplatelet therapy (2019) (0)
- Acute and long-term outcomes of multivessel stenting in patients aged 80 years (2003) (0)
- TCT-357 Impact of Gender and Age on 3-Year Clinical Outcome and Chest Pain of Patients With Coronary Artery Disease Treated With Contemporary Drug-Eluting Stents: A Patient-Level Pooled Analysis. (2016) (0)
- Abstract 4182: Unhealed Plaque Ruptures After Stenting in Acute Myocardial Infarction Assessed by Intracoronary Optical Coherence Tomography: Incidence, Predictors, and Clinical Implication (2009) (0)
- IS MINIMAL LUMINAL AREA BY INTRAVASCULAR ULTRASOUND THE CRITICAL DETERMINANT OF FUTURE MACE IN INTERMEDIATE LESIONS? INSIGHTS FROM PROSPECT (2012) (0)
- Reply: DAPT Cessation and MACE in Elderly Patients: What Is the Optimal Regimen and Duration? (2019) (0)
- Transcatheter aortic valve replacement in patients with end‐stage renal disease: Is “better than nothing” good enough? (2020) (0)
- Transcatheter Cardiovascular Therapeutics 2018. (2019) (0)
- TCT-239 Clinical Utility of Peak Creatine Kinase-MB Measurements in Predicting Left Ventricular Dysfunction and Clinical Outcomes After First Anterior Myocardial Infarction: An INFUSE-AMI Sub-study (2013) (0)
- Abstract 2564: Predictors of Early Stent Thrombosis in Patients with Acute Coronary Syndromes in the Drug-Eluting Stent Era: Analysis from the ACUITY trial (2007) (0)
- Drug-Eluting Stents: A Potential Preemptive Treatment Choice for Vulnerable Coronary Plaques (2011) (0)
- Drug eluting stents in patients with acute coronary syndromes undergoing percutaneous coronary intervention: The ACUITY trial (2006) (0)
- THE EFFECT OF COMPLEX CORONARY REVASCULARIZATION PROCEDURE IN PATIENTS AT HIGH-BLEEDING RISK (2020) (0)
- Impact of multiple polymorphisms on clinical outcomes after percutaneous coronary intervention (2013) (0)
- IMPACT OF PERCUTANEOUS CORONARY INTERVENTION COMPLEXITY IN REAL-WORLD PRACTICE (2019) (0)
- The GRACE of staged revascularization after primary angioplasty st‐elevation myocardial infarction (2011) (0)
- TCT-311 4-Year Clinical Outcomes in High Bleeding Risk Patients After Surgical or Percutaneous Left Main Coronary Artery Revascularization: The EXCEL Trial (2019) (0)
- INCIDENCE, PREDICTORS AND IMPACT OF POST-PROCEDURAL BLEEDING FOLLOWING IMPELLA-ASSISTED HIGH-RISK PCI (2022) (0)
- UNDERUTILIZATION OF HIGH INTENSITY STATINS IN A CONTEMPORARY HIGH RISK PCI POPULATION (2017) (0)
- TCT-483 Impact of HbA1c Levels on Residual Platelet Reactivity and Outcomes after Coronary Drug-Eluting Stents: The ADAPT-DES study (2014) (0)
- TAVR technology‐size matters! (2013) (0)
- Trends in Vascular Access Site Use and Outcomes in Patients Undergoing PCI. (2023) (0)
- Invasive Management in CAD Patients with Stage 4 Renal Dysfunction or on Dialysis (2015) (0)
- Abstract 16599: Impact of Race and Ethnicity on Long Term Outcomes Post Percutaneous Coronary Intervention With Drug Eluting Stents (2020) (0)
- TCT-266 Predictors of Mortality in Non-Anterior ST-segment Elevation Myocardial Infarction: Insights from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial (2015) (0)
- Interventions in Ischemic Heart Disease (2021) (0)
- Braunwald classification of unstable angina correlates with coronary lesion morphology (1996) (0)
- Atrial fibrillation, bleeding, and coronary intervention: current recommendations (2017) (0)
- IMPACT OF POTENT P2Y12 INHIBITOR USE VERSUS CLOPIDOGREL IN REAL-WORLD PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM A LARGE SINGLE-CENTER REGISTRY (2016) (0)
- PROGNOSTIC UTILITY OF PRE-PROCEDURAL TIMI FLOW IN PATIENTS WITH NON ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROMES UNDERGOING PERCUTANEOUS CORONARY REVASCULARIZATION: THE ACUITY TRIAL (2011) (0)
- Ticagrelor monotherapy after percutaneous coronary intervention in patients with concomitant diabetes mellitus and chronic kidney disease: a TWILIGHT substudy (2021) (0)
- Abstract 13775: Dual vs. Triple Antithrombotic Therapy After Coronary Stenting in Patients With Non-Valvular Atrial Fibrillation (2013) (0)
- IMPACT OF BODY MASS INDEX ON MAJOR BLEEDING AFTER PCI: ONE-YEAR RESULTS FROM THE MULTICENTER PROSPECTIVE PARIS REGISTRY (2013) (0)
- P2262Long-term safety and efficacy of the xience everolimus eluting stent in patients at high bleeding risk: a patient-level pooled analysis from four xience post-approval trials (2018) (0)
- Orbital atherectomy for severely calcified lesions: More dissections in women but similar 30‐day outcomes to men (2016) (0)
- IMPACT OF BIVALIRUDIN PROCEDURAL ANTICOAGULATION IN PATIENTS WITH DIABETES MELLITUS AND ACUTE MYOCARDIAL INFARCTION UNDERGOING PRIMARY ANGIOPLASTY: 3-YEAR RESULTS FROM THE HORIZONS AMI TRIAL (2011) (0)
- Insuficiência renal aguda em pacientes com infarto agudo do miocárdio submetidos a angioplastia primária: uma combinação inquietante (2008) (0)
- OP-EHEA190379 2632..2653 (2019) (0)
- TCT-335 Impact of Age on Sex-Based Differences on Cardiovascular Risk Between Men and Women Undergoing PCI: Results from a Large Single-Center Registry with Over 18,000 Patients. (2016) (0)
- In‐Stent Restenosis in the DES Era (2011) (0)
- TCT-419 Predictors of 5-Year Mortality After PCI: An Individual Patient-Data Pooled Analysis of 32,882 Patients From 21 Randomized Controlled Trials (2019) (0)
- TCT-490 Frequency And Impact Of Nuisance Bleeding On Adverse Events After Percutaneous Coronary Intervention: 2-Year Results From The Patterns Of Non-Adherence To Antiplatelet Regimens In Stented Patients (PARIS) Registry (2014) (0)
- Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS Trial (2021) (0)
- Inside This Issue (2020) (0)
- ONE VERSUS THREE MONTH DAPT IN HIGH BLEEDING RISK PATIENTS WITH OR WITHOUT CHRONIC KIDNEY DISEASE: RESULTS FROM THE XIENCE SHORT DAPT GLOBAL PROGRAM (2023) (0)
- COMPARISON OF THE PROGNOSTIC UTILITY OF VARIOUS CLINICAL AND ANGIOGRAPHIC RISK SCORES IN PATIENTS WITH ACUTE CORONARY SYNDROMES: ANALYSIS FROM THE ACUITY TRIAL (2011) (0)
- Reperfusão em mulheres com IAMCST: um encontro para não chegar atrasado! (2015) (0)
- Chronic total occlusions (2021) (0)
- ONE YEAR CLINICAL OUTCOMES IN PATIENTS WITH CORONARY BIFURCATION LESIONS: RESULTS FROM THE RESOLUTE ONYX BIFURCATION STUDY (2021) (0)
- Long-Term Follow-Up of Attenuated Plaques in Patients With Acute Myocardial Infarction (2012) (0)
- TCT-342 Early Multi-center Clinical Outcomes of a No-Implant Interatrial Shunt for Heart Failure With Preserved and Reduced Ejection Fraction: Latest Results From the Early Feasibility ALLEVIATE-HF Programs (2022) (0)
- TCT-367 2-Year Sequential OCT Follow-up Findings and 3-Year Clinical Outcomes of the New Dual Therapy Endothelial Progenitor Cell Capturing Sirolimus-eluting COMBO Stent: The EGO-COMBO Study (2014) (0)
- 600.09 In-Hospital Outcomes of Patients with Bicuspid Aortic Valve Undergoing Transcatheter Aortic Valve Replacement: A Nationwide Analysis (2019) (0)
- TCT-406 Clinical Impact of DAPT Cessation Within 12 Months of Drug-Eluting Stent Implantation in Caucasians and Minorities: Insights From the PLATINUM Diversity and PROMUS Element Plus Post-Approval Study (2019) (0)
- DAPT Duration After DES (0)
- TCT-18 Clinical and Procedural Predictors and Consequences of Stent Thrombosis Following Drug-eluting Stents for Acute Coronary Syndromes: Results From the ADAPT-DES Study (2013) (0)
- TCT-19 Predictors of Target Vessel Revascularization after Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction: Lessons from HORIZONS-AMI (2014) (0)
- PERFORMANCE OF THE ACADEMIC RESEARCH CONSORTIUM FOR HIGH BLEEDING RISK CRITERIA ACCORDING TO SEX (2020) (0)
- BIG DATA: UMA NOVA FRONTEIRA NA PESQUISA E NA PRÁTICA MÉDICA (2020) (0)
- TCT-839 Prognostic Significance of Established CAD in Patients with Left Main Disease Undergoing Revascularization: Analysis from EXCEL Trial (2017) (0)
- TCT-32 Safety and Efficacy of Biodegradable Polymer Biolimus-Eluting Stents in Patients With Non–ST-Elevation Acute Coronary Syndrome: A Pooled Analysis of GLASSY and TWILIGHT (2021) (0)
- EC 1 Prognosis of Patients with Acute Coronary Syndromes with Elevated Troponin and Patent (2012) (0)
- Abstract WP171: Predictors and Outcomes of Stroke After Trans-Catheter Aortic Valve Replacement in the United States, 2012-2014 (2018) (0)
- TCT-259 Impact of ECG-Defined Infarct Location on Mortality in Patients with STEMI Undergoing Primary PCI: Insights from the HORIZONS-AMI Trial (2015) (0)
- NOVEL HIGH-POTENCY ORAL ANTIPLATELET DRUGS VERSUS CLOPIDOGREL IN PATIENTS UNDERGOING COMPLEX PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM A LARGE SINGLE-CENTER ALL-COMERS REGISTRY (2015) (0)
- Limitación de la aplicación de las puntuaciones de riesgo en la clínica: la importancia de la validación (2019) (0)
- TCT-18 Predictors of LVEF Improvement after Primary Stenting in ST-Segment Elevation Myocardial Infarction: The HORIZONS-AMI trial (2014) (0)
- TCT-499 Prognostic Implications of Pre-procedural TIMI Flow in Patients with STEMI Undergoing PCI with Drug-Eluting Stent Implantation (2018) (0)
- TCT-222 Combined and independent impact of diabetes mellitus and chronic kidney disease on clinical outcomes by SYNTAX score in patients undergoing PCI (2017) (0)
- Impact of high-density lipoprotein levels in males and females undergoing percutaneous coronary intervention with drug eluting stents (2020) (0)
- IMPACT OF SEX ON OUTCOMES AMONG PATIENTS WITH A PREVIOUS CORONARY ARTERY BYPASS GRAFT UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2023) (0)
- TCT-406 Clinical Impact of DAPT Cessation Within 12 Months of Drug-Eluting Stent Implantation in Caucasians and Minorities: Insights From the PLATINUM Diversity and PROMUS Element Plus Post-Approval Study (2019) (0)
- Contrast media: physiocochemic properties, physiologic effects and selection (2005) (0)
- SEX-DIFFERENCES IN THE SAFETY AND EFFICACY OF THE COMBO BIO-ENGINEERED STENT: FROM THE MASCOT POST-MARKETING REGISTRY (2018) (0)
- IMPACT OF POSITIVE AND NEGATIVE CORONARY REMODELING ON CULPRIT LESION MORPHOMETRY: THE ADAPT–DES IVUS SUBSTUDY (2013) (0)
- MULTIMODALITY INTRAVASCULAR IMAGING TO EVALUATE PLAQUE CHARACTERISTICS IN PATIENTS WITH DIABETES MELLITUS (2017) (0)
- Panta rhei, also drug eluting stent technology (2020) (0)
- Angiographic Restenosis at 9 Months in the DIVERGE Trial, a Multi-Center Investigation of a Dedicated Drug-Eluting Bifurcation Lesion Stent (2009) (0)
- Prognostic value of the absolute degree of ST-segment elevation of the ECG at baseline and after primary angioplasty: Analysis from the CADILLAC trial (2003) (0)
- TCT-480 Outcomes in Patients with Non-obstructive Coronary Artery Disease With and Without Cardiac Biomarker Elevations: The ACUITY Trial (2012) (0)
- Abstract 19992: Impact of Successful Percutaneous Coronary Intervention of a Chronic Total Occlusion: Five-Year Outcomes from a 1,781 Patient Multinational Registry (2010) (0)
- Optimizing Therapy for Acute Coronary Syndrome (2015) (0)
- TCT-1 Do Proton Pump Inhibitors Interact With Clopidogrel? Insights From ADAPT-DES (2013) (0)
- Abstract 4509: Individual Patient Risks of Major Bleeding and Myocardial Infarction and Their Implications for Mortality and for Treatment Choice in Acute Coronary Syndromes: Findings From the ACUITY Trial (2009) (0)
- Hybrid PCI: The optimal combination for chronic total occlusions due to in‐stent restenosis? (2014) (0)
- 1101-45 Contribution of stent underexpansion to target lesion revascularization after sirolimus-eluting stenting for in-stent restenosis (2004) (0)
- TICAGRELOR MONOTHERAPY AFTER PCI ACROSS THE SPECTRUM OF HIGH-RISK PATIENTS: A DEEP DIVE INTO THE TWILIGHT TRIAL (2022) (0)
- TCT-492 Impact of Hemoglobin Concentration on Infarct Size in Patients With STEMI Undergoing PCI: Patient-Level Pooled Analysis From 2 Randomized Trials (2019) (0)
- TCT CONNECT-47 Impact of Sex at Birth on Long-Term Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome (2020) (0)
- RELATIONSHIP BETWEEN PLATELET REACTIVITY AND CULPRIT AND NON–CULPRIT LESION MORPHOLOGY: THE ADAPT–DES IVUS SUBSTUDY (2013) (0)
- Abstract 21201: Stent Length Remains an Important Risk for Recurrent Events in Women With or Without Diabetes Mellitus After New Generation DES PCI: From the WIN DES Collaboration (2017) (0)
- Evaluation and Treatment of Patients With Lower Extremity Peripheral ArteryDisease (2015) (0)
- Corrigendum to "Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-year final clinical outcomes from the MASCOT post-marketing registry" [Int. J. Cardiol. 283 (2019) 67-72]. (2019) (0)
- coronary syndromes: results from the ACUITY trial The impact of the coronary collateral circulation on outcomes in patients with acute (2015) (0)
- Abstract 6089: Myocardial Blush Predicts Outcomes in Patients with Acute Coronary Syndromes: An Analysis of the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial (2008) (0)
- TCT-7 Relationship Between Traditional Risk Factors, Platelet Reactivity, and Thrombotic Events: A Mediation Analysis From ADAPT-DES. (2016) (0)
- PREDICTORS OF DUAL ANTIPLATELET THERAPY NON-ADHERENCE AFTER PCI: ONE-YEAR INSIGHTS FROM THE PARIS REGISTRY (2013) (0)
- TCT-246 Characterization of the Actuarial Daily Ischemic Risk in the First Year Following ST-Segment Elevation Myocardial Infarction: Analysis from the HORIZONS-AMI Trial (2013) (0)
- Retreatment immediately after gamma radiation for in-stent restenosis results in need for target vessel revascularization beyond target lesion (2002) (0)
- Tratamiento antitromb�tico sin �cido acetilsalic�lico tras implante de stent: �mito o realidad? (2019) (0)
- Antithrombotic Therapy in Non–ST‐Segment Elevation Acute Coronary Syndromes (2012) (0)
- APIXABAN VERSUS WARFARIN AND ASPIRIN VERSUS PLACEBO ACCORDING TO RENAL FUNCTION AFTER ACUTE CORONARY SYNDROME OR PCI IN ATRIAL FIBRILLATION: INSIGHTS FROM THE AUGUSTUS TRIAL (2020) (0)
- Are Contemporary Femoral Approaches Comparable to Radial ? Experience and data on femoral access best practices and how they stack up against the radial approach (0)
- TCT-19 The Impact of Coronary Lesion Severity on Drug-eluting Stent Outcomes in Patients with and without Diabetes Mellitus (2013) (0)
- P1760Incidence and effects of stroke, MI and bleeding on mortality among patients with ACS undergoing PCI: a comparative analysis from the PROMETHEUS registry (2019) (0)
- TCT-198 Worsening Atrioventricular Conduction After Hospital Discharge in Patients With STEMI Undergoing Primary PCI: The HORIZONS-AMI Trial. (2016) (0)
- EFFECT OF SYSTEMIC INFLAMMATION ON OUTCOMES AFTER COMPLEX PERCUTANEOUS CORONARY INTERVENTION (2019) (0)
- TCT-425 Impact of cerebral protection in aortic stenosis patients treated with transcatheter aortic valve replacement on functional and structural integrity of the brain: results of a combined patient-level analysis of three randomized controlled trials (2017) (0)
- TCT-33 Mortality After Repeat Revascularization Following PCI or CABG for Left Main Coronary Artery Disease: The EXCEL Trial (2018) (0)
- Abstract 19124: Detection and Prevalence of Systemic Atherosclerosis: Results from the High-Risk Plaque (HRP) Initiative (2012) (0)
- TCT-635 Combined and Independent Impact of Diabetes Mellitus and Elevated C-Reactive Protein Levels on Risk for Death and MI Following PCI: Insights From a Large Single-Center Registry (2019) (0)
- Prolonged dual antiplatelet therapy in selected patients with acute coronary syndrome (2022) (0)
- Genetic Polymorphism for Platelet Glycoprotein llla Impact Early and Long-Term Outcomes After Elective Percutaneous Coronary Interventions? (2016) (0)
- LACK OF ASSOCIATION BETWEEN ON–TREATMENT PLATELET REACTIVITY AND ISCHEMIC OUTCOMES IN DIABETIC PATIENTS: ONE YEAR RESULTS OF THE ADAPT–DES STUDY (2013) (0)
- PHYSICIAN CHOICE OF DISCHARGE ANTITHROMBOTIC REGIMEN IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION BASED ON BLEEDING AND ISCHEMIC RISK ASSESSMENT: RESULTS FROM AVIATOR MULTI-CENTER REGISTRY (2014) (0)
- Evaluating the need for a practical risk score to predict major bleeding in acute coronary syndromes (2010) (0)
- Clinical Research Effect of Baseline Thrombocytopenia on Ischemic Outcomes in Patients With Acute Coronary Syndromes Who Undergo Percutaneous Coronary Intervention (2016) (0)
- TCT-53 Abstract Withdrawn (2022) (0)
- TCT-544 Influence of Ischemic and Bleeding Risk Factors on Diabetic Patients Undergoing Percutaneous Coronary Intervention: From the Xience Pooled Registry (2019) (0)
- Reply: "Zero": The New Superhero or Superhero in Training? (2019) (0)
- urgical Versus Percutaneous Revascularization or Multivessel Disease in Patients With cute Coronary Syndromes nalysis From the ACUITY ( Acute Catheterization and Urgent Intervention riage Strategy ) Trial (0)
- IMPACT OF LEFT VENTRICULAR DYSFUNCTION ON OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE AVIATOR REGISTRY (2015) (0)
- TCT-180 Impact of Chronic Obstructive Pulmonary Disease in Patients with Left Main Disease Randomized to PCI vs. CABG: A Propensity Score Matched Analysis From the EXCEL Trial (2017) (0)
- Abstract 3204: Implications of Preoperative thienopyridine Use in Patients With non-ST Elevation Acute Coronary Syndrome Undergoing Coronary Artery Bypass Surgery: One year Results From the ACUITY Trial (2007) (0)
This paper list is powered by the following services:
Other Resources About Roxana Mehran
What Schools Are Affiliated With Roxana Mehran?
Roxana Mehran is affiliated with the following schools:
